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SUMMARY
Initial attempts to isolate the gene encoding Vitamin B12 
receptor protein (jbtuB) from Lactobacillus leichmannii, 
resulted in the isolation of the JbtuB gene from E. coli, due 
to either a cross-over or gene exchange event. 
Complementation of an E. coli JbtuB mutant was demonstrated 
and expression analysis, using both in vivo and in vitro 
systems, revealed the cloned gene to encode a polypeptide 
with an apparent Mr of 66,400 as determined by PAGE. 
Nucleotide sequence data confirmed that the cloned gene was 
identical to the JbtuB gene from E. coli.
The initial 2.0 Kb Hindlll genomic DNA fragment from 
L. leichmannii, which exhibited homology to a synthetic 
oligonucleotide probe (derived from the btuB gene from 
E . coli), was re-cloned into an amplifiable high copy number 
vector in E. coli. The recombinant DNA was found to be 
stably maintained and had not undergone any physical re­
arrangements. Nucleotide sequence data revealed three 
putative open-reading frames, one of which encoded a protein 
which exhibited a degree of homology to the C-terminus of 
the Vitamin B., receptor protein (BtuB) from E. coli. The 
functions of the other two open-reading frames remain to be 
elucidated.
The B. 2 binding protein from L. leichmannii has been 
isolated and purified. It has an Mr of approximately 21,500 
as determined by gel filtration. Polyclonal antibodies were 
raised to it for use in the identification of the desired 
gene product from the cloned L. leichmannii genomic 
fragment. Cross reactivity was found between, the antisera 
to the B1 2 binding protein from L. leichmannii and the B12 
receptor protein (BtuB) from E . coli. The reverse case was 
found to be true also.
Transformation of L . leichmannii was achieved by 
electroporation. Vectors pSA3, pC194, pCKl, but not pAM01, 
transformed the organism to chloramphenicol resistance, 
albeit at low frequency.
XXVI

Préfaça
"The first major phase in the clinical investigation of 
Vitamin B12 (cobalamin) metabolism and its derangements 
began with the development and application of methods for 
the estimation of total B12 in tissues and body fluids and 
the assay of total serum B1 2 has been a routine diagnostic 
procedure for many years. Most of the information available 
by such methods has been gained and it is now clear that we 
are well advanced in the second phase, in which the further 
development and application of methods for the estimation of 
individual cobalamins will play an important part".
Linnell and Matthews, 1984.
In 1963 Lindstrand and Stihlberg, using the technique of 
chromatography and bioautography, showed that human sera or 
plasma contained several cobalamins, the chief form being 
Methylcobalamin. By 1971, Matthews and Linnell had refined 
this technique, which enabled them to quantify by 
photometric scanning crimson-stained spots representing the 
individual cobalamins in blood or tissues (for further 
details, see Section 1.3).
Considerable interest has recently been generated in the 
molecular genetics of Lactobacilli, with the speculation 
that strain improvement can be achieved through recombinant 
DNA technology. The majority of this work has been biased
towards the organisms used in the Dairy Industry and Plant 
fermentation. However, these methods could be applied to 
the development of one of the microbiological assay systems 
used to detect B12 deficiency; the one that utilises the 
gram positive organism, Lactobacillus leichmannii (see 
Section 1.8).
With the vast amount of information available in the 
literature regarding the gene encoding the Vitamin B12 
receptor protein in Escherichia coli and Salmonella 
typhimurium, this investigation focuses on the binding of 
cobalamin in Lactobacillus leichmannii with the aim of 
genetically engineering the organism to recognise different 
serum cobalamin analogues. The final objective being to 
undertake site-directed mutagenesis of the structural gene 
encoding the binding/receptor protein, assess the change in 
specificity and efficiency and re-introduce the modified 
gene into L. leichmannii. This will facilitate the 
differential assessment of the various analogues of B1 2 in 
serum.
With this in mind, this thesis focuses on the application of 
molecular biology to the exploitation of the lactic acid 
bacteria and their component macromolecular systems in 
Vitamin B1 2 assays.
1
Chapter 1 - Introduction
1.1 General Introduction to vitamin B12.
Vitamin B12 is a large, complex, water soluble compound with 
a number of functional groups susceptible to a variety of 
chemical modifications, leading to a tremendous number of 
derivatives.
The structure of the Vitamin B^2 molecule is shown in Figure 
1.1. This molecule (cobalamin) consists of two major parts; 
the core, which is almost identical to the haem of 
haemoglobin, other than that the attached metal is cobalt, 
not iron (and one of the a methane bridges is missing) ; and 
a nucleotide, which is set nearly at right angles to the 
core (corrin) portion.
The corrin nucleus is the central structure of all the 
corrinoids, the latter being cobalt-containing cyclic 
structures in the human body, in foods of animal origin 
(meat, poultry, eggs, fish and milk) and in bacteria, which 
make not only Vitamin B12, but also various analogs thereof. 
To use it as a vitamin, the human cell must see it as 
depicted in Figure 1.1 i.e. as a cobalamin with no 
alterations except in the R-adduct.
Cyanocobalamin, one of the most widely known forms of 
Vitamin B12, is obtained by cyanide treatment of all other 
naturally occurring forms. Among the 0-ligands known, the
nh2
°“9
R- CoCxjiomin
Figure 1.1 The Structural Formula of Vitamin B
(taken from Herbert, 1988).
12 '
-R PERMISSIVE NAME
-CN cyanocobalamin
-OH hydroxcobalamin
-h 2o aquacobalamin
-n o 2 nitritocobalamin
-c h3 methylocobalamin
5'-deoxyadenosyl 5'deoxyadenosylcobalamin 
(coenzyme B12)
3
cyanide has the highest affinity for cobalt, since the 
attachment of CN does not require reduction of the cobalt. 
Basic data of some selected corrinoids can be found in Table 
1 . 1 .
Methylcobalamin and adenosylcobalamin are photolabile 
compounds. From the practical point of view, the light 
sensitivity of MeCbl and AdoCbl is rather undesired, since 
many experiments with these compounds, such as estimation, 
purification and the work with enzyme systems have to be 
done in the dark or in dimmed red light. However, they are 
far less photolabile as solids. Prolonged irradiation by 
sunlight inactivates irreversibly all forms of cobalamin.
All eukaryotic animal cells and most prokaryotic cells 
require Vitamin B12 coenzymes to sustain activity and 
viability. Although more than ten B12-dependent enzymes or 
enzyme systems have been isolated from bacteria, only two of 
them have been found in man. These two enzymes require for 
activity two different forms of Vitamin B12: 5' 
deoxyadenosyl cobalamin (Ado Cbl) for methylmalonyl CoA- 
mutase and methylcobalamin (MeCbl) for homocysteine- 
transferase. Each cobalamin coenzyme is formed by a unique 
and complex reaction sequence that results in the formation 
of a covalent carbon-cobalt bond between the central cobalt 
nucleus of the cobalamin molecule and the ligand, either a 
methyl group or 5'-deoxy-5'-adenosyl moiety, which confers 
coenzyme specificity.
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Finally, a word about terminology, since some authors use 
the more familiar 'Vitamin B12', whereas others refer to the 
vitamin as 'cobalamin'. According to the current 
recommendations (IUPAC-IUB Commission on Biochemical 
Nomenclature, 1975), the general term 'cobalamin' should be 
used except when a specific compound, such as 
methylcobalamin is meant.
1.2 Medical aspects of Vitamin B1=.
Vitamin B12 was applied in medicine in the early twenties, 
when two American physicians Minot and Murphy obtained 
positive results in curing pernicious anaemia with a liver 
diet. This disease was reported as early as 1824. It 
remained fatal, however, until this discovery.
Liver contains an appreciable concentration of Vitamin B12 
and this served for the next two decades as the main source 
of the then unknown curing factor, also known as the 
'extrinsic factor'.
Vitamin B12 was obtained in pure crystalline state in 1948 
and its structure was elucidated in the following years.
The production of Vitamin B12 on an industrial scale in the 
early fifties enabled its world-wide application in medicine 
to treat pernicious anaemia.
7*•3 Vitamin B12 deficiency and its detection.
A deficiency of Vitamin B12 strikes two systems
(i) Red blood cells fail to mature, megaloblasts collect in 
the bone marrow, the patient becomes anaemic and 
anaemia can progress to death;
(ii) The nervous system commonly suffers damage to the 
spinal cord, peripheral nerves and the white matter of 
the brain. Patients may suffer numbness and tingling, 
stabbing sensations, poor coordination of the legs and 
fingers, weakness, paralysis, convulsions and many 
other symptoms secondary to neurological damage. It is 
thus essential that the deficiency is quickly detected.
Assays of serum cobalamin (Cbl) came into use in the 1950's, 
although for a number of years they were performed only by 
specialised laboratories. For a time, serum Cbl levels were 
measured only by microbiological assays using either;
Lactobacillus leichmannii (Rosenthal & Sarrett, 1952)
or
Euglena gracilis (Ross, 1950) 
or less frequently,
Ochromonas malhamensis (Ford, 1953)
8or a cobalamin/methionine auxotrophic mutant of
Escherichia coli (Davies & Mingioli, 1950).
The assay procedure using O. malhamensis has been considered 
the most specific, since this organism is supported almost 
exclusively by cobalamins, whereas cobalamins and certain 
other corrins support the growth of the three other 
organisms.
Vitamin B12 normally present in blood is mainly combined as 
a labile complex with the a globulin fraction of serum 
protein (Pitney et al, 1954). In all methods of estimation, 
it is necessary to extract the substance, this being easily 
performed by boiling.
Ross (1952) devised a method of estimating the B12 content 
of human body fluids by measuring turbimetrically, after 
seven days incubation, the growth of E. gracilis v. 
bacillaris. The extract was prepared by boiling at pH 3.6, 
when protein precipitation does not occur. However, alkali 
production by the Euglena cells caused a rise in pH of the 
culture with consequent protein precipitation during 
incubation. To overcome this, Hutner et al, 1956 produced a 
richer and better buffered culture medium and by using a 
more rapidly growing strain of Euglena gracilis, obtained 
satisfactory results in 5-6 days. In 1964, Anderson 
described a modified Euglena method, for the assay of B12 in
9
serum. Sub-normal serum B12 concentrations could be 
detected visually as early as 24 hours after the start of 
the assay. For diagnostic purposes, the assay can be read 
at 3 days, provided that appropriate dilutions are used, 
conditions are optimal and growth is measured in a 1 cm 
cell.
There are several advantages of using the Euglena assay, in 
that it is very sensitive, highly specific and because whole 
serum is often used, preliminary extraction is unnecessary 
and direct measurements of both bound and free B12 can be 
made. However, various factors such as medium, light and 
inoculum can affect growth in aqueous and serum solutions 
differently and are an important cause of variations between 
batches and laboratories. Thus, growth conditions need 
careful control and the technique can be tedious and time 
consuming due to elaborate procedures required for cleaning 
of glassware.
In 1955, Spray reported an improved method for the rapid 
estimation of Vitamin B12 in serum. In Rosenthal and 
Sarett's original method, the assays were read by titrating 
the acid produced by L . leichmannii after 3 days' 
incubation. In 1954, Girdwood had modified the original 
method by using turbidity measurements to assess bacterial 
growth, but he did not give sufficient data to allow a 
critical assessment to be made of the validity of the 
results by turbidimetric modification. Spray's study led to 
the development of an improved culture medium and a more
from serum. Thisreliable method of extracting Vitamin B12 
method gave rather higher results than were obtained using 
Euglena and was not as specific, but had the advantage of 
being able to provide a result in 24 hours. Variations of 
this basic method have been used by many laboratories 
(Matthews, 1962; Raven et al, 1972).
L. leichmannii has a nutritional requirement for a cobalamin 
or cobamide, which can, however, be replaced by a 
deoxyribonucleoside (Kitay et al, 1950). As shown in Table
1.2, any of the five conventional deoxyribonucleosides can 
replace cobalamin in the culture medium, whereas 
ribonucleosides and pentoses have no such effect.
Since L. leichmannii lacks an absolute Cbl requirement, it 
is theoretically possible that unknown samples submitted for 
Cbl analysis could give falsely high results if the sample 
contained one or more deoxyribonucleosides. Studies by Beck 
(1983) on human serum samples have shown that 
deoxyribonucleosides do not occur in quantities sufficient 
to influence the growth of L . leichmannii.
Although it has always been recognized that the 
microbiological techniques are complex and require the use 
of standard sera, they are precise and reproducible (Mollin 
et al, 1976) and are consistently able to diagnose Vitamin 
B12 deficiency. They are, in addition, particularly 
valuable in the diagnosis of Vitamin B12 neuropathy.
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Table 1.2 Nutritional requirement <?( Lactobacillus leichmannii 
(ATCC 7830) for Vitamin B12 (cyanocobalamin) of a 
deoxvribonucleoside.
(taken from Beck, 1983).
Additions to 
assay medium
Turbidity3
None 0
Cyanocobalamin 127
Thymidine 105
Deoxycytidine 119
Deoxyadenosine 92
Deoxyuridine 100
Deoxyguanos ine 112
Deoxyribose 0
Cytidine 0
Adenosine 0
Uridine 0
Guanosine 0
a Turbidity was determined in a Klett colorimeter (Filter 66) 
after cultivation for 8 hours. Final concentrations of 
additions were: cyanocobalamin 0.5 ng ml-1, 
deoxyribonucleosides and ribonucleosides 2.5 ng ml-1 and 
deoxyribose 5.0 nq ml-1. All cultures contained optimal 
concentrations of free purines and uracil.
However, the traditional microbiological assay procedure has 
been replaced increasingly by radioisotope dilution (RID) 
assays, especially in the form of commercial kits. RID 
assays involve extraction of bound cobalamin from a sample 
of serum, its conversion to cyanocobalamin and after mixing 
with a known quantity of radioactive cobalamin, its 
association with a cobalamin ligand with high affinity for 
the vitamin (Mollin et al, 1976; Gottlieb et al, 1965).
This introduction provided an alternative test with the 
apparent advantages of being convenient, easy to perform, 
whilst providing rapid results. They did, however, throw up 
unexpected problems. The results with the RID assays tended 
to be higher than those with microbiological assays (Mollin 
et al, 1976) and more recent work (Hall, 1977; Mahood, 1977; 
Cooper & Whitehead, 1978; Kolhouse et al, 1978 & Mollin et 
al, 1980) has cast doubts on their reliability in 
distinguishing untreated pernicious anaemia from normal.
Kolhouse and colleagues (1978) showed that higher results 
were obtained when the assay employed a B12 binding protein, 
present in all body fluids, termed R-binder, as compared to 
an assay using gastric intrinsic factor (IF) which was 
purified to remove R-binder. Indirect evidence suggested 
that the R-binder detected B12 analogues in addition to 
those detected with an IF assay. Since then, it has been 
shown that the forms of B12 detected in an IF-based assay 
are identical to those measured by microbiological assay 
(Chanarin & Muir, 1982).
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Muir and Chanarin (1983) investigated the competitive 
binding of cobalamin analogues to the B12 binding proteins 
and sought to determine their carrier proteins in normal 
serum. They found that both binding agents were egually 
effective in removing [57Co] B12 from aqueous solution. IF 
was more effective than R-binder in removing [57Co] B12 
added to a serum extract. They found that IF bound both 
types of cobalamin, though the binding was less avid for the 
microbiologically inactive analogues, than for 
microbiologically active analogues.
Oxley (1984) supported this work when he reported the 
findings of the Ligand Assay Resource Committee (LARC), when 
they decided to determine whether the presence of R proteins 
in assay kits was capable of introducing significant errors 
in the Vitamin B12 assays used. The data provided strong 
empirical support for the hypothesis that radioligand assays 
yield higher results than bioassays because the former 
measure both active and inactive cobalamins.
Fish and Dawson (1983) assessed fourteen commercial kits as 
serum B12 assays. The analytical performance and clinical 
correlations were used to rank the methods employed for the 
extraction of the vitamin from its binders and for 
separation of 'bound' from 'unbound' counts. The 
introduction of extraction without boiling and the 
separation by attachment of the B12 binder to a solid matrix 
have not been shown to be generally better or worse than 
conventional methods.
As mentioned previously, Matthews and Linnell (1971) 
developed a technique of chromatography and bioautography.
Cobalamins are extracted from the sample with hot ethanol.
After freeze-drying, the extract is desalted by solvent 
extraction, concentrated in water and the cobalamins 
separated by thin layer chromatography on cellulose/silica 
gel. Cobalamins on the chromatogram (5-50 pg per spot) are 
detected bioautographically by incubating the plate in 
contact with a layer of agar medium inoculated with a 
cobalamin-sensitive strain of Escherichia coli and a growth 
indicator. Crimzon zones appear on the bioautogram, which 
are quantified by transmitted light in a scanning 
densitometer, and compared with appropriate standards (see 
Figure 1.2).
In simple cobalamin deficiency, due, for example, to 
pernicious anaemia, there is a striking and disproportionate 
reduction in the plasma MeCbl, which occurs while the total 
plasma Cbl is still within normal limits and may therefore 
be a better indicator of cobalamin status than the 'serum 
B1 2 ' level alone (Linnell and Matthews, 1984).
Herbert concluded in 1985 that the key to reliable results 
appeared not to reside in a particular assay, but rather in 
determining for each assay, its own range of results in 
participants determined clinically and morphologically 
normal versus participants with deficient Vitamin B12 (with 
b12 deficiency defined independently of a serum B12 assay).
When laboratory assay results differ from clinical
I
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Figure 1.2 Plasma cobalamins separated by two-
dimensional chromatography and bioautographv■
(taken from Linnell & Matthews, 1984).
(a) Normal subject (total Cbl 460 pg ml *) .
(b) Patient with untreated pernicious anaemia. MeCbl is 
disproportionately reduced (total Cbl 80 pg ml-1) .
(c) Patient with untreated tropical ataxic neuropathy.
CNCbl is abnormally increased and accounts for 24% of 
the total Cbl (total Cbl 635 pg ml-1) .
(d) Child with untreated homocystinuria and methylmalonic 
aciduria due to congenitally impaired synthesis of both 
cobalamin coenzymes; note the disproportionate 
reduction in plasma MeCbl (total Cbl 1150 pg ml-1).
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judgement, further evaluation is the appropriate course. 
There is no 'gold standard' for human serum Vitamin B12 
assays.
During the last decade, dietary supplements containing 
vitamins have become more popular and there is a need for a 
fast and sensitive method for the routine analysis of 
Vitamin B12 in these products and other foods. 
Microbiological assays using L. leichmannii or other 
microorganisms are the most widely used methods for 
measuring Vitamin B12 concentration in food. However, this 
technique is rather time consuming and for some time, RID 
methods have been commonly used for the determination of B12 
in serum (Pratt & Woldring, 1982) .
Osterdahl and Johansson reported the development of a rapid 
and sensitive method for the determination of Vitamin B12 in 
dietary supplements (1988a), using a commercially available 
RID kit (Becton Dickinson Immunodiagnostics) . They also 
compared two RID kits for measuring Vitamin B12 in gruel 
(1988b).
1.4 Non-enzvmatic Vitamin B1= binding proteins.
The absorption and transport of Vitamin B12 in man and 
animals is exclusively mediated by proteins. That Vitamin 
B12 in serum is bound to protein (Rosenthal & Sarrett, 1952; 
Pitney et al, 1954) has been known since shortly after the 
isolation of the vitamin. In 1968, Herbert suggested that
I—
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ingested or injected Vitamin B12 attaches both to a- and 0- 
globulin binding proteins, but that which is attached to 0- 
globulin is delivered to tissues within twenty four hours, 
whereas that attached to «-globulin is retained by the 
serum. While both B12-binding globulins may deliver the 
vitamin to reticulocytes and the liver (Retief et al,
1967) - and presumably other tissues as well - Herbert's 
studies suggest that the B12-binding 0-globulin is primarily 
a transport protein (Retief et al, 1967), whereas the B12 
binding a-globulin functions mainly to conserve the vitamin. 
B12 binding a-globulin has a greater affinity for B12 and 
retains the vitamin more tenaciously than does the B12 
binding 0-globulin (Retief et al, 1966).
These binding proteins were named differently by different 
authors and it was not until 1979 when the name 
transcobalamin was commonly accepted.
Transcobalamin II (TCII) is a protein present in trace 
amounts in human plasma that binds B12; it is characterised 
by a molecular size of slightly less than 40,000, a fast 
electrophoretic mobility and an immunologic specificity that 
separates it from all other known B12 transport proteins 
(Hall, 1969) . The other B12 transport protein of human 
plasma known at the time, then referred to as the B12 
binding protein, but now known as TCI, did not take up much 
of the recently absorbed B12. This led to the concept of 
two transport proteins carrying B12 in the plasma for 
separate purposes (Hall & Finkler, 1965) . In 1971, Hall and
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Finkler presented evidence to suggest an active transport 
role for TCII by transferring B12 rapidly from the blood to 
tissue in vivo.
Cobalamin transport in man is very complex and the reader is 
referred to a review (Sennett et al, 1981).
Cobalamin uptake and transport has been observed in a 
variety of bacterial species, but has been studied in detail 
only in Escherichia coli. Although exogenous cobalamins are 
not essential for growth of wild-type E. coli, a process 
exists that facilitates uptake of this group of compounds.
1.5 Vitamin B12 transport in E . coli.
The uptake systems for Vitamin B12 anc* numerous iron- 
siderophore complexes in E. coli are unusual in that they 
employ specific receptor proteins in the outer membrane as 
an essential component of the high-affinity active transport 
process (Neilands, 1982). The uptake of cyanocobalamin (CN- 
Cbl) by cells of E. coli is biphasic consisting of an 
initial rapid phase of B12 binding to specific receptors on 
the outer membrane of the cell envelope which is essentially 
independent of the energy metabolism of the cell, followed 
by a slower energy dependent secondary phase in which the 
B12 is transferred from these receptors into the interior of
the cell.
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In E. coli strains used, White et al (1973) showed that the 
competitive inhibition of CN-[60Co] B12 uptake was obtained 
with unlabelled cyanocobalamin, methylcobalamin, 
deoxyadenosyl cobalamin and cyanocobinamide. The values 
indicated that the initial B12-binding sites can recognize 
each of these corrinoids equally well. The only corrinoid 
tested which was apparently not recognized by the initial 
B12-binding sites was cyanocobalamin 5'-phosphate. White 
and colleagues (1973) suggested that perhaps the B12 
receptors on the outer membrane of the E. coli cell envelope 
serve only as a trap to sequester trace amounts of B12 from 
the growth medium. Such a trapping function may well be the 
primary role of the B12 binding protein found in cell walls 
of Lactobacillus leichmannii (Sasaki, 1972), since the 
studies of Scherrer and Gerhardt (1971) on the effective 
pore sizes of cell wall mucopeptide structures in another 
gram-positive organism, Bacillus megaterium, indicate that 
such matrices are permeable to molecules of B12 size. 
However, it is unlikely that the outer membrane of E. coli 
is permeable to Vitamin B12 and therefore the B12 receptor 
probably also serves to transport B12 across this structure.
Subsequent work led to the proposal of a relatively simple 
model for uptake of cobalamins by coliforms. According to 
this model, shown schematically in Figure 1.3, cobalamin 
uptake proceeds first by the rapid binding of cobalamin to 
an outer membrane receptor. Di Girolamo and Bradbeer (1971) 
reported that the B12 binding site on the cell surface has a 
very high affinity for Vitamin B12. Subsequently, there is
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Figure 1.3 proeosed_pM2lwa2_oI_uEtake_oi_cobMamin_bY
E . coli.
The outer membrane of the bacterial envelope is shown by the 
dashed line; the inner membrane by the solid line; and the 
periplasmic space by the space between the two membranes, 
expanded at left. PCB, periplasmic cobalamin binding 
protein; AdoCbl, adenosylcobalamin; MeCbl, methylcobalamin. 
See text for details.
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The receptor protein for Vitamin B12 (cyanocobalamin) which 
is located in the outer membrane of E. coli is encoded by 
the gene btuB.
1.5.1 BtuB in E. coli.
The btuB gene product is a protein with a molecular weight 
of 66,400 daltons, which is located in the outer membrane of 
E. coli (Heller & Kadner, 1985; Heller et al, 1985). It 
serves as a high affinity (K^ =0.3 nM) receptor for Vitamin 
B12 (Holroyd & Bradbeer, 1984). After its initial binding 
to the BtuB protein the cobalamin was thought to be released 
from the receptor to the periplasmic space in a process for 
which at least the proton motive force and the tonB gene 
product (see later) were required (Bradbeer & Woodrow,
1976) .
This property, shared by several iron transport systems 
makes BtuB fundamentally different from the major porin 
proteins OmpF, OmpC and LamB (Nikaido & Vaara, 1985).
Besides its role in Vitamin B12 transport, BtuB is a 
receptor for phage BF23 (Bradbeer et al, 1976), the E 
colicins (Di Masi et al, 1973) and in association with OmpF 
and lipopolysaccharide, for colicin A (Cavard & Lazdunski, 
1981; Chai et al, 1982). Whereas the uptake of Vitamin B12
a slower release of cobalamin into the interior of the cell,
an event probably requiring two additional steps.
by means of the btuB encoded B12 receptor is tonB dependent, 
the entry of the E colicins and phage BF23, which use the 
same receptor is not (Bassford et al, 1976; Bradbeer et al, 
1976; Davies & Reeves, 1975). These activities seem to be 
only transitory in vivo and restricted to a particular sub­
class of BtuB proteins; most probably those which are newly 
synthesized and not evenly distributed within the outer 
membrane. However, cells retain full activity for Vitamin 
B12 uptake (Kadner & McElhaney, 1980).
In fact, at least twelve different ligands, some of which 
are closely related bind, to the BtuB protein. In doing so, 
they exhibit competitive binding kinetics, in that 
interaction with one ligand prevents the binding of a second 
(Bradbeer et al, 1976; Di Masi et al, 1973).
Previous studies have suggested that Vitamin B^2 is involved 
in the repression of the btuB gene (Kadner, 1978). Growth 
in the presence of 100 nM B12 reduces the B12 uptake by as 
much as 90%. BtuB is usually found at a low level (200 - 
300 copies per cell) when Vitamin B12 is omitted from the 
culture media (Di Masi et al, 1973).
There is also good evidence to suggest that B12, in the 
presence of the genes encoding methyltransferase, metH and 
metF, represses the gene encoding homocysteine 
transmethylase (metE) (Mulligan et al, 1982). The 
methionine (met) regulon of E. coli consists of eleven 
genetic elements (Rowbury, 1983). The last step in the
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synthesis of methionine in E. coli and S. typhimurium is the 
methylation of homocysteine (Rowbury, 1983). This reaction 
is carried out by either of two transmethylase enzymes. One 
is a Vitamin B12_independent enzyme (metE gene product) and 
the other is a Vitamin B12-dependent enzyme (metH gene 
product). The methyl group for this reaction is donated by 
5-methyltetrahydrofdate, which is produced by the metF gene 
product.
metE, F and H genes, as well as all other genes of the 
methionine pathway are negatively regulated by the metJ gene 
product, with 5-adenosylmethionine as the co-repressor. 
However, recently Urbanowski et al, 1987 reported the
presence of another met regulatory locus (metR) in both E. 
coli and S. typhimurium. This genetic data suggests that 
metR codes for the transactivator protein for the expression 
of the metE gene and to a lesser extent, the metH gene that 
codes for the B12 dependent methyltransferase.
Until recently, the nature of the regulation of btuB by 
repression was not understood and no regulatory gene had 
been identified. It was thought that the putative repressor 
was produced in appreciable amounts and was not titrated out 
by multiple copies of its target.
Lundrigan et al, 1987 obtained mutations which defined a new 
gene btuR, required for repression of btuB. It appears to 
encode a repressor of btuB transcription, but has no 
apparent role in the biosynthesis of methionine or in the
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transport of Vitamin B12. The 9ene is not located near any 
of the genes of methionine or Vitamin B12 transport.
Cellular levels of the BtuR repressor and the location of 
the operator site on the cloned btuB region are presently 
under investigation.
Earlier this year Lundrigan and Kadner published results to 
suggest that BtuR does not in fact regulate jbtuB expression 
directly, but that it may be involved in adenosylcobalamin 
metabolism (Lundrigan & Kadner, 1989) .
Very little is known about the structure of BtuB, the 
location of the ligand-binding sites and other functions, or 
its orientation in the outer membrane. BtuB has been 
purified by several techniques. However, purification is 
complicated by the existence of complexes between the 
receptor and porin proteins (Imajoh et al, 1982).
The low level of production of the receptor poses another 
problem for biochemical investigations (Di Masi et al,
1973) .
What is known, is that BtuB has a relatively polar 
composition but lacks substantial regions of hydrophobic 
character long enough to span a membrane in the a-helical 
conformation. Genetic approaches may help identify regions 
of BtuB, which are important in substrate binding and 
transport or in targeting the protein to the outer membrane.
Several groups have indeed been working in this area in 
recent years.
Gudmundsdottir et al, 1988 reported that several receptor 
domains are involved in substrate binding and energy 
coupling, since none of the mutations they constructed 
(linker insertions in jbtuB) affected the entry of only one 
type of ligand.
It has also been suggested that the protein has a binding 
site for calcium, since the binding and transport of CN-Cbl, 
appears to be calcium dependent (Bradbeer et al, 1986).
In 1982, Hunter and Glass reported studies using information 
suppression of jbtuB nonsense mutants which allowed the study 
of the effect of known, single amino acid substitutions on 
receptor function. They reported that ligand uptake was 
largely unaffected by such amino acid changes. The few 
instances in which certain substitutions destroyed 
sensitivity to two lethal agents (phage BF23 and colicin E3) 
without affecting B12 uptake suggested a common region on 
the jbtuB receptor involved in the binding of these 
proteinaceous agents.
In 1985, Heller et al, showed that twelve amino acids could 
be removed from the C-terminus by a PstI deletion of their 
cloned btuB gene and yet it was still capable of imparting 
sensitivity to phage BF23 despite being defective in Vitamin 
Bi2"binding activity.
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Moir and colleagues (1987) found that altering the C- 
terminus of the btuB gene product prevented its function as 
a receptor, as did Heller and his colleagues. However, it 
did not prevent receptor export and this data argues 
strongly that at least 216 C-terminus residues are not 
reguired for transfer to the outer membrane. However, this 
region may be necessary for correct localisation in the 
envelope.
It was mentioned earlier that the transport of Vitamin B12 
was a biphasic process. Its transport across the 
cytoplasmic membrane of E. coli reguires the products of 
btuC and btuD, two genes in the btuCED operon.
1.5.2 BtuCED operon in E. coli.
The btuCED genes appear to be organised as an operon with 
internal promoters. This type of genetic organisation 
suggests that the three genes are involved in a common 
metabolic process and that btuE might be the periplasmic CN- 
Cbl binding protein. However, Rioux and Kadner (1989a) have 
examined the role of the btuE gene and despite its genetic 
location in the transport operon, the btuE product plays no 
essential role in Vitamin B12 transport. Although transport 
is not dependent on BtuE, uptake may still be dependent on 
this periplasmic binding protein. If so, this situation 
would represent a novel type of genetic organisation for 
this type of transport system.
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The btuC gene, has been found to influence Vitamin B12 
uptake or utilisation. The btuC function is required for 
the growth response to Vitamin B12 when the outer membrane 
transport process (jbtuB and tonB function) is defective. 
However, even in a wild-type strain, jbtuC is required for 
proper transport of Vitamin B12 (DeVeaux & Kadner, 1985).
In contrast to the genes btuB and tonB, btuC appears to have 
no known function apart from its involvement in cobalamin 
transport. Mutants in this locus were first isolated and 
characterised by Di Girolamo et al, in 1971, who showed that 
such strains, which were also metE, required increased 
concentrations of cobalamin in the medium for growth in the 
absence of added methionine and displayed several changes in 
cobalamin uptake. These changes included greater 
exchangeability of cellular cobalamin with exogenous 
cobalamin, a reduced energy-dependent phase of cobalamin 
transport and reduced conversion into coenzyme forms of the 
cobalamin taken up.
Reynolds and her colleagues concluded from their results 
that the proton motive force and the tonB gene product are 
involved in the release of cobalamin from the outer membrane 
receptor and that the btuC gene product is necessary for 
cobalamin transport across the inner membrane.
Mutations in btuD confer a less extreme deficiency in 
Vitamin B12 utilisation than do btuC mutations, although 
transport was strongly impaired (DeVeaux & Kadner, 1985).
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The btuCED region may encode a transport system for passage 
of Vitamin B12 across the cytoplasmic membrane. This system 
bears similarities to periplasmic binding protein-dependent 
transport systems, although the putative periplasmic 
component is not required for its function.
The products of btuC, btuD and btuE were identified in maxi 
cells as polypeptides with relative molecular masses (Mr) of 
26,000, 29,000 and 22,000 respectively (DeVeaux et al,
1986), approximating to the sizes predicted from the 
nucleotide sequence (Friedrich et al, 1986).
Fractionation of maxicells indicated that both BtuC and BtuD 
are membrane associated. A substantial portion of BtuE was 
released by procedures that preferentially extract 
periplasmic proteins. However, no obvious signal sequence 
was present at the amino-terminus of the predicted 
polypeptide.
Previous evidence showed that a periplasmic Mr 22,000 
polypeptide was released by osmotic shock and bound Vitamin 
B12 with high affinity, but no direct evidence was presented 
for its role in transport (Taylor et al, 1972; Bradbeer et 
al, 1978).
Recent work by Rioux and Kadner (1989a) showed that non­
polar, in-frame deletions in btuE showed that the absence of 
the btuE product had no significant effect on the binding,
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transport or utilisation of CN-Cbl or its derivatives, 
whether the outer membrane BtuB/TonB system was active or 
not. The Vitamin B12 binding activity that is still present 
at wild-type levels in osmotic shock fluids of btuE mutants 
is likely to be encoded outside btuCED.
They also found an error in the published sequence of btuC.
A C residue should be inserted at position 1012 of the 
sequence described by Friedrich et al, 1986 (see Figure 
1.4). This results in extension of the gene from 292 codons 
ending at nucleotide 1031 to 327 codons ending at nucleotide 
1133, to give an Mr of 35,000.
1.6 Vitamin B1= transport in S. tvphimurium.
The enteric bacteria Salmonella typhimurium and E. coli 
possess two enzymes that are known to use Vitamin B12 as a 
cofactor; tetrahydropteroyl-glutamate methyltransferase and 
ethanolamine ammonia lyase (Cauthen et al, 1966; Chang & 
Chang, 1975; Foster et al, 1964). The first is a methionine 
biosynthetic enzyme (encoded by the metH gene) for which a 
cobalamin-independent alternative (encoded by the metE gene) 
exists (Childs & Smith, 1969). The second is required only 
if the cells are using ethanolamine as a carbon or nitrogen 
source.
The in vivo activities of these enzymes depend upon the 
cells being provided with an exogenous source of the 
vitamin. This nutritional requirement for a preformed
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Figure 1.4 DNA sequence of fetuCEP.
(from Friedrich et al, 1986).
The non-coding strand is presented and the predicted 
polypeptide sequence of the open reading frames is shown in 
one-letter code above the DNA sequence. The numbering 
begins at the SmaI site located at the 3' end of himA. Some 
regions of local dyad symmetry are underlined with arrows. 
Lines are drawn over potential promoter sequences, and 
putative Shine-Dalgarno sequences are enclosed in boxes.
31
corrinoid ring has led to the generally held belief that 
enteric bacteria are unable to synthesise cobalamin de novo. 
However, Jeter et al, 1984 reported that S. typhimurlum 
synthesised cobalamin de novo under anaerobic culture 
conditions.
The process of Vitamin B12 transport in Salmonella 
typhimurium is thought to be similar to that in E. coli. 
Rough strains of S. typhimurium are susceptible to phage 
BF23 and the E. colicins (Guterman et al, 1975). Resistance 
to these lethal agents results from mutations in bfe 
(susceptibility to phage BF23 and the E. colicins), which is 
located at the position on the S. typhimurium chromosome map 
analogous to that of the E. coli btuB gene. In the latest 
version of the S. typhimurium genetic map (Sanderson & Roth, 
1988), the bfe locus was renamed btuB.
Rioux and Kadner (1989b), investigated the involvement of an 
outer membrane transport component for Vitamin B12 uptake in 
S. typhimurium analogous to the btuB product in E. coli. An 
Mr 60,000 protein in the S. typhimurium outer membrane was 
repressed by growth with Vitamin B12 and was eliminated in a 
btuBg mutant. The JbtuBg product thus appears to play the 
same role in Vitamin B12 transport by S. typhimurium as does 
the E . coli JbtuBE product.
They also reported that S. typhimurium has also a low- 
affinity transport system, which allows entry of cobalamins 
but not of cobinamide, which suggests that it differs in
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substrate specificity from BtuB. Cobalamin binding was of 
low affinity and showed no saturation even at 100 nM CN-Cbl. 
This new system appears to mediate transport only across the 
outer membrane, since cobalamin uptake still requires all of 
the components involved in passage across the cytoplasmic 
membrane, and it is unlikely that the new transport system 
is tonB dependent.
The low affinity and capacity for CN-Cbl suggests that some 
other nutrient may be the primary substrate of this 
transport system and that cobalamins enter by being poor 
analogues of this substrate. A likely substrate could be an 
iron siderophore, since the uptake of iron siderophores 
requires an outer membrane transport component, similar to 
that of Vitamin B12.
The uptake and transport of iron bears many resemblances to 
that of Vitamin B12 and therefore it is necessary at this 
point to include some detailed information on the transport 
of iron in E. coli, in order to show the features common to 
both systems.
1.7 Iron transport in E. coli.
Most substrates taken up by E. coli pass through the outer 
membrane via water-filled pores formed by proteins 
designated porins (Benz, 1988). However, these pores are 
inactive for the uptake of iron (III) siderophores or 
Vitamin B12. These compounds bind to specific outer
membrane receptor proteins and are released into the 
periplasm in a TonB and energy-dependent process.
Schôffler and Braun (1989) proposed a model in which the 
activity of the FhuA (formerly TonA) receptor is regulated 
by the energized state of the cytoplasmic membrane and that 
TonB forms the coupling device between the outer and the 
cytoplasmic membrane (Hantke & Braun, 1978). According to 
this model, TonB assumes different conformations in response 
to the energized state of the cytoplasmic membrane, thereby 
allosterically regulating the conformation of FhuA.
A similar model was developed for the uptake of Vitamin B12 
across the outer membrane, which has been mentioned 
previously (Reynolds et al, 1980). This model gained 
support by a mutation in the structural gene (btuB) of the 
Vitamin B12 receptor. Vitamin B12 was absorbed, but was not 
transported into cells carrying the btuB 451 mutation. This 
mutation could be suppressed by two mutations in tonB, 
suggesting a physical interaction between the receptor and 
the TonB protein (Heller et al, 1988). The single amino 
acid replacement in the Vitamin B12 receptor was located 
close to the aminoterminal end in which a consensus sequence 
called the 'TonB-box' is found in all receptor proteins 
involved in TonB-dependent transport systems (Coulton et al, 
1986; Heller & Kadner, 1985; Lundrigan & Kadner, 1986; 
Pressler et al, 1988 and Sauer et al, 1987).
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The fhuA gene encodes an outer membrane protein which is an 
essential constitutent of the ferrichrome transport system. 
The FhuC, D and B proteins catalyse the transport of 
ferrichrome and of other Fe3+-hydroxamate compounds from the 
periplasm, through the cytoplasmic membrane, into the 
cytoplasm (Hantke, 1983). The FhuC protein was found in the 
cytoplasmic membrane (Fecker & Braun, 1983). The fhuC 
sequence revealed a rather hydrophilic protein displaying a 
strong homology to ATP-binding proteins (Coulton et al,
1987). Such proteins were found in transport systems for 
certain sugars, peptides and amino acids, which depend on 
periplasmic binding proteins (Ames, 1986).
This was taken as evidence that transport of ferrichrome 
across the outer membrane may follow a periplasmic binding 
protein dependent transport mechanism (PBT). Recently 
sequences homologous to ATP-binding proteins were also found 
in the BtuD protein for Vitamin B12 transport (Friedrich et 
al, 1986), supporting the hypothesis that outer membrane 
receptor dependent transport systems follow the PBT 
mechanisms across the cytoplasmic membrane.
Periplasmic transport proteins were also identified to be 
involved in Vitamin B12 (Reynolds et al, 1980) and Fe3+- 
dicitrate (Pressler et al, 1988), strengthening the notion 
of a PBT mechanism. Furthermore, the Vitamin B12 and the 
Fe3+-dicitrate transport systems contain, respectively, one 
and two very hydrophobic proteins in the cytoplasmic 
membrane, which are typical of the PBT systems.
1
The location of FhuD, which is the only candidate for a 
periplasmic protein of the fhu operon, was investigated by 
Foster and Brun, 1989. It was released by converting cells 
to spheroplasts, showing a periplasmic location.
Furthermore, FhuD was synthesised in two forms which 
differed in size by 3KDa. The larger protein is probably 
the precursor, which is converted to the mature form by 
cleavage of the signal peptide comprising 30 amino acids. A 
signal peptide which is typical for proteins which cross the 
cytoplasmic membrane.
Iron (III) transport into E . coli is unigue in that the 
metal ion has to be solubilised by compounds of low 
molecular weight called siderophores. In addition, 
essential constituents of the transport systems are receptor 
proteins in the outer membrane which are highly specific for 
the iron (III) siderophore complex. How the activity of 
these receptor proteins is regulated is of general interest. 
Apparently, they are functionally coupled to the 
energization of the cytoplasmic membrane and the products of 
the tonB and possibly the exbB gene have been implicated in 
this process (for a recent review, see Braun, 1985) .
After lengthy discussion of the genetic approaches used in 
E. coli, for the understanding of B12 uptake and transport, 
the genetics of the lactic acid bacteria will be reviewed, 
with a view to understanding B12 uptake and transport in 
Lactobacillus leichmannii.
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ii8 Genetics of lactic acid bacteria.
The lactic acid bacteria are of considerable economic 
importance, not only in the dairy industry, but also in the 
fermentation of meat and vegetables and the ensilation of 
grass. They consist of both coccoid (lactic streptococci) 
and rod-shaped bacteria (lactobacilli). There has been 
speculation on the feasibility of using genetic manipulation 
to improve these organisms in their capacity to act as 
starter cultures (Kondo & McKay, 1985; Sandine, 1987). In 
this respect, there has been much recent progress towards 
the development of a transformation system and vectors for 
lactic streptococci (Simon et al, 1986; Sanders & Nicholson, 
1987; de Vos, 1987).
In contrast, the bacteria of the genus Lactobacillus appear 
less amenable to genetic manipulation. The understanding of 
molecular biology and the improvement of Lactobacillus 
strains in food fermentation, have been hampered by the 
absence of an in vitro DNA transfer system.
Since rod lactic acid bacteria are essential for a wide 
range of dairy fermentations and other industrial production 
(see Table 1.3), their genetic manipulation is crucial to 
the improvement of existing technological processes. The 
reasons for the widespread use of Lactobacilli in the 
preparation of foods and other fermentation processes is due 
to the many properties they possess (see Table 1.4).
Table 1.3 Industrial applications of Lactobacillus strains, 
(taken from Chassy, 1985) .
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Product Organism
Yoghurt L. bulgaricus
Fermented milks L. acidophilus 
L . casei 
L. bulgaricus
Cheeses L. bulgaricus 
L. helveticus
Soy sauce L. delbrueckii
Crackers L. plantarum
Pickles L. plantarum
Cured ham L. casei 
L. plantarum
Sausages, meats L. plantarum 
L. reuteri
Distillery mashes L. casei 
L. fermentum 
L. plantarum 
L. delbrueckii
/
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Product Organism
Feed additives L . acidophilus
L. bulgaricus
L. lactis
Silage starters L . pi antarum
Lactic acid L. delbrueckii
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Table 1.4 Advantages of Lactobacillus strains for 
industrial processes.
(taken from Chassy, 1985).
Methods already exist for large-scale cultivation 
Non-pathogenic
No toxins or toxic products formed
Aerotolerant
No aeration required
Moderately thermophilic (51-54°C)
Can withstand low pH
Natural products discourage contamination and spoilage 
Ferment diverse carbohydrate feedstocks (whey, silage, 
plant juices and hydrolysed starch)
Rapid and abundant growth 
Cultures are stable and viable 
Non spore-forming
The development of a procedure for protoplast production and 
regeneration in Lactobacillus species could be the first 
step to obtain protoplast fusion or transformation, as 
already achieved in group N Streptococci (Gasson, 1980;
Kondo & McKay, 1982) and in other gram-positive species 
(Hopwood, 1981).
1.8.1 Protoplast formation, regeneration and fusion.
Genetic analysis of lactobacilli has been impaired by the 
lack of a reliable transformation system and by 1984 there 
were still no published methods completely suitable for the 
efficient production of protoplasts from the Lactobacillus 
strains used.
Chassy and Giuffrida (1980) had reported that Lactobacilli 
can be lysed by lysozyme in the presence of PEG. PEG used 
as an osmotic stabilizer caused fusion and aggregation of 
Lactobacillus protoplasts. Mutanolysin, an endo-N- 
acetylmuramidase isolated from Streptomyces globisporus has 
also been used to produce protoplasts of L. casei (Shimizu- 
Kadota & Kudo, 1984).
Since then, protoplast formation and regeneration has been 
reported in Bacillus thuringiensis (Temeyer, 1987), L . 
reuteri (Vescovo et al, 1984), Leuconostoc mesenteroides 
(Otts & Day, 1987) and L . casei (Lee-Wickner & Chassy,
1984). Transfection has also been reported in Lactobacillus
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(Boizet et al, 1988; Shimizu-Kadota & Kudo, 1984; Chassy, 
1987; Cosby et al, 1988).
Protoplast fusion is a system of genetic exchange widely 
used in gram-positive bacteria (Hopwood, 1981) to transfer 
either chromosomal markers or plasmids (Dancer, 1980; 
Gasson, 1980) . Some examples can be found listed in Table 
1.5.
Table 1.5 Protoplast fusion.
Organism Reference
Streptomyces coelicolor 
Bacillus subtilis 
Bacillus megaterium 
Streptococcus lactis 
Clostridium acetobutylicum
Hopwood & Wright, 1978 
Chang & Cohen, 1979 
Vorobjeva et al, 1980
Kondo & McKay, 1982 
Reid et al, 1983
More recently, protoplast fusion has been described in 
Lactobacillus species (Cocconcelli et al, 1986; Iwata et al, 
1986; Baek et al, 1986a, 1986b).
In 1986, Simon et al, reported the high-efficiency 
transformation of S. lactis protoplasts by plasmid DNA. The
U2
procedure used similar conditions to that used by Chang and 
Cohen in 1979 for B. subtilis i.e. PEG induced DNA uptake by 
protoplasts.
The following year, Morelli and colleagues reported a method 
for the transformation of Lactobacillus protoplasts by 
plasmid DNA. The procedure also involved PEG treatment of 
protoplasts to induce DNA uptake.
Protoplast transformation procedures have no doubt opened 
the way for the application of recombinant DNA technology to 
various gram-positive bacteria genera. Unfortunately, these 
techniques are often neither efficient nor reproducible, 
presumably because protoplasts are difficult to prepare and 
to re-generate.
It is clear that the development of a plasmid transformation 
system is fundamental for further improvements in 
Lactobacillus genetics.
Another approach to strain improvement which has been tried, 
is by conjugal exchange of genetic information between
bacteria.
¿►3
1.8.2 Conjugal transfer.
The demonstration by Vescovo and his colleagues (1983) that 
pAM01 conjugation extends to three different Lactobacillus 
species supported the proposed use (Gasson & Davies, 1980) 
of this plasmid as a molecular vector in lactic acid 
bacteria.
pAM/81 is 26.5 Kb broad host range plasmid, originally 
isolated from S. faecalis (Clewell et al, 1974), carrying 
erythromycin resistance.
It is conjugally transferable to and between a number of 
other Streptococcus species (Gibson et al, 1979; Le Blanc et 
al, 1978), including S. lactis (Gasson & Davies, 1980), 
Staphyloccus aureus (Engel et al, 1980), Clostridium 
acetobutylicum (Oultram & Young, 1985; Oultram et al, 1987), 
various species of Bacillus (Orzech & Burke, 1984) including 
B. subtilis (Oultram & Young, 1985) and various 
Lactobacillus species (Vescovo et al, 1983; Gibson et al, 
1979; West & Warner, 1985; Shrago et al, 1986; Romero & 
McKay, 1985 ; Tannock, 1987; Sasaki et al, 1988).
Sasaki et al (1988) reported the conjugal transfer of pAM£l 
to L. plantarum by a filter mating method. The conjugal 
transfer frequency of pAM/31 from Streptococci to 
Lactobacilli has been reported to be generally low. They 
examined various factors affecting the transfer frequency of
this plasmid from S. faecalis to L. plantarum. They found 
that frequency depended on the type, pore size and side of 
the membrane filter used. They also found that the passage 
of sterilised water through the membrane under reduced 
pressure after donor and recipient cells were trapped on it, 
increased the transfer frequency about 10-fold.
Also in 1988, Thompson and Collins reported evidence for the 
conjugal transfer of plasmid pIP501 from S. faecalis into 
commercially used strains of lactic streptococci and from 
these strains into two strains of L. helveticus, a species 
used in the manufacture of hard cheeses, notably Emmental. 
Furthermore, they provided evidence that the plasmid could 
be transferred between derivatives of one strain of L. 
helveticus and from L. helveticus back to S. faecalis.
pIP501, a plasmid originally isolated from S. agalactiae 
(Hershfield, 1979) has several useful characteristics which 
include:-
(i) a potentially broader host range than pAM^l
(ii) it carries two antibiotic resistant markers allowing 
the scoring of the unselected marker as evidence for 
plasmid transfer (Err and Cmr).
(iii) it has been the source of DNA used for the 
construction of potential cloning vectors (Behnke et 
al, 1981).
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pIP501 has also been reported by Shrago and Dobrogosz (1988) 
to transfer conjugally from S. faecalis to L. plantarum.
West and Warner had previously reported transfer of this 
plasmid to L. plantarum in 1985.
The E. coli/Streptococcal shuttle plasmids, pVA838 and pSA3 
(Dao & Ferretti, 1985) were mobilised from S. sanguis to L. 
plantarum by pVA797 (broad host range streptococcal plasmid) 
by cointegrate formation (Shrago & Dobrogosz, 1988).
In 1987, Trieu-Cuot and colleagues developed a vector 
strategy that allowed transfer of plasmid DNA by conjugation 
from E . coli to various gram positive bacteria, in which 
transformation via natural competence had not been 
previously demonstrated. The prototype vector pAT187 
contains the origins of replication of pBR322 and of the 
broad-host range plasmid pAM£l, a kanamycin resistance gene 
known to be expressed in both gram negative and gram 
positive bacteria, plus the origin of transfer of the IncP 
plasmid RK2. This shuttle plasmid was mobilised efficiently 
by the self-transferable IncP plasmid pRK212-l (co-resident 
in the E. coli donors) to S. lactis, Staphylococcus aureus, 
B. thuringiensis and Enterococcus faecalis. For a summary 
of the afore mentioned facts, refer to Table 1.6.
The development of a gene transfer system whereby plasmid 
cloning vectors can be introduced into Lactobacilli has been 
a priority for investigators of Lactobacillus spp. Suitable
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vectors might be found among those already used successfully 
with other gram-positive genera. Alternatively vectors 
based on Lactobacillus indigenous plasmids could be 
constructed.
1.8.3 Lactobacillus plasmids.
Plasmids are widely distributed among members of the genus 
Lactobacillus (Chassy et al, 1976; Chassy et al, 1978;
Hofer, 1977; Ishiwa and Iwata, 1980; Klaenhammer, 1984; 
Klaenhammer & Sutherland, 1980; Morelli et al, 1983; Smiley
& Fryder, 1978; Vescovo et al, 1981, 1982; Nes, 1984).
Lactose metabolism in L. casei (Chassy et al, 1978; Hofer,
1977) has been shown to be dependent on the presence of 
plasmids. The phospho-/9-galactoside galactohydrolase gene, 
one of the lactose metabolic genes has been cloned from the 
35 Kb lactose plasmid pLZ64 into E. coli (Lee et al, 1982).
N-acetyl-D-glucosamine metabolism also appears to be plasmid 
determined in two strains of L. helveticus, but the 
biochemical pathway has not been characterised (Smiley & 
Fryder, 1978).
Plasmids have also been implicated in the multiple 
antibiotic resistance of isolates of a number of species of 
Lactobacilli (Ishiwa & Iwata, 1980; Morelli et al, 1983; 
Vescovo et al, 1982).
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Axelsson et al, 1988 identified and described the first 
cloning, to date, of a plasmid-encoded antibiotic resistance 
gene (Err) from Lactobacillus reuteri.
In view of the recent advances in laboratory gene transfer 
techniques in Lactobacilli, plasmids containing antibiotic 
resistance markers or constructions thereof, will become 
useful as cloning vectors for these industrially important 
bacteria.
This year, studies have been carried out to show that a 
strain of L. hilgardii, a lactic acid bacterium generally 
associated with alcoholic fermentation, harbours several 
cryptic plasmids (Josson et al, 1989). Two of these 
plasmids have been characterised and one of these, pLABlOOO 
(3.3 Kb) appeared to replicate in a variety of gram-positive 
species. They describe the construction of gram-positive 
cloning vectors based on this replicon. Different shuttle 
vectors were developed using the pLABlOOO plasmid, which 
could be stably maintained in Lactobacillus under selective 
conditions. They are presently developed as promoter-probe 
vectors or expression secretion vectors for Lactobacillus. 
These new vectors will enable the expression of different 
heterologous genes in lactic acid bacteria and used possibly 
to improve Lactobacillus strains used in silage or dairy
fermentations.
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Reports on plasmids from gram-positive hosts being able to 
replicate in gram negative organisms are scarce (Ehrlich, 
1977; Kok et al, 1984; del Solar et al, 1987).
Up until recently, the low transformation efficiency of 
ligated plasmid DNA from gram-positive bacteria has resulted 
in that most cloning strategies developed in these bacteria 
usually involve the construction of recombinant plasmid DNA 
molecules in E. coli, where standard DNA methodology can be 
applied and their subsequent introduction by transformation 
in the gram-positive of interest. Table 1.7 shows the 
Lactobacillus DNA cloned to date.
Returning to the fact that the development of a plasmid 
transformation system is essential for further improvements 
in Lactobacillus genetics, an alternative method has 
recently been investigated and is proving to be very 
successful. This method has been adapted from the methods 
of electric field - induced fusion of membranes - termed 
electrofusion - and the generation of small localised holes 
in biological membranes - termed electroporation - which 
were first developed for eukaryotic cells by the group of 
Zimmermann (for a review see Zimmermann, 1982).
1.8.4 Electroporation.
Electroporation, one of the most versatile tools available 
for the introduction of DNA into cells, involves the 
application of a brief, high voltage pulse to a suspension
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of cells plus DNA. The result is transient membrane 
permeability and the subsequent uptake of DNA. 
Electroporation has been used to introduce DNA into both 
eukaryotic and prokaryotic cells.
Since current methods for the transfection and 
transformation of Lactobacilli using protoplasts are slow, 
inefficient and inconsistent, Chassy & Flickinger, 1987 
evaluated electroporation as a simple alternative.
Compared to most other mechanisms, electroporation is less 
time-consuming, less tedious, less expensive (and in some 
cases, the only method available for recovering plasmid- 
containing transformants).
An optimal voltage and time constant must be found for each 
cell type (see further details in Chapter 7 of this thesis) 
and electroporation apparatus, since sub-optimal conditions 
either fail to introduce DNA or result in excessive cell 
death due to permanent disruption of the cell membranes.
Aukrust and Nes (1988) reported the transformation of L. 
plantarum with pTVl. pTVl contains the pE194 replicon from 
Staphylococcus aureus and Tn917 from S. faecalis pTVl was 
shown to replicate as a high copy number plasmid in L. 
plantarum and the two encoded antibiotic resistance traits 
were expressed. There have been no previous reports on 
transposition in Lactobacilli, although a Lactobacillus
insertion sequence ISL1 has been found in L. casei (Shimizu- 
Kadota et al, 1985; Shimizu-Kadota, 1987).
Luchansky et al, (1988) described the transfer of different
plasmids to L. acidophilus by electroporation and their 
efforts to test the efficiency of this technology with other 
gram-negative genera.
Although the electroporation protocol was not optimized for 
each of the various genera and strains tested, the results 
demonstrate that many gram positive bacteria were amenable 
to plasmid transformation via electroporation, using a 
common protocol.
Other successes in electroporation by several groups of 
workers are listed in Table 1.8.
pGK12, used by Luchansky and colleagues is a small 4.4. Kb 
plasmid carrying Cmr (from pC194) and Err (from pE194) . It 
replicates in a variety of gram-positive hosts as well as E. 
coli, using the origin of replication from pWVOl, a small 
cryptic plasmid native to S. cremoris (Kok et al, 1984).
Efforts to optimise electroporation could address several 
parameters affecting the physical condition of the recipient 
cells (growth media, aeration, pH, cell age, integrity of 
the cell wall), selection of a suitable replicon and vector 
markers and evaluation of resident plasmid DNA in the 
recipient.
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Table 1.8 List of organisms that have either been transformed
or transfected bv electroporation.
Organism Vector Transformation/ Reference 
Transfection
S. lactis ~ transformation Harlander, 1986
L. casei PL-1 
(40 kb)
transfection Chansy &
Flickinger, 1987
PLZ15 
(28 kb)
transformation Chassy &
Flickinger, 1987
pSA3 (Err ) 
pLP825 (Cmr) 
pNZ12 (Cmr )
transformation
Chassy & 
Fiickinger, 
1987
E. carotovora pBR329 transformation Ito et al, 1988
L. plantarum pTVl transformation Aukrust & 
Nes, 1988
L. plantarum Tn917 (transposition) Aukrust &
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E. coli
S. cremoris
S. lactia LMO230 
(now Lactococcus 
lactis subsp. 
lactis
E. coli 
E. coli 
E. coli 
E. coli
B. thuringiensis
pUC18
pMU1328 
pMU1329
pMU1328 
pMU1329 
pLSl 
pAM/91
pUC12
q 3RF
M13mpl9RF
pSA3
pBR322
QB phage 
RNA
pC194
p U B U O
transformation
transformation
transformation
transformation
transfection
transformation
transfection 
of RNA
transformation
Calvin & 
Hanawalt, 
1988
Powell 
et al, 1988
Powell 
et al, 1988
Wilson & 
Gough, 1988
Taketo, 1988
Taketo, 1988
Taketo, 1989
Bone &
Ellar, 1989
I
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Leuconostoc
paramesenteroides
Bordetella
Clostridium
perfringens
Clostridium
acetobutylicum
Lactococcus lactis 
subap. lactis
S. pyogenes
pAM01
pRK404 
(broad hoat 
range cloning 
vector)
pAM01
pHR106
(7.9 kb 8huttle 
vector)
pMTL500E 
(ahuttle 
vector - 
Err gene and 
replication 
machinery of 
pAM/91
pSA3 
pGB301
pGK12
(ErrCmr )
tranaformation
transformation
tranaformation
tranaformation
tranaformation
tranaformation
David et al, 
1989
Zealey 
et al, 1988
Allen £
Blaschek,
1988
Oultram 
et al, 1988
McIntyre & 
Harlander, 1989a
Suvorov
et al, 1988
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B. thuringiensis pC194 transformation Mahillon et al
pE194 1989
Brevibacterium pUL340 transformation Haynes & Britz
1actofermentum 1989
Corynebacterium pUL340 transformation Haynes & Britz
glutamicum 1989
B. thuringiensis pX193 transformation Schurter
B . cereus et al, 1989
E. coli
K. pneumoniae pKT231 transformation Wirth
Pseudomonas (broad host- et al, 1989
putida range for gram
Ervinia carotovora negative bacteria,
expressing
Kmr & Smr
L. acidophilus pAM/?l
pC194
pGB354a transformation Luchansky
pGKVlb
pSA3
pTRK13C
pTVld
pVA797®
et al, 1988
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Bacillus, 
Enterococcus,
Lactococcus, pGK12 transformation Luchanslcy
Leuconostoc, et al, 1988
Listeria,
Pediococcus,
Propionibacterium and 
Staphylococcus
E. coli TGI M13 DNA transfection Heery & Dunican
1989
ZidCtOCOCCUS pGB301 transformation McIntyre &
lactis subsp. Harlander, 1989b
lactis
a
b
6.2 kb, Cmr (Behnke & Gilmore, 1981)
4.6 kb, CmrErr (van der Vossen et al, 1985)
c 12.5 kb, Cmr (Luchansky et al, 1988)
d 12.4 kb, CmrErr (Youngman et al, 1983)
e 30.7 kb, CmrTra+ (Evans & Macrina, 1983)
(Tra+ - self transmissible conjugative plasmid)
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This section would not be complete without mentioning the 
classical techniques of microbial genetics, such as chemical 
mutagenesis.
1.8.5 Classical genetic manipulation of Lactobacilli.
As a genus, Lactobacillus sp. are fastidious and require 
various nutrients, including amino acids, vitamins and 
nucleotides for growth. Their nutritional requirements do 
not appear to be the result of an absence of the genes 
encoding the required enzymes for each pathway, but result 
from the mutational loss of one or more metabolic steps. 
Evidence for this phenomenon in L. casei, L. plantarum, L. 
helveticus and L . acidophilus has been reported by Morishita 
et al, 1974 and 1981. These complicated nutritional 
requirements of lactic acid bacteria often make classical 
genetics tedious.
However, Rodriquez-Quinones et al, (1982) reported NTG
mutagenesis in L. plantarum. They showed that efficiency 
was good with optimal concentrations 500 pg ml-1 or lower. 
The frequencies they obtained of induced mutations were of 
two orders of magnitude higher than spontaneous mutants.
With the view to improving strains, the mutagenesis approach 
does have short-comings in that it's impossible to derive 
strains with completely new genes or with mixtures of genes 
from two or more separate strains.
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A classical method which does result in transferring genes 
between strains is that of phage-mediated transduction. 
Bacteriophages are common among Lactobacilli and the 
majority of strains isolated from natural sources appear to 
be lysogenic for one or more phage (i.e., they harbour phage 
in a latent state) (Yokokura et al, 1974). However, no 
laboratory has reported successful transduction of a genetic 
trait between Lactobacilli. Exploitation of this technique 
awaits investigation.
1.9 Aims of this project.
Information regarding the molecular genetics in the Lactic 
acid bacteria is accumulating and therefore, these studies 
were initiated to genetically engineer strains of 
Lactobacillus leichmannii, which have increased specificity 
to different cobalamins.
To achieve this, the gene encoding the Vitamin B12 binding 
protein in L. leichmannii will be cloned and expression 
studies carried out to identify the gene product. The 
nucleotide sequence of the gene will be ascertained in order 
to attempt to alter the specificity of the binding protein, 
by site-specific mutagenesis. Finally, the modified gene(s) 
will be replaced into the original organism and the changes 
in specificity evaluated.
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Chapter 2 : Methods and Materials
2.1 Bacterial strains and plasmids.
The bacterial strains and plasmids used in this study are 
listed in Tables 2.1 and 2.2 respectively.
2.2 Bacteriophage.
The bacteriophage used in this study are listed in Table 2.3.
2.3 Media.
2.3.1 Lactobacilli media.
Rich media i.e. MRS broth (de Man et al, 1960) was used to 
grow all Lactobacilli used in this study.
2.3.2 Enterobacteriaceae media.
Rich media i.e. Luria-Bertani broth (LB), as described in 
Maniatis et al., 1982 was used routinely to grow the enteric 
organisms used in this study.
2.3.3 Bacilli media.
Rich media i.e. Nutrient broth was used routinely to grow
Bacillus subtilis.
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Table 2.1 Bacterial strains
Strain Genotype Source Reference
Lactobacillus
leichmannii 8964 NCIB White, 1958
Lactobacillus 
leichmannii 4797
- ATCC Bergey et al, 
1925
Lactobacillus - NCIB
casei 7473
Lactobacillus 
pi ant arum
- P. Warner West &
Warner, 1985
NCDO 1752
Escherichia 
coli DH1
F-, recAl, end A 1 
gyrA96 thi-1, hsdRn
(rkMfc)' SUPE44* A
D . Cardy Hanahan, 1983
Escherichia F-, hsdS20 (rß/MB ), D . Cardy Boyer &
coli HB101 recAB, ara-14, proA2, 
lacYl, galK2, rpsL20 
xyl-5, mtl-1, supE44,
Roulland- 
Dussoiz, 1969
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Strain
Escherichia coli 
CSH26AF6
Escherichia 
coli TGI
Escherichia 
coli Ll-431
Escherichia 
coli NFB362
Genotype Source
F~, ara, h(lac-pro), D. Cardy
thi, rpsL, A(recA-srl)
F6, sup , A-
(pro-lac)supE, thi, F , D. Cardy
traO, proAB+ , lacIe*,
„V15lac Zv
argF40, argRll, J-P. Bohin
rpsL40, btuB
MC400, argE3, J-P. Bohin
rpoB, recA6,
Reference
Jones & 
Holland, 1984
Carter et al,
1985
Aufrère et al,
1986
Aufrère et al, 
1986
srl-300 :s TnlO
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Tabi» 2.2 Plasmids
Plasmid Characteristics Phenotype Source Reference
pBR327 Multicopy cloning 
vector
AprTcr D . Hodgson Soberon 
et al, 1980
pBR32 5 Multicopy cloning 
vector
AprTcrCmr D . Cardy Bolivar,
1978
pBR3 29 Multicopy cloning 
vector
AprTcrCmr D . Hodgson Covarrubias 
& Bolivar, 
1982
pAT153 High copy variant 
of pBR322
AprTcr C. Oakley Twigg &
Sherratt, 1980
PACYC184 Stringent cloning 
vector
TcrCmr C. Oakley Chang & 
Cohen, 1978
pNF48 High copy number 
vector harbouring 
btuB gene
AprSmr J. P. Bohin AufrSre 
et al, 
1986
pSDCl Derivative of Apr This work
pBR327
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Plasmid Characteristics Phenotype Source Reference
pSDC2 Derivative of 
pBR327
Apr - This work
pSDC3 Derivative of 
pBR327
Apr - This work
pAM/31 Broad host range 
plasmid
Err M. Gasson Clewell et al, 
1974
pC194 High copy number 
plasmid
Cmr R. Saunders Iordanescu, 
1975
pSA3 E. coli- 
Streptococcus 
Shuttle vector
Tcr
CmrErr
M. Gasson Dao &
Ferretti,
1985
pSECl Derivative of 
pBR32 5
AprCmr - This work
pSEC2 Derivative of 
pBR325
AprCmr - This work
pBS phagemid vector Apr I. Garner Stratagene
pBS3 Derivative of Apr _ This work
pBS
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Plasmid Characteristics Phenotype Source Reference
pBS7 Derivative of Apr
pBS
This work
pCKl High copy CmrKmr M. Gasson Gasson &
number plasmid Anderson
1985
Table 2.3 Bacteriophage
Phage Characteristics Source References
M13tgl30
"
Amersham Int. Kieny et al. 1983
M13tgl31 - Amersham Int. Kieny et al, 1983
VCS-M13 helper phage I. Garner Stratagene
BF23 Tg-like phage R. E. Glass Heller, 1984
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2.3.4 Antibiotics.
Antibiotics, where appropriate, were normally prepared as 100 
x stocks and used at the following concentrations (unless 
otherwise stated):
Antibiotic Stock concentration 
(mg ml-1)
Final concentration
(Mg ml-1)
Ampicillin (Ap) 100
Chloramphenicol (Cm) 35
Kanamycin (Km) 50
Streptomycin (Sm) 20
Tetracycline (Tc) 20
Erythromycin (Er) 20
100
15
50
20
20
10
Antibiotic stock solutions were prepared as described in 
Maniatis et al., 1982.
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2.3.5 Chemicals used in this study.
Chemicals Supplier
General materials BDH/Sigma or Fisons
Restriction enzymes and buffers Amersham International
T4 DNA ligase Amersham International
T4 polynucleotide kinase Amersham International
35S-methionine Amersham International
32P-nucleotides Amersham International
Nitrocellulose filters Schleicher & Schul1
Restriction enzymes and buffers Boehringer-Mannheim (BRL)
DNA polymerase I (nick translation) Boehringer-Mannheim (BRL)
DNA sequencing materials
(acrylamide, bisacrylamide, 
ammonium persulphate, 
sodium dodecylsulphate and urea)
BioRad Laboratories
X-ray film Fuji Photo Film Co. Ltd.
Organic acids and Solvents May & Baker
Sephadex G50 Pharmacia
DNA sequencing nucleotides Pharmacia
DNA polymerase I (Klenow) Pharmacia
Calf intestinal alkaline 
phosphatase (CIAP)
BCL
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2.4 Growth and maintenance of bacterial cultures.
2.4.1 Organism maintenance.
All Escherichia coli strains (with the exception of TGI) were 
maintained on LB agar plates containing the appropriate 
antibiotic where required, for up to 6 weeks at 4°C. E. coli 
TGI was maintained on M9 minimal agar plates containing 0.1 
ml, 0.1% (w/v) thiamine litre-1 . For longer term storage, an 
overnight culture was mixed with an equal volume of sterile 
glycerol in a glass vial and stored at -20°C.
All Bacillus strains were maintained on NB agar plates and 
Lactobacillus strains on MRS agar plates, in the same way as 
for E. coli. Long term storage again was the same as for E. 
coli.
2.4.2 Growth conditions.
E. coli and Lactobacillus strains were grown at 37°C unless 
otherwise stated in the text. Liquid cultures were routinely 
propagated in 25 ml universal bottles in a Gallenkamp Orbital 
Shaker (150 rpm).
Bacillus strains were grown at 30°C.
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2.4.3 Light microscopy.
All cultures were examined by phase contrast microscopy using 
an Olympus PM-6 phase contrast microscope operating at xlOOO 
magnification.
2.4.4 Spectrophotometry.
Routine determinations of culture optical density were 
performed at a wavelength of 600 nm through a 1 cm light path 
using an LKB Ultrospec II spectrophotometer.
2.5 Chromosomal DNA extraction.
2.5.1. Escherichia coli.
Chromosomal DNA extraction was carried out using the technigue 
of Marmur, 1961 with modifications (Oakley & Murrell, 1988). 
Volumes were scaled down to allow all operations to be carried 
out in 35 ml polypropylene Oakridge tubes. Cells were 
harvested and pellet resuspended in 6 mis of T.E. (10 mM Tris- 
HC1, 1 mM Na-EDTA pH 8.0) and transferred to a 35 ml 
polypropylene Oakridge tube, to which 3.75 ml 0.25 M EDTA pH 
8.0 and 50 mg lysozyme were added and mixed gently. After 
incubation at 37°C for 15 mins, Proteinase K (250 til of 20 mg 
ml-1 stock) was added, followed by 3.25 ml SDS (10% w/v), 
which was added slowly with mixing and again incubated at 37°C 
until lysis occurred.
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Sodium perchlorate (4 mis of 5M) was added (to aid DNA 
membrane separation) and placed at 60°C for 15 mins with 
occasional gentle stirring. An egual volume of TE saturated 
phenol/chloroform/iso-amylalcohol (25:24:1) was added and 
mixed gently. To facilitate complete separation of aqueous 
and organic phases, centrifugation was carried out using 8 x 
50 rotor (18,000 rpm, 30 min, 4°C) and upper aqueous layer 
transferred to fresh Oakridge tube. An equal volume of 
chloroform was added and mixed gently, then centrifuged again 
(18,000 rpm, 30 min, 4°C) to separate aqueous and organic 
phases. Extraction was repeated twice. After final 
extraction, the aqueous phase was transferred to a 
polycarbonate 250 ml centrifuge pot. Sodium chloride was 
added (final concentration 0.1 M) and then two volumes of 100% 
ethanol. DNA was gently removed and washed with 70% ethanol 
at room temperature. The washed DNA was dried under vacuum 
for 30-60 min and then slowly resuspended overnight in 10 ml 
TE.
RNAse (20 mg ml-1 in TE) was added to final concentration of 
100 nq ml-1 and the solution incubated at 37°C for 30 min. 
Chromosomal DNA was then purified by a Caesium chloride (CsCl) 
density gradient step.
The RNAse treated DNA solution was made up to 30 ml with TE 
into which 30 g CsCl was dissolved. Finally 3 ml of Ethidium 
bromide (10 mg ml-1 stock) were added and the resulting 
mixture spun using a Beckman L8-70 centrifuge (45,000 rpm, 16 
hr, 20°C). The resulting DNA band was extracted and ethidium
bromide removed by repeated iso-amylalcohol extraction and the 
DNA directly precipitated from CsCl as described by Davies et 
al., 1980.
2.5.2 Lactobacillus.
A modified method of Vanderslice et al, 1986 was used, whereby 
cells were harvested by centrifugation (8,000 rpm, 10 min,
4°C), and washed in 0.01 M Tris-HCl pH 8.2 and resuspended in 
this buffer. An equal volume of 24% w/v PEG 20,000 was added 
followed by 1/5 volume 0.02 M Tris-HCl, with 300 mg lysozyme 
dissolved. Incubation at 37°C for 40 mins was followed by 
centrifugation (20,000 g 15 mins) and pellet resuspended in 
0.1 M Tris-HCl, 0.01 M EDTA pH 8.5. Suspension was mixed with 
1/10 volume of 10% sarkosyl NL-30 and incubated at 37°C for 15 
mins. lg CsCl ml-  ^ lysate was added and 400 ¿tl of ethidium 
bromide (5 mg ml-  ^ stock) and centrifuged 36,000 rpm, 47 hrs, 
20°C. DNA was extracted by standard method (Maniatis et al, 
1982) .
2.6 Isolation of plasmid DNA.
2.6.1. Lactobacillus.
(a) Small scale (mini-prep).
The method devised by West & Warner, 1985 was used with the 
following volume modifications: the addition of 600 nl of 
lysis buffer, followed by the addition of 50 of 2M Tris 
(pH 7.0), in order to achieve neutralisation.
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r(b) Large seal«.
The above method was adapted to lyse larger batch cultures 
(1 litre). The RNase step and the chloroform/isoamyl-alcohol 
extraction were omitted.
2.6.2 E. coli.
(a) Large scale.
The alkaline lysis technique of Birnboim and Doly, 1979 was 
used as described by Maniatis et al, 1982 except that solution 
II (alkaline SDS solution) was not placed on ice prior to use 
as the SDS precipitates. Also the inclusion of a 
centrifugation step (18,000 rpm 30 min) prior to CsCl gradient 
centrifugation removed material from the subsequent gradient. 
After removal of ethidium bromide, plasmid DNA was directly 
precipitated from CsCl as described previously.
(b) Small scale (mini-prep).
A scaled down version of the large scale prep, working with
1.5 ml of culture, instead of one litre, was used. Solution 
II again was not placed on ice prior to use and also the 70% 
(v/v) ethanol wash of the DNA pellets was omitted, as this 
resulted in loss of plasmid.
76
7 7
2.7 General solutions and media.
These solutions are referred to in the text of this chapter 
and their compositions, and where appropriate, the procedures 
for their preparation are described below:
Chloroform (for DNA extraction) 24:1 (v/v) chloroform: 
isoamyl alcohol
Luria-Bertani media (LB) 10 g Bacto tryptone
(per litre) 5 g Bacto yeast extract 
5 g NaCl (pH 7.2)
Phenol (neutralised, for DNA Neutralised with 1 M
extraction) Tris-HCl pH 8.0, followed 
by 0.1 M Tris-HCl pH 8.0 
and containing 0.1%
(w/v) 8-hydroxyquinoline
3M Sodium acetate pH 6.3 3M NaAc brought to pH 6.3 
with acetic acid
20 x SSC 3M NaCl
0.3 M trisodium citrate
TE 10 mM Tris-HCl 
pH 8.0, 1 mM EDTA
TBE 0.089 M Tris-borate 
0.089 M boric acid
0.002 M EDTA
M9 Salts ( X  10) 60 g Na2 HP04 anhydrous
(per litre) 30 g KH2 P04 anhydrous
10 g n h4ci 
5 g NaCl (pH 7.4)
M9 minimal medium 100 ml (x 10) M9 salts
(per litre) 10 ml 10 mM CaCl2 
0.1 M MgS04
K medium M9 minimal medium
(per litre) 50 ml 20% (w/v) Bacto 
casamino acids 
0.1 ml 0.1% (w/v) thiamine 
10 ml 20% (w/v) glucose
Western Transfer 14 g glycine
buffer (WTB) 2.42 g Tris
(per litre) 200 ml Methanol
Tris-buffered 20 mM Tris pH 7.6
saline (TBS) 0.15 M NaCl
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Hershey salts 
(per litre)
Hershey medium 
(per litre)
3.0 g KC1
5.4 g NaCl
1.1 g NH4C1
15 mg CaCl2 2H20 
0.2 g MgCl2 6H2o 
0.2 mg FeCl3 6H20 
87 mg KH2 P04 anhydrous
12.1 g Tris-HCl (pH 7.4)
Hershey salts 
20 ml 20% (w/v) glucose 
10 ml 2% (w/v) proline 
1 ml 0.1% (w/v) thiamine
2.8 General techniques used for DNA manipulation.
2.8.1 Restriction endonuclease digestion.
Restriction endonucleases and restriction endonuclease buffers 
(x 10) were obtained, both from Amersham International and 
BRL, and used according to the manufacturers' instructions.
2.8.2 Dephosphorylation of DNA.
The terminal 5' phosphates were removed from DNA by treatment 
with calf intestinal phosphatase (CIP). This treatment 
minimized recircularisation of plasmid DNA and increased the
frequency of recombinant plasmid DNA molecules during ligation 
and transformation.
The method of D. Hodgson (pers. comm.) was used. To every 10 
Ml of restriction digestion solution;
1.5 /il 0.5 M glycine pH 9.4 (NaOH)
1.5 Ml 10 mM MgCl2, 1 mM ZnCl2 
0.5 Ml CIP (BCL)
were added, mixed and incubated at 37°C for 30 min. The 
volume was then made up to 100 m ! with distilled H20, the DNA 
extracted with an equal volume of phenol (Section 2.8.6), 
followed by a chloroform extraction and finally ethanol 
precipitated (Section 2.8.7).
2.8.3 Ligation of DNA.
DNA samples were mixed in appropriate volumes of TE buffer.
To subclone fragments, a 4:1 fragment to vector ratio was used 
with a DNA concentration <50 ng ml-1. For construction of 
gene libraries and subcloning using 'blunt-end' restriction 
endonucleases, a ratio of 6:1 fragment to vector was used and 
the DNA concentration increased to 100 m9 ml” . Ligations 
were carried out using T4 DNA ligase (Amersham) according to 
the recommendation of the supplier, at 15°C for a minimum of
80
18 hours.
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2.8.4 Agarose gel electrophoresis.
Horizontal slab gels were prepared by boiling agarose (Sigma) 
Tris-borate-EDTA (TBE) electrophoresis buffer and cooled 
slightly before pouring. DNA samples were prepared by adding 
0.1 volume of loading buffer (0.25% w/v bromophenol blue, 15% 
w/v Ficoll-type 400) and they were then loaded into the gel 
slots. Electrophoresis was carried out with the gels 
completely submerged in buffer at 100-125 volts or 60 volts 
overnight. As DNA molecular weight markers, \+ bacteriophage 
DNA digested with the restriction endonuclease Hindlll was 
used. This generated fragments of sizes : 23.17, 9.46, 6.75,
4.26, 2.20, 1.92 and 0.58 kb. Restriction fragment sizes were
determined with the DNASIZE programme adapted from Schaffer 
and Sederoff (1981) and run on a BBC Model B microcomputer.
The DNA was stained within the agarose gels with ethidium 
bromide (0.5 nq ml-1) as described by Maniatis et al, 1982 and 
then visualised by transillumination with short-wave UV light 
and photographed using Polaroid Type 655 black and white film.
2.8.5 Quantitation of DNA.
The mini gel method as described by Maniatis et al, 1982 was 
routinely used to estimate the amount of DNA in a given 
sample. \+ (Hindlll restricted) DNA was the standard DNA used 
(50 ng l-1) for all estimations.
DNA in solution was estimated by using the method described by 
Schleif & Wensink, 1981.
2.8.6 Extraction of DNA with phenol/chloroform.
Phenol/chloroform mix was prepared by dissolving 100 g phenol 
crystals and 100 mg 8-hydroxyquinoline in 100 ml chloroform 
and 4 ml iso-amyl alcohol. This was equilibrated by shaking 
the mixture with two changes of 0.2 volume 1 M Tris pH 8.0 and 
two changes of 0.2 volume TE, before storage in foil-covered 
bottles. For the extraction procedure, DNA samples were mixed 
with an equal volume of phenol mix, to form an emulsion and 
the phases were separated by a 2 min spin in an MSE 
microcentaur. The upper aqueous phase was recovered, taking 
care not to disturb the interface. A further extraction with 
chloroform/iso-amyl alcohol (24:1) was carried out to remove 
any remaining phenol. DNA was then recovered by ethanol 
precipitation.
2.8.7 Precipitation of DNA.
To a DNA solution, one fiftieth volume of 5M NaCl and two 
volumes of 100% ethanol were added, mixed gently and placed at 
-20°C overnight. DNA was recovered by centrifugation in an 
MSE microcentaur (5 min, high speed, 4°C). All traces of the 
supernatant were discarded by use of a vacuum line and the DNA 
pellet dried under vacuum and resuspended in TE buffer.
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For DNA prepared using an I.B.I. electroeluter or during ssDNA 
preparation for sequencing, 0.5 volume of ammonium acetate 
(7.5 M pH 7.5) and two volumes of 100% ethanol were added, 
mixed by vortexing and placed at -20°C overnight and DNA 
recovered as described above.
2.8.8 Preparation of DNA fragments from agarose gels.
DNA fragments to be eluted were separated by electrophoresis 
in agarose gels, 0.5% to 2% (w/v) depending on the size of 
fragment to be isolated. Once separated, the desired fragment 
was excised from the gel, and placed in an I.B.I. 
electroeluter. Fragments were eluted according to 
manufacturer's instructions and then ethanol precipitated as 
described previously.
2.9 Transformation.
2.9.1 E. coli.
The technique used was essentially that described by Holland, 
1983. 1 ml of overnight culture of E. coli was used to
inoculate 100 ml of LB in a 250 ml flask. This culture was 
grown to A600 of 0.5. From this point, all operations were 
carried out on ice and using ice-cold solutions. 40 ml of 
culture was added to two universal bottles and left on ice to 
chill. Cells were pelleted by minimal spins in a multex 
angled centrifuge and the resulting supernatant carefully 
removed. Resuspension was in equal volume of 0.1 M MgCl2>
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Cell washing was repeated in 20 ml of 0.1 M CaCl2 (Grade 1 
CaCl2 Sigma) and final resuspension left the cells in 2 ml of 
0.1 M CaCl2. These cells were held on ice for 24 hours 
(Dagert & Ehrlich, 1979).
200 Ml of Competent cells were aliguoted into 1.5 ml Eppendorf 
tubes and 50 ng DNA added to the cells, mixed gently and then 
left on ice for 30 min. These were then heat shocked at 42°C 
for 2 min and returned to ice for 15 min. Two volumes of LB 
were then added to each tube, incubated for 1 hour at 37°C, to 
allow expression of genes, dilutions were made and cells 
plated out onto selective media.
2.9.2 L. leichmannii.
Electroporation, one of the most recent advances for the 
introduction of DNA into cells (involving the application of 
brief, high voltage pulse to a suspension of cells and DNA, 
resulting in a transient membrane permeability and the 
subsequent uptake of DNA), was investigated. This was due to 
the fact that current methods of transformation of 
Lactobacilli were slow, inefficient and inconsistent. Details 
of the experimentation can be found in Chapter Seven of this 
thesis.
2.10 Southern transfer of DNA.
This method followed the basic protocol of Southern, 1975, 
adapted by Maniatis et al, 1982. Denaturation and
neutralisation of DNA in the gel matrix were both carried out 
for 30 min, at room temperature. The transfer buffer was 20 x 
SSC instead of 10 x SSC. Before placing the nitrocellulose on 
it, the neutralised gel was wetted with 2 x SSC to remove 
excess salt. Usually the transfer of DNA was allowed to 
proceed overnight. When the filter was removed from the gel, 
it was soaked in 2 x SSC for a few minutes before drying and 
baked, under vacuum at 80°C for 2 hours.
2.11 Transfer of bacterial colonies to nitrocellulose and the 
binding of liberated DNA (colony blots).
The procedure of Grunstein & Hogness, 1975, as described by 
Maniatis et al, 1982 was used, with the following 
modifications. Large petri dishes (20 cm x 20 cm) were used 
containing 500 ml LB agar with the appropriate antibiotic(s). 
Nitrocellulose was placed onto the LB agar plates and colonies 
picked onto duplicate plates. Once the plates had been 
incubated at 37°C overnight, the master plate was stored at 
4°C for up to 6 weeks and the nitrocellulose was treated as 
described by Maniatis et al, 1982.
85
86
2.12 Nick translation of DNA.
A modification of the procedure described by Maniatis et al, 
1982, was used routinely.
X n1 DNA in TE (250 ng)
1 fil 1 mM dATP
1 Hi 1 mM dTTP
1 ni 1 mM dCTP
1 /il 32P-dGTP (10 /iCi Hl-1)
4 /il 10 x Nick translation buffer 
0.8 h 1 DNA polymerase I
1 /il DNAse I (1 /il of 1 mg ml-1 stock in 50 /il HzO, 
then 1 /il of above in 50 ml H20)
Y /il H20
X and Y were adjusted to give 20 /il final volume.
The above constituents were incubated at 15°C for 3 hours. 
Reaction was terminated by the addition of 5 /il 0.25 M EDTA 
(pH 8.0) and the nick translated probe separated from 
unincorporated dNTPs by passage through G50 Sephadex.
Labelled DNA was stored at -20°C until required, upon which it 
was denatured by boiling for 15 min immediately prior to use.
2.13 Oligonucleotide synthesis.
Oligonucleotides were synthesized on an Applied Biosystems 
synthesizer model 380A (Applied Biosystems, Foster City, CA) .
8 7
2.13.1 Purification of oligonucleotides.
Purification was achieved by two different methods. The 
latter being the most convenient.
(a) After deprotection using ammonia and end acid 
detritylation, sample was freeze dried and resuspended in 100 
/lx 1 ddw. 10 /il aliquots were electrophoresed through a 42% 
(w/v) urea-polyacrylamide gel (sequencing gel). All 
oligonucleotides synthesised for this work were less than 30 
bases and therefore a 20% (w/v) polyacrylamide gel was used, 
being 20 cm in length. Gel was pre-run for 1-1^ hours at 700 
volts (which drops to 500 volts). An equal volume of 80% 
(v/v) formamide : 20% (v/v) glycerol, was added to sample. 
This was then subjected to 90°C for 3 mins and loaded onto 
gel. The oligo's can be found to run with the dye front 
according to the table below.
% acrylamide
Bromophenol
blue
Xylene
cyanol
10 12 mer 55 mer
12 10 mer 4 6 mer
16 9 mer 35 mer
20 8 mer 28 mer
Gel was run for the required amount of time, wrapped in cling 
film, and placed on a TLC plate. Oligonucleotide could be
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visualised as a band under short wave U.V. Band was cut out 
and placed in 5 mis of elution buffer (10 mM Mg acetate, 300 
mM NH4 acetate, 0.1% (w/v) SDS and 1 mM EDTA) at 37°C, shaking 
overnight. DNA solution was carefully extracted and diluted x 
10 with ddw. This was then passed through a column of G25 
Sephadex with a 0.1 ml layer of DE52 anion exchanger on top. 
Column was equilibrated with 50 mM NH^HCO-j and oligo' eluted 
with 50 mM NH4HC03/1 M NaCl. A260 was measured and fractions 
containing the oligo' were pooled. Aliquots were freeze dried 
and resuspended as required.
(b) By use of a Nensorb nucleic acid purification cartridge 
(DuPont). The method is unique; no salt is required to elute 
the nucleic acid. Samples containing up to 20 m9 of DNA were 
quickly purified, according to the manufacturer's instructions 
and recovered in a salt-free liquid, typically 50% methanol in 
water.
2.13.2 End-labelling.
2 ng of purified oligonucleotide was ethanol precipitated 
overnight (see Section 2.7.7) and resuspended in 14 /¿I of 
water. To this was added 2 m 1 10 x kinase buffer (0.7 M Tris- 
HC1 (pH 8.0), 0.1 M MgCl2, 50 mM DTT), 2 Ml of T4 
polynucleotide kinase and 2 Ml (20 nCi) of [7-32P] ATP. The 
mixture was incubated for 45 min at 37°C.
i
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2.14 Hybridisation of Southern filters and colony blots.
The procedure described by Maniatis et al, 1982 was
essentially followed with the following modifications. 
Nitrocellulose filters from either Southern or colony blotting 
were placed dry in heat-sealed sterilin bags containing pre­
hybridisation solution.
(a) For use with [7~32P]-labelled oligonucleotide.
6 x SSC
1 x Denhardts (Denhardt, 1966)
200 fig ml-1 sheared, heat-treated Herring sperm DNA.
Room temperature, 1 hour.
(b) For use with [a-32P]-labelled DNA. (Nick translated).
3 x SSC 
1 x Denhardts
100 fig ml-1 sheared, heat-treated Herring sperm DNA.
45°C, 1 hour
After pre-hybridisation, the pre-hybridisation was replaced 
with fresh solution supplemented with the 32P-labelled probe.
Hybridisation was carried out for a minimum of 18 hours at the 
respective temperatures, followed by a variety of stringency 
washes, employing previously published guide-lines (Marmur &
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Doty, 1962; Dove & Davidson, 1962; Bonner et al, 1973) to 
estimate the percentage DNA homology required for 
hybridisation. The damp filters were covered in cling-film 
and examined by autoradiography at -70°C.
2.15 Autoradiography.
Autoradiography was carried out at -70°C for 32P-labelled 
material and at room temperature for 35S-labelled material 
using Harmer film cassettes (with intensifying screens for 
32P) and Fuji RX X-Ray film. Autoradiograms were developed in 
Kodak LX—24 developer and fixed in Kodak FX-40 according to 
the manufacturer's instructions.
2.16 Construction, maintenance and screening of a
Lactobacillus leichmannii limited gene library.
Genomic DNA from L. leichmannii was totally digested with the 
restriction endonuclease Hindlll. All DNA fragments in the 
size range, 1.5 kb to 2.4 kb, were electroeluted from a 
preparative 0.7% (w/v) agarose gel and ligated into the 
Hindlll site of the appropriate vector, which had been 
dephosphorylated and transformed in either E. coli HB101 or E. 
coli DH1. 1000 of the resulting antibiotic resistant
(depending on the vector used) colonies were then colony 
blotted onto nitrocellulose and onto a master plate. This 
colony blot was then probed with either [q-32P]-labelled pNF48
1.5 kb EcoRl insert (see Figure 2.1) or [7-32P]-labelled 
oligonucleotide.
i
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2.17 Expression analysis.
2.17.1 In vivo E. coli Maxicell system.
This procedure was an adaptation of the method proposed by 
Sancar et al, 1979 to label plasmid-coded proteins in vivo 
with 35S-methionine. A recA strain carrying the plasmid of 
interest was grown in 15 ml K-medium (Rupp et al, 1979;
Section 2.7) and grown to a cell density of A600 = 0.5 (2 x 
108 cells ml-3) and placed on ice. 10 ml cells were UV- 
irradiated (using gentle agitation) with a dosage of 
approximately 50 Jm-3 in a petri dish. The cells were then 
transferred to a sterile flask and freshly prepared 
cycloserine was added to a final concentration of 200 /ig ml 
The culture was incubated with shaking for 14-16 hours, but no 
longer than 16 hours.
Cells were harvested and washed twice in an equal volume of 
Hershey salts (Section 2.7) and finally resuspended in 5 ml 
Hershey medium (Section 2.7). Following 1 hour incubation, 
cells were again harvested and washed once in 10 mM Tris-HCl 
pH 8.0. SDS-sample buffer (50 nl of 2 x concentration) was 
added to the pellet and samples boiled for 5 min to solubilise 
cell proteins. Samples were stored at -20°C or analysed 
directly on SDS polyacrylamide gels (Section 2.20).
Figure 2.1 Plasmid pNF48 harbouring the E. coli btuB 
structural gene.
El
-
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2.17.2 DNA-directed in vitro transcription-translation 
(Zubay) coupled system.
The bacterial cell-free coupled transcription-translation 
system first described by De Vries & Zubay, 1967 and later 
modified (Zubay, 1973; Collins, 1979), allows the expression 
in vitro of genes contained on a bacterial plasmid or a 
bacteriophage genome, provided that the relevant control 
signals are present (e.g. Pribnow box for initiation of 
transcription, Shine-Dalgarno sequence for translation). The 
system has been used in this study for the identification of 
protein products of cloned inserts. Advantages of this system 
are firstly, incorporation of radioactive label into protein 
is far more efficient than is possible using in vivo methods 
and secondly, DNA derived from bacteria other than E. coli is 
efficiently expressed (Pratt et al, 1981).
The system was used according to the manufacturer's 
instructions (Amersham International), using 35S-methionine as 
the labelled amino acid. Plasmid encoded proteins were 
identified by fluorography of electrophoresed samples on 
polyacrylamide gels (Section 2.20).
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2.17.3 Gram positive coupled transcription-translation.
The method devised by Thompson et al., 1984 was used.
Cells were harvested and resuspended in S30 buffer (50 mM 
Hepes-KOH pH 7.5 at 20°C, 10 mM MgCl2, 60 mM NH4C1, 10% (v/v)
glycerol; 5 mM ^-mercaptoethanol) using 2.5 ml buffer per gram 
wet weight. French pressed twice 12,000 psi and centrifuged 
(30 min, 4°C, 15000 rpm). Supernatant was removed and re­
centrifuged under similar conditions, at which stage the 
resultant 30,000 x g supernatant (which gave 1 A260 5 /*!)
was designated "S30". This was assayed immediately for 
activity in coupled transcription-translation. Incubation was 
carried out at 30°C in 30 m ! S30 buffer with the final 
concentration of MgCl2 adjusted to 12 mM. Each assay 
contained 2 A260 units of S30, 2 m<? plasmid DNA (added last),
8 jil synthesis mix (see below) and 2 Ml [ 35S]-methionine.
4
95
Synthesis mix contained
200 mM Hepes-KOH (pH 8.2) at 20°C
48 mM ammonium acetate
95 mM potassium acetate
7 mM dithiothreitol
5 mM ATP
3.4 mM CTP, UTP, GTP
100 mM phosphoenolpyruvate - Na3
19 amino acids (-methionine) - each at 1.4 mM
7.5 % (w/v) polyethylene glycol 6000
folinic acid, Ca++ salt, 0.14 mg ml-1 (final cone.)
This mix was stored in small aliquots at -70°C, under which 
conditions it is stable indefinitely.
Assay mixtures were incubated for 20 min at which time 
unlabelled methionine (250 fold excess) was added and 
incubation was allowed to proceed for a further 10 min at 30°C 
to allow completion of all radiolabelled polypeptides.
Samples for analysis were mixed with one third volume of SDS 
sample buffer, and boiled for 10 min prior to loading on a 
single percentage linear SDS polyacrylamide gel (Section 
2 . 2 0 ) .
2.18 DNA Sequencing.
The dideoxynucleotide chain termination method of DNA 
sequencing (Sanger et al, 1977; Sanger et al, 1980) was
employed.
2.18.1 Template preparation.
Template was prepared by either of two methods.
(a) Using M13tgl30 and Ml3tgl31 vectors.
Template preparation was essentially as described by Bankier 
et al, 1986, with the following modifications. E. coli TGI 
was used as the host for M13 recombinant propagation. After 
propagation of phage for 5^ hours, cultures were transferred 
to 1.5 nl Eppendorf tubes and centrifuged in an MSE 
Microcentaur (20 min, high speed, room temperature). After 
careful transfer of supernatants to a fresh Eppendorf tube, 
150 /¿I of PEG (6,000 mwt, 20% w/v) was added to each
supernatant, vortexed briefly and left standing at room 
temperature for a minimum of 10 min. The supernatant/PEG 
solution was centrifuged to remove PEG. Any residual PEG was 
removed after a brief 30 sec. spin. The resulting phage 
pellet was then resuspended in 100 /¿I TE, allowed to stand at 
room temperature for 10 min and 50 /¿I TE saturated phenol 
added, vortexed well and centrifuged for 5 min at room 
temperature, . 90 /¿I of the resulting aqueous layer was
removed and placed into a fresh Eppendorf tube containing 7.5M 
NH4 acetate (45 nl) and 100% ethanol (200 fi 1) , vortexed and 
placed at -20°C overnight. After precipitation, the vacuum- 
dried pellet was redissolved in 20 TE and stored at -20°C.
(b) Using Bluescribe M13 plasmid.
pBS(+/—), formerly pBluescribe M13 (+/-) is a 3,204 bp 
phagemid derived from pUC19 (see Figure 2.2). The vector 
carries a colEl origin, ampicillin resistance, T3 and T7 
promoters flanking the pUC19 polylinker and a lacZ promoter 
for blue/white color selection or fusion protein induction 
with IPTG. It also carries an M13 origin of replication 
allowing single strand DNA rescue, via helper phage infection 
for single strand sequencing.
A method devised by I. Garner (pers. comm.) was followed. 
Firstly, clones of bluescribe recombinants were isolated and a 
stock of helper phage VCS-M13 was produced and titrated on XL- 
1 blue (kindly donated by I. Garner). Titre should be of the 
order of 1 x lO^/lO12 pfu ml- .^ A 10 ml overnight 
recombinant culture was used to inoculate 500 ml of media. 
Incubation on rotating table at 37°C took place for 2.5 hours 
(early exponential phase), followed by addition to each flask 
of 3.5 x 1010 pfu VCS-M13 and incubation continued for 4 
hours. Cells were harvested (8,000 rpm, 4°C, 10 min) and 
supernatant transferred to sterile pot. To this was added 20 
ml of 20% PEG 6000/2.5 M NaCl and left overnight at 4°C. 
Precipitated phage particles were pelleted (9,000 rpm, 4°C, 10
9 7
The pBS (+/-) phagemids are 3.2 kb colony forming hybrids, 
derived from the phage fl and Stratagene's pBS plasmid.
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min) and supernatant was carefully removed. Visible pellet 
was resuspended in 20 ml TE and a clearing spin carried out 
(4°C, 10 min, high speed MSE Microcentaur). Phage particles 
re-precipitated with 4 mis of 20% PEG 6000/2.5 M NaCl for 30 
min and again pelleted. Pellet was resuspended in 200 nl of 
TE, extracted with 500 ¿il phenol and centrifuged at full speed 
in an MSE Microcentaur, 4°C, 10 min. Upper phase was 
extracted with 500 nl of chloroform/isoamyl alcohol (24:1) and 
spun as above. Samples were ethanol precipitated, resuspended 
in 200 nl TE and stored at -20°C.
Yields are much less than the M13 vectors, although usually 5 
Hi of the above 200 /¿I is sufficient to sequence as with M13 
recombinants.
2.18.2 Dideoxy Sequencing.
This was carried out using the extended method of DNA 
sequencing with Klenow fragment. Recently, by modifying the 
standard dideoxy DNA sequencing procedure to separate chain 
extension and chain termination, more DNA sequencing data is 
obtained with the large fragment of DNA polymerase I (Klenow). 
Using this separated reaction strategy, it is possible to read 
far more from a single set of reactions.
For the template-primer annealing reaction, between 2.5 nl and 
5 /i1 of template DNA was mixed with 1.5 Ml sequencing buffer 
(5), 7.5 ng of primer (range between 17-25 bp) and sterile H20 
up to 10 ¿il final volume. Annealing was accomplished at 55°C
for 1 hour. All subsequent steps i.e. sequence reactions and 
denaturing were carried out in microtitre trays. Denaturation 
was carried out in an oven (Mini/696/Clad) at 80°C for 15 min 
and placed immediately on ice prior to loading the whole of 
each reaction mixture on a 6% (w/v) polyacrylamide, Tris- 
borate-urea sequencing gel.
2.18.3 Buffer gradient acrylamide gel electrophoresis.
The procedure described by Bankier et al, 1986 was followed 
using either 40 cm x 20 cm or 100 cm x 20 cm vertical 
sequencing gel apparatus (Raven). The power supply used for 
electrophoresis was an L.KB Model 2103 power pack.
2.18.4 Sequence analysis.
All DNA sequence derived from this work was recorded and 
analysed using the Microgenie Sequence Analysis Program of 
Queen & Korn, 1986 and an IBM PCAT computer.
2.19 Outer membrane preparation.
The method described by Achtman et al, 1983 was followed, with 
modifications to the type of centrifuge used only.
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2.20 Polyacrylamide gel electrophoresis (PAGE).
2.20.1 Slab gels.
Proteins were analysed on 4-15% (w/v) non-denaturing 
exponential gradients or single percentage (w/v) linear, SDS- 
polyacrylamide gels (Laemmli, 1970). The constitution of 
buffer and acrylamide solutions are given in Tables 2.4 and 
2.5. Ammonium persulphate was always freshly prepared and the 
gel, once poured, was overlaid with water saturated butan-1- 
ol. Electrophoresis was carried out using an LKB gel system 
at a constant current of 8 mA for 16 hours or 30 mA for 3 
hours.
2.20.2 Gel staining.
(a) Coomassie blue staining.
Gels were stained for at least an hour in 300 ml, 10% (v/v) 
glacial acetic acid, 30% (v/v) propan-2-ol, 0.05% (w/v) 
Coomassie brilliant blue. Destaining was carried out in the 
above solution, without stain for 30 min and then in 300 ml, 
10% (v/v) glacial acetic acid for 2 hours.
(b) silver stain.
Gels were soaked in 50% methanol for a minimum of 8 hours with 
three changes. 1.6 g of silver nitrate was dissolved in 8 mis
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Table 2.4.1 stock solutions for non-denaturing PAGE
Stock solution Composition
Acrylamide A
Acrylamide B
Resolving gel buffer 
Ammonium persulphate (Amps) 
Temed
Electrophoresis buffer
Sample buffer 
(per 100 nl sample)
25% (w/v) acrylamide 
1.25% (w/v) bisacrylamide
60% (w/v) acrylamide 
0.3 % (w/v) bisacrylamide
3M Tris-HCl (pH 8.8)
10% (w/v)
used as supplied
0.05 M Tris 
0.26 M Glycine
10 /¿I 75% (v/v) glycerol 
10 /¿I 0.1% (w/v) bromophenol 
blue
I1
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Table 2.4.2 Composition of non-denaturing exponential
gradient gels.
Stock Solution 4% 15%
Acrylamide A
Acrylamide B
Resolving buffer
double distilled water
30% (v/v) glycerol
Temed
4.6 ml
3.75 ml
20.4 ml
17.5 /il
7.2 ml
3.75 ml
7.2 ml
10.625 ml
7.5 /xl
Amps 150 /il 75 /il
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Table 2.5.1 Stock solutions for SDS-PAGE.
Stock Solutions Composition
Resolving gel buffer
Stacking gel buffer
Acrylamide stock
Ammonium persulphate (Amps)
TEMED
Electrophoresis buffer
Sample buffer (x2)
0.75 M Tris-HCl pH 8.8 
0.2 % (w/v) SDS
0.25 M Tris-HCl pH 6.8 
0.2 % (w/v) SDS
44% (w/v) acrylamide 
0.8% (w/v) bisacrylamide
1% (w/v)
As supplied by manufacturer
0.025 M Tris 
0.129 M Glycine 
0.1 % (w/v) SDS
0.025 M Tris-HCl pH 6.8 
0.8 % ( W / V )  SDS 
10 % (v/v) glycerol 
5 % (v/v) /9-mercaptoethanol
Bromophenol blue
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Table 2.5.2 Composition of SDS-PAGE resolving gels.
Stock Solution 15% 11% 8.5%
Resolving gel buffer
Acrylamide stock
double distilled water
Amps
27.0 ml
18.4 ml
7.2 ml
1.9 ml
27.0 ml
13.6 ml
12.0 ml
1.9 ml
27.0 ml
10.6 ml
15.0 ml
1.9 ml
Temed 0.1 ml 0.13 ml 0.13 ml
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Table 2.5.3 Composition of SDS-PAGE stacking gels.
Stock Solution 4.5% 7.5%
Stacking gel buffer
Acrylamide stock
double distilled water
Amps
10 ml
3 ml
7 ml
0.5 ml
10 ml
3.3 ml
6.7 ml
0.5 ml
Temed 0.04 ml 0.04 ml
of ddw and slowly added to a solution containing 42 ml 0.36% 
NaOH and 2.5 ml NH3. The volume was made up to 200 ml and was 
used to stain the gel for 15 mins. After two washes with ddw, 
gel was soaked in developer (2.5 ml 1% citric acid, 0.4 ml 
formaldehyde, made up to 500 ml with ddw) until the bands 
appeared. Reaction was stopped with a solution containing 10% 
(v/v) acetic acid and 45% methanol.
2.20.3 Fluorography.
Fluorography, or impregnation of gels with a fluor increases 
the sensitivity of X-ray film to [35S]-labelled proteins.
In this study, it was carried out according to the method of 
Skinner & Griswold, 1983. After electrophoresis, 
polyacrylamide gels were fixed in glacial acetic acid for 5 
mins, then soaked in 20% (w/v) solution of PPO in glacial 
acetic acid for 1^ hours, with gentle agitation. Gels were 
then transferred into ddw for 30 mins, with agitation, during 
which time the PPO precipitated in the gel. Gels were then 
dried under vacuum at 60°C for 2 hours.
2.20.4 Photography.
Stained gels and autorads were routinely photographed from 
above using a Pentax SP500 camera with Kodak Panatomic X film 
(ASA 32).
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2.21 Vitamin B1= receptor protein purification.
The method used was essentially that of Sasaki, 1972 with 
modifications. 4 litres of cells were harvested (8,000 rpm, 
4°C, 20 mins) and passed through a French Pressure cell twice 
(18,000 psi). Cell walls were sedimented at 27,600 x g for 20 
mins and washed twice with TSM (10 mM Tris-succinate buffer pH
7.2 containing 5 mM Magnesium acetate). Supernatant and 
washings from the walls were combined and again subjected to 
the above centrifugation. Walls were resuspended in the same 
buffer at a concentration of 25 mg walls per ml in a final 
volume of 150 ml. 5 mg of Vitamin B12 (Sigma) was added to 
the suspension, followed, by a incubation for 20 min with 
stirring. 5 mg of ribonuclease and 100 mg of lipase was then 
added, followed again by incubation at 37°C for 24 hours.
Walls were spun down as before, washed twice with ddw and 
resuspended in ddw. HC1 was added to give a final 
concentration of 0.2 M and an approximate concentration of 15 
mg ml-1 of walls. This was followed by incubation, with 
stirring, at 37°C. The Vitamin B12 receptor protein would 
then be found in the supernatant. The supernatant was 
neutralised with 10 M NaOH and dialysed against 0.01 M 
phosphate buffer (pH 7.0), containing 0.1 M NaCl (PBN) at 4°C 
for 48 hours.
A280 and A361 values were measured and protein amount 
determined (Section 2.22). Then the dialysed material was 
concentrated down to a third of the volume and placed onto a
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CM-cellulose column equilibrated with PBN. The column was 
eluted first with PBN and then with a linear gradient 
concentration of phosphate buffer (pH 7.0), containing a 
constant concentration of 0.1 M NaCl.
2.22 Protein determination.
Protein concentration was assayed using a modified Lowry 
method described by Herbert et al, 1971, using bovine serum 
albumin standards. The phenol reagent of Folin-Ciocalteu is 
reduced by phenols and many other substances, such as proteins 
to molybdenum blue, which may be determined colormetrically.
To 0.5 mis of a suitable dilution of protein sample, 0.5 mis 
of 1 M NaOH was added and the sample boiled for 5 mins to 
ensure complete solubilisation and then rapidly cooled. 2 mis 
of 0.5% (w/v) CuS045H20 dissolved in 1% (w/v) sodium potassium 
tartrate were added to 50 mis of 5% (w/v) Na2C03 and 2.5 mis 
of this freshly prepared solution were added to each protein 
sample. Samples were left to stand for 10 min at room 
temperature and 0.5 mis of a 50% (v/v) solution of Folin- 
Ciocolteu reagent (BDH) rapidly added and mixed well. Samples 
were left to stand at room temperature for 30 min and A750 
measured against a blank of ddw treated as described above. 
Protein concentrations were determined by reference to a plot 
of protein concentration against absorbance prepared by using 
standard bovine serum albumin concentrations for each assay. 
Chromic acid-washed tubes were employed at all times.
I
2.23 Assay for receptor protein.
The method used was that described by Aufrère et al, 1986.
2.24 Preparation of antisera.
Antisera was raised in a New Zealand White rabbit. A blood 
sample was taken from the ear before injection; this contained 
pre-immune serum.
100 ng of protein in 1 ml of phosphate buffer (pH 7.0), 
containing 0.1 M NaCl was mixed with 1 ml of Freund's complete 
adjuvant by passing the mixture repeatedly between two glass 
syringes. The resulting stiff white emulsion was injected 
sub-cutaneously into the back of the neck. 21 days later, a 
booster injection of the same protein sample, mixed with 1 ml 
of Freund's incomplete adjuvant was administered and this was 
repeated after seven days. One week later, the rabbit was 
bled. Blood was taken once every two weeks for several weeks. 
Pre-immune and post-immune sera were stored in aliquots at - 
2 0 ° C .
2.25 Western transfer of protein.
Transfer of proteins separated by PAGE to nitrocellulose.
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The method of Towbin et al, 1979 was used.
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A nitrocellulose membrane filter was cut to the size of the 
polyacrylamide gel, soaked in Western transfer buffer (WTB) 
and placed on top of the gel. Care was taken to remove air 
bubbles between the gel and the nitrocellulose. Using a 
BioRad Transblot tank and power supply according to the 
manufacturer's instructions, transfer of proteins from gel to 
nitrocellulose was carried out at 280 mA for 3 hours.
After transfer, the nitrocellulose filter was rinsed in ddw to 
remove excess salt. Filter was then stained to visualise 
protein bands with Ponceau S (0.5% (w/v) in 5% (v/v) TCA). 
Stain was totally removed by washing in Tris buffered saline 
(TBS). Two 10 min washes in TBS were followed by fresh TBS 
containing 2% (w/v) dried milk and shaken for 1 hour to allow 
protein to bind non-specifically to the nitrocellulose. 
Antiserum at a dilution of 1:500 was added and the filter 
allowed to shake in this solution overnight at room 
temperature. The filter was then washed twice in TBS 
containing 0.1% (v/v) Tween 20.
Detection of antigen-antibody complexes using a horseradish 
peroxidase colour reaction.
Peroxidase conjugated goat anti-rabbit IgG was used as 
secondary antibody and chloronaphthol (Sigma) as the colour 
reaction reagent.
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After the washes in TBS as indicated above, filter was 
transferred to a fresh solution of TBS, containing 0.1% (v/v) 
Tween 20 and 1:300 secondary antibody and left shaking for 2 
hours. After 2 washes in TBS containing 0.1% (v/v) Tween 20 
and 2 washes in TBS, filter was transferred to a solution 
containing 1% (w/v) NaCl, 1% (v/v) 1 M Tris HC1 (pH 7.5), 
0.05% (w/v) 4-chloro-l-naphthol (Sigma) and 10% (v/v) of 
methanol.
50 jil hydrogen peroxide (Fisons) was then added to initiate 
the staining reaction. Before completion of reaction, filter 
was washed with ddw, air dried and stored in the dark.

113
Chapter 3. The isolation and cloning of L. leichmannii
genomic DMA exhibiting homology to the E. coli gene (btuB) 
encoding the vitamin receptor protein.
3.l Introduction.
In order to identify and isolate a specific DNA fragment 
encoding the Vitamin B12 receptor protein in Lactobacillus 
leichmannii, a heterologous hybridisation approach was 
employed, rather than a direct 'shotgun' approach. The 
latter method was not chosen, due to the low transformation 
efficiency of ligated plasmid DNA into protoplasts, as 
compared to that of CaCl2-treated E. coli, together with the 
fact that it relies upon expression of the gene for its 
initial isolation.
The cloning strategy used involved the construction of 
recombinant plasmid DNA molecules in E. coli where standard 
DNA methodologies could be applied.
In addition, the structural gene for the Vitamin B12 
receptor (btuB) has been cloned from E. coli (Heller et al. , 
1985; Aufr6re et al., 1986; Moir et al., 1987), which may be 
used as a heterologous probe. Consequently there is 
considerable information available pertinent to the 
structure and expression of this gene.
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3.2 Results and Discussion.
In an attempt to isolate any 'jbtuB-like' sequences encoding 
the Vitamin B12 receptor protein in L. leichmannii, a 
synthetic oligonucleotide was designed from the E. coli btuB 
gene, to use as a heterologous probe to the Lactobacillus 
genome.
3.2.1 Design and synthesis of the oligonucleotide probe.
An E. coli mutant has been described (Kadner & Liggins,
1973) in which Vitamin B12 transport was completely 
defective. Subsequent complementation analysis indicated 
that the mutation in this strain was in the btuB gene. The 
mutational lesion was determined by nucleotide sequencing 
and a single amino acid substitution near the amino terminus 
of btuB was identified (Heller & Kadner, 1985). This 
mutation was associated with a T to C transition at residue 
394 - as illustrated in Figure 3.1. This nucleotide change 
predicts the substitution of proline for leucine at the 
eighth amino acid residue of the mature polypeptide.
An oligonucleotide probe was designed from this region. 
Initially, the amino acids around residue 394 were studied 
with respect to codon usage. The IBM 'Staden' program was 
used to determine the frequency of codon usage for each 
amino acid in the entire btuB gene (Figure 3.2). The 
deduced nucleotide sequence of the mixed oligonucleotide
Figure 3.1 Nucleotide sequence of the structural gene 
for the Vitamin B12 receptor (JbtuB) in 
Escherichia coli.
10 20 30 40 SO 60 70 80 90 100 110 120 130
SATCTTASATBAATTCCTftTTTBT3AGCTACSTCTGBM:ASTAACTTSTT«CAACCTSTASCATCCACTTSCCSGTCCTBTGASTTAftTft6GBAflTCCAGTSCSAATCTBSftGCTGftCGCSCfiBCSGTAA
H O  150 160 170 180 190 200 810 220 230 240 250 260
SSAAAGG7SCEA7GAT78EG77A7GEBEAGAG7EGGEA77EG67GEGAAE7GA7GA7G7E77A37A7G77ASA7AEGGG7GGAAECGG6AA3AGE7E3GGGEGAAGG7GECA7E7EGT7GTGA7GA7EGC
270 2B0 290 300 310 320 330 340 350 360 370 . 380 390
GTAATATTGATGAAACCTGEGGCATCCTTCTTCTATTGTGGATGCTTTACAATGATTAAAAAAGCTTCCCTGETSACGGCGTGTTCCGTCACGSCATTTTCCSCTTSSSCACASGATACCAGCCCGGATA
HetneLysLysAlaSerLeuLeuThrAUCysSerValThrAlaPheSerAHTrpAnBlnAspThrSerProAspT
400 410 420 430 440 450 460 470 480 490 500 510 520
G7G7G6TGG77AG7EG7AAGGG77T7SAAGAGGG6GG0A6GAG7G7GG77GGAGGAAGGAGGG77B7GAG0G67EAEGA7A7GEAGGGG7GGEA670GAEG7GGGTGAA7GA7G7GGTGGGGEG7G77GG 
hrleuValValThrAlaAsnArgPheGlualrProArgSerThrValLeuAlaProThrThrValOalThrArgG'.nAsplleAspArgTrpGlnSerThrSerValAsnAspValLeuArgArgLeuPr
530 540 550 560 570 580 590 600 610 620 630 640 650
GG6CGTCGA7ATCACCCAAAACGGCSGT7CAGGTCAGCTCTCA7CTA7777TAT7E6C6G7ACAAA7SECAG7EA7GTGTTG676TTAATT6A766CGTACBCCTBAA7C7G6E3SBG67GAG76G7TC7 
oGlyValAspIleThrGlnAanGlyGlySerBlyGlnLeuGerSerllePhelleArgElyThrAsnAlaSerHisValLeuValLBuHeAspGlyValArgLeuAsnLeuAlaBlyValSerSlySer
660 670 680 690 700 710 720 730 740 750 760 770 780
EEESAGE77A6GGAB7TGCG7A77B0BGT737EGABGE7S77BAA7A7A7GGG76EGGGBCGGTGEBG78T77A7G677GE3A7SGAA7AGGEBGGG7B67GAA7A7EA7GAE3AGEE6GBA7EAAGCGE
AlaAspLeu3erGl!iPheProrieA!aLsuVaiGlnArgValGluTyr!leArgSlyProArgSerAlaValTyr61y5erAspAlaI!eE!yG!yValValAsnIleI'.eThrThrArgAspGluProG
790 BOO 810 820 B30 840 850 860 870 880 890 900 910
GAAGBSAAA777£AG£A6GG7GGGGAAGGAATAG77A7£AEAA£7A7GA7ST£7G7AGSGAG£AACAAE7GGGGGA7AAGAGAGGGG7AAGE£7G77GGGGGA77A7GGGGA7AG7GA73377A7EA7G7 
lyThr Giuli sGarGlyGlyTrpBlyGerAsnGerTyrGlnAsnTyrAspValSerThrBlnSlnGlnLeiiElyAspLysThrArgValThrLeuleuBlyAspTyrA’.aHisThrHiaGlyTyrAspVa
920 930 940 950 960 970 980 990 1000 1010 1020 1030 1040
7B773GG7A7GE7AA7AGE33AAEBEAASESEAGAEASA7AAGGA7G6T77777AA67AAAAG6G777A7GBG6GGG7SGAGGA7AAG777AG7SA7EGE7EGAGGSGG777673CBGGGG7A73GG7A7
lVaiAlaTyr61yA5nThr31yThr61nAlaGlnThrAspAsnA5pGlyPheLeuSerLysThrLBuTyrSlyAlaLBu61uHi5AsnPheThrAspAlaTrpSerG!yPlieValflrgGlyTyr61yTyr
115
1050 1060 1070 1080 1090 1100 1110 1120 1130 1140 1150 1160 1170
EATAACCSTAC£AATTAT3ACGC3TATTAT7CTCC£GSTTCACES7TGC7CGATSCCC5TAAACTCTATAGCCAAAGTTBSBA:BC:SS3£T3CGETATAACGGCSAACTSATTAAATCACAAC'EATTA 
AspAsnArgThrAsnTyrAspAlaTyrTyrSs-PraSIySerProLeuLauAspThrArgLyiltuTyrSerBlnSerTrpAspAlaBlyLBuArgTyrAsnS’yGluLeullalysierBlrieLlle'
1180 1190 1200 1210 1220 1230 1240 ¡250 1260 1270 1290 1290 1300
£CAG;TATABCCATABCAAAGA7TACAACTAC6A!C£:CATTATGS~:GTTAT3A77C3TCG3CGACSCT:GATGASA7SAASCAATACACCSTCCAETEGECAAACAATGT£ATC6TT6ETCAlSBTAG
hrEer'yrSerHisSerlysAspTyrA5-7yrA5p?roHÌ57yrSlyArg7yrA*pSerSerAlaThrLeuAsp61uHetLysGlii7yrTh7Val31nTrpA!aAsnA5nVaiIl»VilGlyHi5SlySe
1210 1320 1330 1340 1350 1360 1370 1380 1390 1400 1410 1420 1430
7AT7SG7GCGBGTS7CSAC7GSCASAAACA5AC7ACGACGCC26G7ACAGET7At G773AG3A75GA7ATSA‘CAACS7AATACC36CATC7A7C7BACC6GGC75CAACAAB7C5BCGAt TT7AC:tTT 
r:i»6!yA!aBlyValAsp7rpGlr.LysSln7hr7hrThrPrcGly7hrSiy7yr0alSluAspGly7yrA5pBlnArgAsn7hrSlyIleTyrLeu7hrBlyliuB!nBlRValSlyAspPhsThrPhe
1440 1450 1460 1470 1480 1490 1500 1510 1520 1530 1540 1550 1560
3AASSCG£CA6fi£6GA37GA£6ATAAG7CACAE77T3G7EG7CA7S6AA£C73EEAAA££AGGS£GS377SBEAAT7£A7EGAAEE77ATEEE7TCA778£7TG£7AGSGGACA7E7TATAAE6GACGAA 
3!uBlyA!aArgArgSerAspA5pAsnSerBlnPheSIyArgHUGly7hr7rpBl!iThrSerAlaGly7rpBluPh*l!eGluBlyTyrArgPheneAlaSerTyrBlyThrSgrTyrLysAlaProA
1570 1580 1590 1600 1610 1620 1630 1640 1650 1660 1670 1680 1690
ATE7B6BGEAAE7B7A7GGE77E7AC3GAAA7;ESAA7C7GBA:eEGSA2AAAA3EAAAEAG7EGGAAG6EBE377TBAABGE7TAAEEE:7ESGB7SAAE73GCGTATT7CESBATATEGTAAESATS7 
snLeuGlyBlnLeu7yr61yPheTyrElyA5r.PrcAsnLauAspPro81uLysSerLysGinTrpSluGlyAUPheBluGlyL8u7hrAiaGlyValAsn7rpArgIleSerB!yTyrArgAsrAspVa
1700 1710 1720 1730 1740 1750 1760 1770 1780 1790 1800 1810 1820
CAGTSAET7BA7CGA7TA7GATSATEACACEE7GAAA7AT7ACAAEBAAGGSAAAGEEEGGA7TAAGGGEGTEGAG5E5ACEGEEAAT77TBATACESGACEAE7GAEGEATAE7GTBAGT7A7BA77AT 
!SerAspLeuneA5p7yrA5pAspHÌ5ThrLBuLys7yr7yrAs!!31uGlyly5AUArgIl8Ly531yValGluAla7hrAlaA5r\PheA5p7hr31yPj-oLeu7hrHÌ57hrVal3er7yrA5p7yr
1830 1840 1850 1860 1870 1880 1890 1900 1910 1920 1930 1940 1950
67E3ATSEGEGEAATSEGA77AEEGACAEGEESTTBT7AEBCEG7GETAAAEAGEAGG7BAAA7AEEAGETEEAE7GGCAGT7G7ATGAE77CGAE7GGGG7ATTAE7TATEAS7AT77AGGEAE7EGE7 
ValAspAlaArgAsnAlaIle7hrA5p7h7ProLeui.BuArgArgAlaLysEln61r.ValLys7yrSlnLeuA5pTrpBlnLsu7yrAspPhBA5pTrpGlyIlB7hrTyrGln7yrLBuGlyThrArg7
1960 1970 1980 .990 2000 2010 2020 2030 2040 2050 2060 2070 2080 
ATEATAAGGATT AC7EATE7T A7EET7 A7EAAAEC57T AAAA73E3E3St 37BAGG77376G3A7E773£EG77E£E7A7EEB37GAGG7E7£A£E7GA£AG77£B7B£7AAAA7 AGEEAAEE7S77EGA 
yrAspLysAsp7yrSerSerTyrProTyrGln7hrValLys!lBtBlySlyValSBn.Bu7rpA5pLBuAlaValAla7yrPrcValTlirSsrHi5L8u7hrValArgGlyLysIlBAlaAsnLBuP!!sAs
2090 2100 2110 2120 2120 1140 I1S0 2160 2170 2180 2190 2200 2210 
CAAAGA77ATGA6ACA6TC7A7GSE7ACGAAAC73CAGEAC6SSAA7ACA£C7737CTB3CA6E7ACA:E77C7SAACEAGETGECACGE7BE73S7E7TTEAGT£G5G£G7CGETSGGT7STE36t C7A 
pLy5Asp7yrG!u7hrValTyrGlyTyrGln7hrA!aGlyArgSluTyr7hrLsuSerG!ySBrTyr7hrPhfiEnd
2220
'3A33AGA7C
Figure 3.2 Codon usage of the Escherichia coli btuB gene
T T T P h e 1 1 ( 1 . B )
T T C P h e
"7 ( 1 . 1 )
T T A L e u 5 ( 0 .8 )
T T G L e u a ( 1 . 3 )
C T T L e u 6 ( 1 .0 )
C T C L e u "7 ( 1 . 1 )
C T A L e u 0 ( C . O )
C T G L e u i p ( 3 . 1 )
A T T 1 l e 1 A ( 2 . 3 )
A T C I l e 9 ( 1 . 5 )
A T  A I l e 2 ( 0 . 3 )
A T G M e t 3 ( 0 . 5 )
G T T V a l 11 ( 1 . 3 )
G T C V a l 1 5 ( 2 . A )
G T A V a l 2 ( 0 . 3 )
G T G V a l 1 3 ( 2 . 1 )
T A T T y r 3 8 ( 6 . 2 )
T A C T y r 1 1 ( 1 .8 )
T A A E n d 0 ( 0 . 0 )
T A G E n d 0 ( 0 . 0 )
C A T H i s a ( 1 . 3 )
C A C H i  s 3 ( 0 . 5 )
C A A G i n 1 A ( 2 . 3 )
C A G G i n 2 0 ( 3 . 3 )
A A T A s n 1 A ( 2 . 3 )
A A C A s n 1 A ( 2 . 3 )
A A A L y s 1 6 ( 2 . 6 )
A A G L y s c ì ( 0 . 8  >
G A T A s p 3 6 ( 5 . 9 )
G A C A s p 1 3 ( 2 . 1 )
G A A G i u 12 ( 2 . 0 )
G A G G i u 6 ( 1 .0 )
T C T S e r 8 ( 1 . 3 )
T C C S e r 7 ( 1 . 1 )
T C A S e r •7 ( 1 . 1 )
T C G S e r A ( 0 . 7 )
C C T P r o 2 ( 0 . 3 )
C C C P r o 3 < 0 . 5 >
C C A P r o 3 ( 0 . 5 )
C C G P r o 10 ( 1 . 6 )
A C T T h r 10 ( 1 . 6 )
A C C T h r 2 5 ( A  . 1 )
A C A T h r 7 ( 1 . 1 )
A C G T h r 1 A ( 2 . 3 )
G C T A l a 7 ( 1 . 1 )
G C C A l a 1 0 ( 1 . 6 )
G C A A l a 7 ( 1 . 1 )
G C G A l a 1 5 ( 2 .  A  )
T G T C y s 1 ( 0 . 2 )
T G C C y s 0 ( 0 . 0 )
T G A E n d O ( 0 . 0 )
T G G T r p 1 A ( 2 . 3 )
C G T A r g 1 A ( 2 . 3 )
C G C A r  g 1 A ( 2 . 3 )
C G A A r  g 0 ( 0 . 0 )
C G G A r  g 3 ( 0 . 5 )
A G T S e r 9 ( 1 . 5 )
A G C S e r 1 3 ( 2 . 1 )
A G A A r  g 1 ( 0 . 2 )
A G G A r  g 0 ( 0 . 0 )
G G T G l y 2 2 ( 3 . 6 )
G G C G l y 2 1 ( 3  . A  )
G G A G l y 1 0 ( 1 . 6 )
G G G G l y 1 1 ( 1 . 8 )
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probe is presented in Figure 3.3. It is made up of 27 bases 
with four degeneracies.
Since there is considerable amino acid sequence homology 
existing within outer membrane proteins, such as ompC, ompF 
and phoE, the 'diagon' sub-routine of the 'Staden' program 
was employed to determine the level of homology between the 
btuB gene and the proposed oligonucleotide with these outer 
membrane proteins. The results obtained are presented in 
Figure 3.4 and suggest a high probability that the synthetic 
probe chosen would not hybridise to any genes in 
L. leichmannii which may encode proteins similar to the 
outer membrane proteins mentioned above. This correlates 
well with the work of Heller and Kadner (1985), who also 
came to the conclusion that there are no strongly conserved 
sequences common to outer membrane proteins.
The newly synthesised oligonucleotide was purified according 
to the method detailed in Section 2.13.1. The melting 
temperature for the mixed oligonucleotide probe was 
estimated to be 85°C (Lathe, 1985).
L. leichmannii genomic DNA was prepared and digested to 
completion with a variety of restriction endonucleases, 
fractionated by agarose gel electrophoresis, Southern 
blotted onto nitrocellulose and probed at low stringency 
with the [7-32P]dATP labelled oligonucleotide. The 
resulting autoradiograph is presented in Figure 3.5.
Figure 3.3 Design and sequence of the synthetic 
oligonucleotide.
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(a) 4 5 6 7 8 9 10 11 12
- Ser - Pro - Asp - Thr - Leu - Val - Val - Thr - Ala
(b)
TCG GGC CTA TGA GAC CAG CAC TGA TTG
(c)
AGC/TCCGGATACTCTC/GGTC/GGTC/GACTAAC
(a) Amino acid sequence of the N-terminal region of the 
mature E. coll BtuB polypeptide, (b) Reverse translation to 
nucleotide triplets of amino acids 4 to 12 and (c) The 
oligonucleotide probe derived from them.
Figure 3.4 Comparison of the proposed synthetic 
oligonucleotide with other outer membrane 
proteins.
Key:-
(a)
(b)
(c)
(d)
(e)
(f)
(g)
btuB ORF vs ompF ORF
btuB ORF vs mixed oligonucleotide probe
ompF ORF vs mixed oligonucleotide probe
btuB ORF vs ompC ORF
ompC ORF vs mixed oligonucleotide probe
btuB ORF vs phoE ORF
phoE ORF vs mixed oligonucleotide probe.
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Figure 3.5 Examination of L. leichmannii genomic DNA for 
homology with the synthetic oligonucleotide.
L. leichmannii 4797; L. leichmannii 8964, L . casei 7473 and 
E. coli HB101 genomic DNAs were restricted as indicated, 
fractionated by agarose gel electrophoresis and Southern 
blotted onto nitrocellulose. The resulting blot was probed 
with the [7 32P]dATP labelled 27' mer oligonucleotide at low 
stringency and subjected to autoradiography.
Key to tracks
A E. coli HB101 genomic DNA restricted with EcoRl 
B L. leichmannii 4797 genomic DNA restricted with Sail
C L. leichmannii 4797 genomic DNA restricted with Hindlll
D L. leichmannii 4797 genomic DNA restricted with EcoRI
E L. casei 7473 genomic DNA restricted with Sal I
F L. casei 7473 genomic DNA restricted with Hindlll
G L. casei 7473 genomic DNA restricted with EcoRI
H L. leichmannii 8964 genomic DNA restricted with Sail
I L. leichmannii 8964 genomic DNA restricted with Sindlll
J L . leichmannii 8964 genomic DNA restricted with EcoRl
Tracks K to T are autoradiographs of corresponding tracks A 
to J probed with [7 32P]dATP labelled oligonucleotide.
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Progressively more stringent washes were employed until the 
probe was washed off.
3•2 ? 2 Cloning of L. leichmannii DNA exhibiting homology to 
the synthetic oligonucleotide.
The 2.0 Kb ifindlll fragment of L. leichmannii 4797 was 
chosen for isolation. The cloning strategy adopted (Figure 
3.6) involved the construction of a selective gene bank in 
the Hindlll site of pBR327; the resulting library being 
screened by hybridisation.
Due to possible sequence homology between the synthetic 
oligonucleotide probe and the resident btuB gene of the 
surrogate E. coli HB101 host used to construct the gene 
library, the amplifiable high copy number vector pBR327 
(Figure 3.13) was used to optimise the autoradiograph signal 
of any positive clone over the background signal resulting 
from this homology.
Screening of the library was carried out with [7 ~32P]dATP 
labelled synthetic oligonucleotide and the resulting 
autoradiograph (Figure 3.7) shows two clones clearly above 
background, designated clone 1 and clone 2. Plasmid DNAs 
from both clones were isolated, restricted with ffindlll, 
fractionated by agarose gel electrophoresis, Southern 
blotted and probed with the labelled oligonucleotide probe. 
Both clones harboured a single 2.0 Kb ffindlll DNA fragment
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Figure 3.6 Cloning strategy adopted for the isolation of 
L. leichmannii DNA exhibiting homology to the 
synthetic oligonucleotide.
I
Transform E.coli HBIOI
r
Select Apr 
colonies
Colony blot
1 .
Probe with P-labelled  
oligo’ or btuB gene
1
A u to ra d io g ra p h
1.
Isolate positive colonies
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Figura 3.7 Screening of a selective L. leichmannii gene
bank for sequences homologous to the synthetic 
oligonucleotide.
The cloning of the L. leichmannii DNA exhibiting homology to 
the synthetic oligonucleotide was carried out as outlined in 
Figure 3.6. The resulting colony blot was probed at high 
stringency. The figure shows two clones (clones 1 and 2) 
clearly above background.
Keys to controls
A pBR327
B pNF48
which exhibited strong homology to the oligonucleotide 
probe. These clones were redesignated pSDCl and pSDC2.
3.2.3 Cloning of L. leichmannii DNA exhibiting homology to 
the E. coli btuB gene.
Screening of the Lactobacillus limited genomic library was 
also carried out with a [o-32P]dATP labelled 1.5 Kb EcoRl 
fragment isolated from plasmid pNF48 (Figure 2.1) harbouring 
the E. coli btuB gene. Two putative clones, identical to 
those above - pSDCl and pSDC2 - were clearly identified 
above background.
3.2.4 Characterisation of pSDCl and pSDC2.
Initially, the clones were mapped with respect to the 
restriction endonuclease sites in the vector (Figure 3.8). 
pSDCl and pSDC2 appeared to produce similar restriction 
patterns although undigested DNAs appeared different. There 
appeared to be anomolies with the expected fragment sizes of 
various restriction enzymes from the 'vector' portion of 
pSDCl. Therefore, digests were carried out on pBR327 in 
conjunction with pSDCl (see Figure 3.9). All digestions 
concerning the vector alone yielded fragments of the correct 
size (other than a partial digestion with restriction 
endonuclease sphl).
Numerous double digests were therefore carried out in order 
to determine the restriction endonuclease sites within the
1 2 4
■■■
Figura 3.8 Restriction endonuclease mapping of the
L. leichmannii clones pSDCl and pSDC2.
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pSDCl plasmid DNA was digested to completion with a number 
of restriction endonucleases and the resulting DNA fragments 
were fractionated by agarose gel electrophoresis.
Key to tracks:-
A pSDCl DNA restricted with tfindlll
B pSDCl DNA restricted with EcoRI
C pSDCl DNA restricted with BamHI
D pSDCl DNA restricted with PstI
E pBR327 DNA restricted with EcoRI
F pSDCl DNA restricted with Hindi
G pSDCl DNA restricted with Aval
H pSDC2 DNA restricted with HindiI
I pSDC2 DNA restricted with Hindi
J pSDC2 DNA restricted with Aval
K pSDCl DNA
J
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L. leichmannii clone pSDCl.
Keys to tracks
Figure 3.9 Restriction endonuclease mapping of the
A B C D E  F G H | J k l m n o p Q r s t
A \ HindlII DNA markers
B pBR327 DNA
C pSDCl DNA
D pSDC2 DNA
E pBR3 27 DNA restricted with HindiII
F pBR327 DNA restricted with Hindi
G PBR327 DNA restricted with Aval
H pBR327 DNA restricted with BamHI
I pBR327 DNA restricted with Pst I
J pSDCl DNA restricted with HindlII
K pSDCl DNA restricted with Hindi
L pSDCl DNA restricted with Aval
M pSDCl DNA restricted with BamHI
N pSDCl DNA restricted with PstI
O pBR3 27 DNA restricted with Clal
P pBR327 DNA restricted with SphI
Q pBR327 DNA restricted with EcoRI
R pSDCl DNA restricted with Clal
S pSDCl DNA restricted with SphI
T pSDCl DNA restricted with EcoRI
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insert (Figures 3.10, 3.11 and 3.12). From this data, a 
restriction map of pSDCl was determined, as detailed in 
Figure 3.13.
3.2.5 Expression analysis of the cloned Lactobacillus DNA.
The structural gene encoding the Vitamin B12 receptor 
protein, is required in its entirety for the purpose of 
expression and manipulation, initially in E . coli and then 
for re-introduction into Lactobacillus for analysis. These 
studies were therefore designed to determine the expression 
and functionality of the Lactobacillus 'btuB-like' sequence 
in a heterologous host and to identify the resulting gene 
product.
3.2.5.1 Complementation analysis.
The E . coli btuB~ mutant, Ll-431 was transformed with the 
recombinant pSDCl and pNF48 (control). Transformants were 
selected onto LB agar containing ampicillin
(100 /ig ml-1). Approximately equal numbers of transformants 
were obtained. To detect whether the recombinant pSDCl had 
complemented the btuB lesion due to an intact and functional 
btuB gene, located within the 2.0 Kb Hindlll fragment of 
pSDCl, the T5-like phage, BF23 was employed, since as 
previously described, BF23 also uses the BtuB protein as its 
receptor and therefore plaques will form on plates 
containing a complemented lesion of btuB. This hypothesis
128
Figure 3.10 Restriction endonuclease napping of pSDCl.
pSDCl plasmid DNA was digested to completion with a number 
of restriction endonucleases and fractionated by agarose gel 
electrophoresis.
Key to tracks:-
A A NindlII DNA markers
B pSDCl DNA restricted with PstI and PvuII
C pSDCl DNA restricted with PstI and EcoRV
D pSDCl DNA restricted with PstI and Sail
E pSDCl DNA restricted with PstI and Aval
F pSDCl DNA restricted with PstI and Hindi
G pSDCl DNA restricted with PstI and Hindlll
H pSDCl DNA restricted with PstI only
I pSDCl DNA restricted with PvuII and EcoRI
J pSDCl DNA restricted with EcoRV and Sail
Figure 3.IX Restriction endonuclease mapping of pSDCl
Key to tracks:-
A pSDCl DNA restricted with EcoRV and Bgill
B pSDCl DNA restricted with EcoRI and EcoRV
C pSDCl DNA restricted with EcoRI and Hindi
D pSDCl DNA restricted with EcoRI and SacI
E pSDCl DNA restricted with EcoRI and Sail
F pSDCl DNA restricted with EcoRI and Xho I
G pSDCl DNA restricted with Hindi and EcoRI
H pSDCl DNA restricted with Hindi and PvuII
I pSDCl DNA restricted with PstI and Cia I
J pSDCl DNA restricted with PstI and EcoRI
K pSDCl DNA restricted with PstI and Hindlll
Figur« 3.12 Restriction endonuclease mapping of pSDCl
Key to tracks:-
A X Hindi!I DNA markers
B pSDCl DNA restricted with EcoRI and PvuII
C pSDCl DNA restricted with EcoRI and EcoRV
D pSDCl DNA restricted with EcoRI and Hindlll
E pSDCl DNA restricted with EcoRl
F pSDCl DNA restricted with Hindi and PstI
G pSDCl DNA restricted with Hindi and PvuII
H pSDCl DNA restricted with Hindi and EcoRl
I pSDCl DNA restricted with Hindi
J pSDCl DNA restricted with PstI and HindiII
K pSDCl DNA restricted with PstI and Hindi
L pSDCl DNA restricted with Pst I and EcoRl
M pSDCl DNA restricted with PstI
M M
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Figura 3.13 Restriction endonuclease map of pSDCl with the 
published map of pBR327 for comparison.
Key
El BcoRI
Hill tfindlll
BI BamHI
EV BcoRV
PII PvuII
PI Pst I
SI Sail
HII Hindi
AI Aval
XI Xmal
Cl Clal
Spl SphI
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held true for E. coli Ll-431 transformed with pSDCl, as did 
E. coli Ll-431 transformed with pNF48.
The 2.0 Kb tfindlll insert of pSDCl was subsequently recloned 
in the opposite orientation in pBR327, by restriction of 
pSDCl with Hindlll, followed by religation and 
transformation into E. coli HB101. The resultant plasmid 
was designated pSDC3 and the orientation of the insert 
confirmed by restriction analysis. Subsequent 
transformation and failure of complementation of the btuB 
lesion in Ll-431 with pSDC3 revealed that the cloned JbtuBL 
gene was not expressed from a regulatory region contained 
within the cloned DNA fragment but was possibly expressed 
from a foreign (vector) promoter.
3.2.5.2 In vivo expression analysis.
In order to identify any polypeptides encoded by the 2.0 Kb 
Lactobacillus Hindlll fragment, it was necessary to attempt 
to express the gene located on plasmid pSDCl and/or pSDC2 in 
an E. coli gene expression system. The two in vivo gene 
expression systems applicable to recombinant plasmids in 
common use are, minicells (Clarke-Curtiss & Curtiss, 1983) 
and maxicells (Sancar et al., 1979). The uses and relative 
merits of these systems are discussed by Stoker et al.
(1984) .
The maxicell system was chosen because it is versatile, 
amenable to use with large numbers of samples and with 
careful handling, can produce good results.
The use of maxicells relies on the deficiency in DNA repair 
observed in UV-sensitive strains, such as those which carry 
a recA mutation. The recA strain carrying the plasmid of 
interest is UV-irradiated and incubated overnight to allow 
the breakdown of UV-damaged chromosomal DNA, whilst leaving 
undamaged plasmid DNA molecules intact. Plasmid-coded 
proteins can then be preferentially labelled with 
3 5S-methionine and samples analysed by SDS-PAGE.
The plasmids pSDCl, pNF48, pSDC2 and pBR327 were transformed 
into the E . coli maxicell strain CSH26AF6 (Stoker et al.,
1984). The resulting transformants were allowed to 
synthesise proteins in the presence of 3 5 S-methionine as 
described in Chapter 2 (Section 2.17.1). The de novo 
synthesised plasmid encoded proteins were electrophoresed on 
an 11% SDS-denaturing polyacrylamide gel and visualised by 
fluorography. The resulting fluorograph (Figure 3.14) 
clearly shows the pattern of proteins synthesised by the 
E. coli maxicells harbouring pBR327 and additional proteins 
encoded by pSDCl and pSDC2.
Ijl.2,5,3 In vitro expression analysis.
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The specific matching of a cloned gene with a previously 
unidentified polypeptide product and whether that gene has
IEiquro 3 . 1 4  In  vivo translation products of nann 
B.8DC2 .
The fluorograph shows 3 5S-methionine labelled polypeptide 
products of pSDCl and pSDC2 using the E. coli maxicell 
system.
Key to tracks
A pNF48 encoded polypeptides
B pSDCl encoded polypeptides
C pSDC2 encoded polypeptides
D CSH26AF6 control
E pBR327 encoded polypeptides
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been cloned together with its own promoter, is frequently 
difficult to establish using in vivo systems. However, in 
vitro systems circumvent these problems. Two further 
advantages of the in vitro system, first described by De 
Vries and Zubay (1967) are that, incorporation of 
radioactive label into protein is far more efficient than is 
possible using in vivo methods and also DNA derived from 
bacteria other than E. coli is efficiently expressed (Pratt 
et al., 1981) .
Following the in vitro transcription-translation reactions 
using the E. coli cell free coupled transcription- 
translation system (Section 2.17.2) and 3 5S-methionine as 
the labelled amino acid, the resulting proteins were 
electrophoresed on an 11% SDS-denaturing polyacrylamide gel 
and fluorographed. The resulting fluorograph (Figure 3.15) 
shows that when either pSDCl or pSDC2 were used as 
templates, they directed the synthesis of a single major 
polypeptide with an Mr of 66,400, in addition to vector 
(pBR327) specific polypeptides.
The polypeptide encoded by pSDCl and pSDC2 had an identical 
Mr to that produced by pNF48 which harbours the E . coli btuB 
gene. This polypeptide was thus proposed to be the product 
of the L. leichmannii btuB gene.
After the success of gene expression from circular DNA, 
pSDCl was digested to produce linear templates for analysis 
in the Zubays in vitro system. pSDCl was digested with 
Hindlll initially which resulted in the loss of the
Figure 3.j5 In vitro translation products of psdci and 
p8DC2.
The fluorograph shows the various 3 5S-methionine labelled 
plasmid encoded products. The Mr 30,000 polypeptide 
corresponds to 0-lactamase of the vector pBR327.
Key to tracks:
A pNF48 encoded products
B pBR327 encoded products
C pSDCl encoded products
D pSDC2 encoded products
13 7
Mr-66,400 protein, as produced by pNF48 (positive control) 
and pSDCl. This implies that the 2.0 Kb Rindlll insert did 
not in fact possess its own promoter, but possibly the 
66,400 polypeptide was the result of read-through from 
vector sequences. This data correlates well with the 
complementation data. To test this hypothesis the following 
digests of pSDCl were made; Pvull (to release two linear 
fragments) and PstI (to release one linear fragment, 
inactivating the ampicillin gene in the process). The 
resulting autoradiograph is shown in Figure 3.16. It can be 
seen that a protein with an Mr of 66,400 was expressed, 
using the Pvull restricted DNA as the template. This 
suggests that a functional promoter sequence exists possibly 
between the Hindlll site of the initial insert and the newly 
formed Pvull site in pSDCl (see Figure 3.13). The PstI 
restricted DNA used as the template produced a spurious 
result. There was no expression of the Mr-66,400 protein, 
although there was expression of an Mr-30,000 protein - 
another protein which had the same molecular mass as 
0-lactamase and normally co-migrates on a polyacrylamide gel 
with 0-lactamase.
The 2.45 Kb Pvull fragment was therefore sub-cloned into 
pBR329, which has a unique Pvull site. Putative sub-clones 
were subjected to plasmid analysis and digested with both 
Hindlll and Pvull in order to determine the orientation of 
the insert (Figure 3.17). All putative sub-clones exhibited 
homology to the [a-3 2P]dATP labelled 1.5 Kb FcoRl fragment 
from pNF48. Clones were designated pSDC41 and pSDC42, in 
accordance with pSDCl and pSDC3 respectively.
gjqur9 3,1$ In vitro translation products of linear 
templates of dSDCI.
The fluorograph shows the various 3 5s-methionine labelled 
template encoded products. The Mr 30,000 polypeptide 
corresponds to /3-lactamase of the vector pBR327.
Key to tracks:
A pSDCl encoded products
B pSDCl/Pstl encoded products
C pSDCl/PvuII encoded products
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Figure 3.17 Plasmid analysis of putative sub-clones of 
D8DC1.
Nineteen putative clones were subjected to plasmid analysis, 
restricted with both PvuII and Hindlll (separately) and 
fractionated on an agarose gel.
Key:
a tracks DNA digested with PvuII
b tracks DNA digested with Hindlll
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After further restriction analysis (data not shown) of 
pSDC41, in order to correlate with the data produced from 
analysis of pSDCl, the final restriction map is presented in 
Figure 3.18. It was this construct, pSDC41, which was used 
in subsequent studies.
It appears that from the work carried out and detailed in 
this chapter that L. leichmannii DNA can be expressed in a 
heterologous host.
To complement these expression studies, the nucleotide 
sequencing of this gene was initiated to enable comparative 
analysis with the E . coli btuB gene.
3 •3•6 Nucleotide sequence of the L. leichmannii btuB gene
Jb tu B iX -
The restriction map of the b t u B region previously 
determined (Figure 3.18) was used as a basis for the 
sequencing strategy outlined in Figure 3.19. The specific 
restriction fragments required for sequencing were all 
derived from the recombinant pSDC41. Each specific 
restriction fragment was prepared by digestion of pSDC41 
with the appropriate restriction enzymes, fractionated on a 
2.5% preparative agarose gel and sub-cloned in both possible 
orientations into bacteriophage M13 strains tg 130 and 
tg 131. E. coli strain TGI was used as host for the M13 tg 
phages. Each restriction fragment was sequenced by the
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Figure 3.18 Restriction endonuclease map of d 8 DC4 1  with 
published map of pBR329 for comparison.
Key:-
PII PvuII
Hill tfindlll
EV EcoRV
PI PstI
El EcoRI
BI BamHI
AI Aval
Spl SphI
10
0
 bp
Fiqure 3.19 Sequencing strategy for the L. leichmannii b<-„B 
gene region.
14 2
Key:-
Hill HindiII
HI I Hindi
PI PstI
EV EcoRV
SI Sail
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dideoxynucleotide chain termination procedure (Sanger et 
al., 1977).
Nucleotide sequence data was generated initially from the 5' 
and 3' ends of the 2.45 Kb PvuII DNA insert. When this 
sequence data was compared for homology with the nucleotide 
sequence of the E. coli btuB gene, the sequences were found 
to be 100% homologous. By comparing the restriction 
endonuclease sites it could be seen that these also appeared 
to be identical. Therefore, it appeared that the cloned 
btuB sequences were in fact those belonging to E. coli and 
not from L. leichmannii.
3.3 Summary and Overview.
It was thought that the structural gene for the Vitamin B12 
receptor (btuB) had been cloned from L. leichmannii by 
heterologous hybridisation, utilising an internal btuB gene 
fragment from E. coli and a synthetic oligonucleotide, 
derived from the E. coli btuB gene, as gene probes.
A heterologous hybridisation approach was used to isolate 
the putative btuB gene from L. leichmannii in these studies, 
as it did not rely upon expression of the cloned gene for 
its initial isolation, unlike a direct 'shotgun' approach, 
in which gene libraries are either conjugated or transformed 
into E. coli or Lactobacillus mutants.
1 4 4
The 2.0 Kb Hindlll DNA fragment (thought to have been cloned 
from L. leichmannii) was shown to complement the btuB lesion 
in E. coli LI—431, only as part of the recombinant pSDCl, 
indicating that the fragment did not contain its own 
promoter seguences. From the in vitro transcription and 
translation studies, together with the in vivo maxicells 
studies, it was proposed that the Mr~66,400 polypeptide 
produced was the functional product of the L. leichmannii 
btuB gene. In vitro transcription and translation studies, 
together with complementation studies also revealed the 
direction of transcription of the proposed btuBL gene to be 
in the orientation presented in Figure 3.19.
The fact that the cloned btuB seguence was that of E. coli 
and not L . leichmannii suggests some sort of recombination 
event had occurred. The probability of this event occurring 
had been markedly reduced by the use of a recA~ strain of E. 
coli, HB101. It is unlikely for an event such as described 
in this chapter to have occurred, unless the host strain 
HB101 was indeed no longer recA-.
There were in fact initial cloning problems with the 
putative clones clumping in liquid culture. After numerous 
attempts to propagate the positive clones, several were 
found that could grow 'normally' in liquid culture. The 
clumping of cells may be due to the synthesis of a 
detrimental gene product cloned within the recombinant. 
Rearrangement of these recombinants may have occurred which 
allowed the cells to grow 'normally'. This rearrangement is
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reflected in the results obtained from restriction analysis. 
Unfortunately, the restriction map of the jbtuB gene from 
E. coli was not referred to until after the nucleotide 
sequence data had been generated. Had this been done, 
several weeks' work would have been redirected.
Another important point gained from the literature was that, 
although Salmonella typhimurium had been shown to possess a 
gene [formerly known as bfe (Mojica & Garcia, 1976) and 
later renamed btuB, since it was found to be at the 
analagous map position as the E. coli homolog (Sanderson & 
Roth, 1988)], which encodes for a Vitamin B1 2 receptor 
protein of similar size to E. coli; the Vitamin B1 2 binding 
protein in Lactobacillus is in fact reported to be in the 
region of a third the size; Mr-15,000 (Sasaki & Kitahara, 
1964a) and later, Mr-21,500 (Sasaki, 1972). This 
information leads to the conclusion that the btuB gene 
cloned was indeed isolated from E. coli and not L. 
leichmannii.
With no (or very little) information available on genes 
encoding Vitamin B1 2 receptor proteins in other organisms, 
particularly Gram-positive organisms, it was necessary to 
attempt to re-clone the gene encoding the Vitamin B12 
binding protein in L. leichmannii.
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CHAPTER 4 ~ CLONING OF THE STRUCTURAL GENE FOR THE VITAMIN 
B12 RECEPTOR PROTEIN FROM LACTOBACILLUS LEICHMANNII
4.1 Introduction.
Initial cloning studies were based on the presumption that 
the Vitamin B1 2 receptor protein in Lactobacillus 
leichmannii was of a similar size to that found in E. coli 
and S. typhimurium. However, evidence for this could not be 
found in the literature.
It was over twenty five years ago that Kitahara and Sasaki 
(1963) presented evidence to show that Vitamin B1 2 requiring 
Lactobacilli characteristically take up and preserve large 
amounts of B12 in vivo, from the surrounding media. The 
cellular site of B12 accumulation was shown to be located in 
the cell wall, where a B12~binding principle exists (Sasaki 
& Kitahara, 1963a; 1963b; 1964b). Initial attempts at 
isolation and purification of the B12 polypeptide complex 
revealed a molecular weight of 15,000 (Sasaki & Kitahara, 
1964a). Several years later, Sasaki (1972) obtained a value 
nearer 21,500 daltons with microheterogeneity on a sephadex 
G—75 column, after cation-exchange chromatography of the 
complex.
Thus, it can be seen that the Vitamin B12 receptor protein 
found in Lactobacillus spp. is only a third of that found in 
E. coli and S. typhimurium. Presumably however, there will 
be conserved domains for the binding of the Vitamin.
4.2 Results and Discussion.
The 2.0 Kb Hindlll genomic DNA fragment of L. leichmannii 
previously shown to contain homologous sequences to the 
synthetic oligonucleotide probe (see Figure 3.5) was chosen 
for isolation. The cloning strategy adopted was similar to 
that described previously, as detailed in Figure 3.6, 
involving the construction of a selective gene bank in the 
HindZZZ site of an amplifiable high copy number vector 
pBR325 (Bolivar, 1978). Other vectors, pACYC184 (Chang & 
Cohen, 1978) and pAT153 (Twigg & Sherratt, 1980) were tried, 
but failed to produce any positive clones. The resulting 
gene library was screened by hybridisation using a [7- £P] 
labelled oligonucleotide probe, as before. The resulting 
autoradiograph (Figure 4.1) shows one clone very clearly 
above background, designated clone, 1. Subsequent plasmid 
and hybridisation analysis of the clone revealed that it 
harboured a 2.0 Kb Hindlll insert. This clone, chosen for 
further analysis was redesignated pSECl. pSECl was mapped 
with respect to several restriction endonucleases (Figures 
4.2, 4.3 and summarised in 4.4).
In order to verify that the cloned 2.0 Kb Hindlll fragment 
was derived from L. leichmannii genomic DNA and that no 
rearrangements had occurred during the cloning procedure,
L. leichmannii genomic DNA was digested to completion with a 
number of restriction endonucleases, fractionated by agarose 
gel electrophoresis, Southern blotted and then probed at
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Figure 4.1 Screening » selective L . leichmannii gene
bank for seguences homologous to the 
synthetic oligonucleotide.
The cloning of the L. leichmannii DNA showing homology to 
the oligonucleotide probe was as described in the text. The 
resulting colony blot was probed at high stringency. The 
Figure shows one clone very clearly above background.
Key to controls.
A pNF48
B pBR32 5
Figure 4.^ Restriction endonuclease mapping of the
L. leichmannii recombinant pSECl.
pSECl plasmid DNA was digested to completion with a number 
of restriction endonucleases and the resulting DNA fragments 
were fractionated by agarose gel electrophoresis.
to tracks:
1 A DNA restricted with Hindlll
2 pSECl DNA restricted with Hindu]
3 pSECl DNA restricted with EcoRI
4 pSECl DNA restricted with EcoRV
5 pSECl DNA restricted with Pvu II
6 pSECl DNA restricted with Pstl
7 pSECl DNA restricted with Hindi
8 pSECl DNA restricted with BamHl
9 pSECl DNA restricted with Clal
1 0 pSECl DNA restricted with Bgill
1 1 A DNA restricted with Hindlll
1 2 pSECl DNA restricted with Ncol
13 pSECl DNA restricted with Kpnl
14 pSECl DNA restricted with Aval
15 pSECl DNA restricted with Sail
16 pSECl DNA restricted with Smal
17 pSECl DNA restricted with Pvu I
18 pSECl DNA restricted with Mlul
19 pSECl DNA restricted with Xhol
2 0 pSECl DNA restricted with Sau 3 a
Figure 4.3 Restriction endonuclease mapping of the
L. leichmannii recombinant pSECi.
pSECl plasmid DNA was digested to completion with a number 
of restriction endonucleases and the resulting DNA fragments 
were fractionated by agarose gel electrophoresis.
Key to tracks :-
1 A DNA restricted with Hindlll
2 pSECl DNA restricted with Hindlll and Mlul
3 pSECl DNA restricted with Hindlll and Aval
4 pSECl DNA restricted with Hindlll and Hindi
5 pSECl DNA restricted with Hindlll and Bglll
6 pSECl DNA restricted with Hindlll and PvuII
7 pSECl DNA restricted with EcoRV and Aval
8 pSECl DNA restricted with EcoRV and Hindi
9 pSECl DNA restricted with EcoRV and Bglll
10 pSECl DNA restricted with EcoRV and PvuII
11 pSECl DNA restricted with Bglll and Hindi
12 pSECl DNA restricted with Bglll and PvuII
13 pSECl DNA restricted with Mlul and Aval
14 pSECl DNA restricted with Mlul and Bglll
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Figure 4.4 Restriction endonuclease map of pSECl (with 
published map of PBR325 for comparison).
The 2.0 Kb Hindlll fragment within pSECl has mapped with 
respect to a number of restriction endonucleases.
Key:-
El ScoRI
NI Wool
PII PvuII
Cl Clal
Hill Hindlll
EV EcoRV
BI BamHI
SI Sail
AI Aval
PI Pstl
BII Bglll
XI Xhol
MI Mlul
HII Hindi
Ori Origin of replication
IR Inverted repeat
Tc tetracycline resistance gene
Ap ampicillin resistance gene
Cm chloramphenicol resistance gene
None of the following sites were present:-
Pstl ScoRI Kpn I Ncol XhoI Smal
BamHI Clal SalI Acci Pvul
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high stringency with [a-32P]-labelled pSECl 2.0 Kb ffindlll 
insert. The resulting autoradiograph banding pattern 
(Figure 4.5) was compared to the restriction endonuclease 
map (Figure 4.4). The banding pattern of the restricted 
genomic DNA probed with the pSECl insert correlated with the 
cloned DNA, indicating that the pSECl insert was derived 
from L. leichmannii DNA and had not undergone any physical 
rearrangement, as was found in the initial cloning studies, 
detailed in Chapter 3 of this thesis.
4.3 s u m m a r y  and Overview.
This chapter details the successful isolation and cloning of 
a 2.0 Kb Hindlll genomic DNA fragment of L. leichmannii 
exhibiting homology to the synthetic oligonucleotide probe 
(described in Chapter 3), into a recA" strain of E. coli 
DH1.
There are many examples of genes cloned into E. coli from 
Gram-positive organisms including Lactobacillus genes. 
Examples of the latter have already been listed in Table 
1.7. Examples of genes from other Gram-positive organisms 
cloned into E. coli include; two chloramphenicol 
acetyltransferase genes from Clostridium butyricum (Dubbert 
et al., 1988); a-amylase gene from Clostridium 
acetobutylicum (Verhasselt et al., 1989); the gene for 
phospho-0-galactosidase from Staphylococcus aureus (Breidt & 
Stewart, 1987); the tagatose 1,6-bisphosphate aldolase gene 
from Steptococcus lactis (Yu et al., 1988) and the arginine
Figure 4.5 Verification of the origin and continuity of
the L. leichmannii recombinant pSECl.
L. leichmannii genomic DNA was restricted as indicated, 
fractionated by agarose gel electrophoresis and transferred 
to a nitrocellulose filter. This filter was then probed 
with the pSECl 2.0 Kb Hindlll insert at high stringency 
(assuming an appropriate 5% bp mismatch) .
Key to tracks:-
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A A DNA restricted with ffindlll
B L. leichmannii genomic DNA restricted with ffindlll
C L. leichmannii genomic DNA restricted with PvuII
D L. leichmannii genomic DNA restricted with ifincll
E L. leichmannii genomic DNA restricted with EcoRV
F L. leichmannii genomic DNA restricted with Bglll
G L. leichmannii genomic DNA restricted with Aval
Tracks H to M are autoradiographs of corresponding tracks B 
to G probed with pSECl 2.0 Kb Hindlll insert.
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repressor gene from Bacillus subtilis (Smith et al. , 1986), 
to name just a few.
DNA from Gram-positive organisms has, over the years, been 
preferentially cloned in E. coli, as opposed to a Gram­
positive cloning system such as Bacillus subtilis, because 
direct cloning of DNA sequences within plasmids which can 
propagate in B. subtilis (Ehrlich, 1977; Gryzcan et al., 
1978) is very inefficient when compared to the E. coli 
system. The central problem as recognized by Canosi et al. 
(1978) and confirmed subsequently by Gryzcan et al. (1980),
seems to be that B. subtilis requires plasmid multimers for 
efficient transformation of competent recipient cells. 
Therefore, the cloning system of choice is that of E. coli, 
which is the most extensively studied and best understood, 
with well developed methodologies.
CHAPTER 5
Chapter 5 Nucleotide sequence of the 2.0 Kb L. leichmannii 
genomic DNA insert of pSECl.
5.1 summary.
The 2.0 Kb genomic DNA fragment from L. leichmannii has been 
sequenced. It has been shown to possess three putative open 
reading frames; ORF 1, ORF 2 and ORF 3 (with predicted Mr 
values of 8,602, 17,388-23,013 and 17,792 respectively), the 
first of which bears homology to the Vitamin B12 receptor 
protein (BtuB) of E. coli. This first open reading frame is 
thought to be present only in part and that the remainder 
could be found on a larger genomic DNA fragment from L. 
leichmannii. This, however, remains to be elucidated.
5.2 Introduction.
To-date there is only a limited amount of information 
available on the molecular structure of genetic material 
from Lactobacilli, and none at all from L. leichmannii. The 
complete nucleotide sequence of the cloned Lactobacillus 
genomic DNA was determined, in order to locate the gene 
encoding the Vitamin B12 receptor protein in L . leichmannii, 
and also to enable comparative analyses to be made, with 
respect to promoter structure, preferred codon usage and 
derived amino acid sequences, between the Lactobacillus gene 
(encoded within the cloned 2.0 Kb insert) and,
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a) other Lactobacillus genes and
b) genes encoding a Vitamin B12 receptor protein from other 
organisms.
5.3 Results and Discussion.
5.3.1 Nucleotide sequence of the 2.0 Kb Lactobacillus DNA 
insert of pSECI.
The 2.0 Kb L. leichmannii genomic DNA insert of pSECI was 
prepared for sequencing by the digestion of pSECI with 
HindIXl, fractionated on an agarose gel and sub-cloned in 
both possible orientations into the tfindlll site of a 
phagemid vector derived from pUC19 - pBS (+/-). The vector 
possessed ampicillin resistance, lacZ for blue/white colour 
selection and an M13 origin of replication allowing single 
stranded DNA rescue via helper phage infection for single 
strand sequencing. These details are illustrated in Figure 
2.2, along with several other features, which can be found 
in Chapter 2 of this thesis.
Ten putative sub-clones were chosen for plasmid analysis, 
digested with ffindlll, fractionated on an agarose gel and 
were all found to contain 2.0 Kb DNA inserts (Figure 5.1). 
In order to determine whether the fragment had been cloned 
in both possible orientations, the recombinants were 
digested with both EcoRV and Bglll, fractionated on an 
agarose gel and the orientation determined by the sizes of 
the resulting fragments. A 0.6 Kb fragment would result
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Ficrure 5.1 Construction of pBS rBP.omhjnants for nucleotide 
sequence analysis.
pSECl plasmid DNA was restricted with ffindlll to release the 
2.0 Kb DNA insert, and subsequently sub-cloned into the pBS 
(+/-) vector. Ten putative sub-clones were subjected to 
plasmid analysis, digested with Hindlll and fractionated on 
an agarose gel.
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from one orientation (a) and a 1.5 Kb fragment from the 
other (b), shown in Figure 5.2. Clones 3 and 7 were chosen 
for further study and were redesignated pBS3 and pBS7.
Recovery of single stranded DNA from cells containing pBS 
recombinants was as described in Methods and Materials 
(Section 2.18.1), using E. coli TGI as the host and VCS-M13 
as the helper phage.
The sequencing strategy, outlined in Figure 5.3 involved the 
synthesis of oligonucleotide primers in both directions.
Each section of the insert was sequenced by the 
dideoxynucleotide chain termination procedure (Sanger et 
al., 1977).
L. leichmannii DNA (2,000 bp), which contained sequences 
homologous to the synthetic oligonucleotide, derived from 
the btuB gene of E. coli, was sequenced (see Figure 5.4).
The DNA sequence contained at least two putative open 
reading frames (ORFs) - the first being of two possible 
lengths, depending upon the position of the putative 
promoter region. Thus, ORF 2a consisted of 471 bp 
(nucleotide position 450 to 920) and encoded a polypeptide 
of 157 amino acid residues, with a predicted Mr of 17,388. 
ORF 2b consisted of 633 bp (nucleotide position 283 to 920) 
and encoded a polypeptide of 211 amino acid residues, with a 
predicted Mr of 23,013. The second putative ORF, ORF 3 was 
preceded by a consensus Shine-Dalgarno (SD) sequence - 
AGGAGGA - (Shine-Dalgarno, 1974) 11 bp upstream from the
Figure S.2 Isolation of pBS3 and pBS7.
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Plasmid DNA from the ten sub-clones (presented in Figure 
5.1) were restricted with both EcoRV and Bglll and 
fractionated on an agarose gel, to determine orientation of 
the 2.0 Kb DNA insert.
Key to tracks
A clone 1 — pBS(b)
B clone 2 - pBS(b)
C clone 3 - pBS(a)
D clone 4 - pBS(b)
E clone 5 - pBS(a)
F clone 6 - pBS(a)
G clone 7 - pBS(b)
H clone 8 - pBS(b)
I clone 9 - pBS(a)
J clone 10 - pBS(b)
(a) and (b) refer to orientation of the insert. See text
for details.
Figure 5.2 Isolation of pB83 and pBS7.
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Plasmid DNA from the ten sub-clones (presented in Figure 
5.1) were restricted with both EcoRV and BglII and 
fractionated on an agarose gel, to determine orientation of 
the 2.0 Kb DNA insert.
Key to tracks
A clone 1 — pBS(b)
B clone 2 - pBS(b)
C clone 3 - pBS(a)
D clone 4 - pBS(b)
E clone 5 - pBS(a)
F clone 6 - pBS(a)
G clone 7 - pBS(b)
H clone 8 - pBS(b)
I clone 9 - pBS(a)
J clone 10 - pBS(b)
(a) and (b) refer to orientation of the insert. See text 
for details.
Figure 5.3 Sequencing strategy for the L. leichmannii 
2.0 Kb DNA insert from pSECl.
Key:
A Aval
M Mill I
Hill tfindlll
HII Hindi
B Bglll
E EcoRV
P PvuII
Arrows indicate the direction and extent of sequence data 
obtained from independent primers.
Open squares indicate the beginning of reverse complement 
synthetic oligonucleotides used as primers and closed 
squares indicate the positions of the 17-mer M13 sequencing 
primer (kind donation by H. Baybutt).
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presumptive start codon (ATG). This ORF consisted of 492 bp 
(nucleotide position 1498 to 1989) and encoded a polypeptide 
of 164 amino acid residues, with a predicted Mr of 17,792.
In addition, a possible open reading frame (ORF 1) of 217 bp 
exists, which is located at nucleotide positions 4 to 234. 
However, the codon ATG at nucleotide 4 may not be the 
initiator codon, but a codon for an internal methionine. 
Further cloning and seguencing of a larger L. leichmannii 
genomic DNA fragment would be necessary to ascertain this 
fact.
5.3.2 Upstream sequences of the putative ORFs.
The putative promoter regions for ORFs 2a, 2b and 3 are 
presented in Figures 5.5, 5.6 and 5.7 respectively.
5.3.2.1 ORF 2a.
Sequences beginning at nucleotide 352 (TTGCCA; -35) and 
nucleotide 381 (TATATT; -10) exhibited much similarity to 
reported promoter consensus sequences for both Gram-positive 
(Graves & Rabinowitz, 1986) and Gram-negative organisms 
(Rosenberg & Court, 1979; Hawley & McClure, 1983).
Comparison of the putative L. leichmannii promoter with 
either the Gram-negative or Gram-positive consensus 
promoters exhibited identity in 5 out of 6 nucleotides in 
both the -35 and -10 sequences. The spacing, however, 
between the -35 and -10 sequences was 23 nucleotides, which 
is greater than the distance normally found for the majority 
of bacterial promoters reported to-date (see Figure 5.8).
Figure ?,4 p\K¡l«otld» a «guanea of ¡,, geichmannii 2.Q KJb 
genomic fitt iBSggt.
The sequence consists of 2,000 bp containing two open reading 
frames (ORFs). Putative -35 and -10»regions are as indicated, 
along with putative ribosome binding sites (SD)•
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Figure 5.5 The nucleotide sequence of the transcriptional 
control region of ORF 2a.
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Figure 5.8 Compilation of promoter sequences from Gram
positive organisms.
(adaption from Graves & Rabinowitz, 1986).
-45 -35 -15 -10 -5
1 TATAATAAACTA TTGACA CCGATATTACAATTGTAA TATTAT TGATTTA
2 TATAGAAAAGTG TTGAAA ATTGTCG AACAGGGTGA TATAAT AAAAGAG
3 TACAAAAAGGTA TTGACT TTCCCTA CAGGGTGTGT AATAAT TTAATTA
4 TGCAAAAAGTTG TTGACT TTATCTA CAAGGTGTGG CATAAT AATCTTA
5 TTTAAATTTTAT TTGACA AAAATGG GCTCGTGTTG TACAAT AAATGTA
6 CATGAAGTCTCC TTGAAA TCAGAAG ATATTTAGGA TATATT TTTCTATG
7 CCGAAAAAACGG TTGCAT TTAAATC TTACATATGT AATACT TTCAAAG
8 CCCGATTTATCA TTGACA AAAAATACTGAATTGTAA TACGAT AAGAACA
9 TCACTCATCATG TTCATA TTTATCA GAGCTCGTGC TATAAT TATACTA
10 TACATATAAAGG TTTATT CTAAAAT GAAAAGATGA TACAAT CATATTCAGTTA
11 AATAAAGGGGGG TTGTTA TTATTTT ACTGATATG TAAAAT ATAATT
12 CAAAAAAGGGCA TTGATT TCAGAGCACCCTTATAAT TAGGAT AGCTTT
13 ACTTGGATTAGG TTGACG CTTTTTTGTCCATTACTG TATAAT ATTTCTATCTA
14 TTTAAAAAACTA TTGCAA TAAATAA ATACAGGTGT TATATT ATTAAACG
15 TGAAAAAAGTTG TTGACA AAAAAGA ACGTGAATGT TATATT AGTAA
16 GTGTCATAACCC TTTACA GTCATAA AAATTATGG TATAAT c a t t t c t g
17 TTCAAAAAAGTA TTGACC TAGTTAA CTAAAAATGT TACTAT TAAGTAG
18 TGATATTATGTA TTGACT TAGACAA CTGAAGGTGT TATTCT AATATCG
19 GCTAAAAAGTTG TTGACA GTAGCGG CGGTAAATGT TATGAT AATAAAG
20 ATAAATTACACT TTTAAA AAGTTTA AAAACATGA TACAAT AAGTTATG
21 GCACTAGTGAAG TTGACA ATGAATAGGTAACGCAAA TATAAT AAGTAAGACTG
22 AAAAAAATAAGG TTTCGA AAGTTGA AAGGTATGG TATCCT ATTATGG
23 TTGTGACAACCA TTGCAA GCTCTCG TTTATTTTGG TATTAT ATTTGTG
24 AAATCCACAGGC CCTACT ATTACTTCTACTATTTTT TATAAA TATATA
16 7
25 CAAGTTTTCCCT TTCCCT AATTCGT TTTTTTTTAG TACAAT TAGATATTAGT
26 GACAAAGAACTT ATACGG TGGGACA AAGACTATGC TAAAAT AGAGGGA
27 TAGCAATTTAAT GTGTAT AATCATA AGTTTATTGA TATAAT GGAGAATA
28 TACAGAACCAAA TTCAAA AATTATA TGGAGATCTG TATAAT AAAGAATAA
29 TTAGAAATGGGC GTGAAA AAAAGCG CGCGATTATG TAAAAT ATAAA
30 GTGTCAGTGTCC TTGCCAGCAGCAGCTCAGGTAACGCAACCTATAAT GAACG
31 TCACTCGAACAG TTATGA AAAACCG TAATGACAG TTAAGT GGTAGA
32 ATACCGTAGTTG TTCATAGTTTCGTCAA AATCGTCACT TACAAT AATCTT
-45 -35 -15 -10 -5
Gram - Ta AAAAA TTGAcA a A a T TG T A t a A T AAtAt
E. coll a t TTGACa t t t tg TAtAAT
Sequences are aligned by the -35 and Pribnow regions. The 
3' nucleotide listed is the major site of initiation, which 
often occurred at more than one nucleotide. The consensus 
sequence derived from the compiled list is given below. The 
E. coll consensus sequence (McClure, 1985) is also provided 
for comparative purposes.
Bases that appear in any given position in more than 41% of 
the examples are in small letters, those more than 50% in 
capital letters, and those more than 75% are in tall capital 
letters.
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Sequences
1. S.
2 . B.
3. B.
4. B.
5. B.
6. B.
7. B.
8. B.
9. S.
10. S.
11. B.
12 . Co.
13. B.
14. B.
15. B.
16. B.
17. B.
18. B.
19. B.
20. C.
21-27. B.
28. S.
29. B.
30. L.
31. L.
32. L.
subtilis rrnA pi (Ogasawara et al, 1983)
through TR7 respectively (Ogasawara et al, 1985).
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Covering the region 6-10 bp upstream of the presumptive 
initiator codon (ATG) is the sequence AGGAG. This is a 
shorter version of the consensus for the Shine-Dalgarno 
sequence of Gram-positive cells (Murray & Rabinowitz, 1982), 
as well as for E. coli, as mentioned previously, and 
presumably serves the same function in Lactobacillus.
5.3.2.2 ORF 2b.
Sequences beginning at nucleotide 209 (TTATGA; -35) and 
nucleotide 231 (TTAAGT; -10) exhibited much weaker 
similarity with the reported consensus sequences, only 
exhibiting identity in 3 out of 6 nucleotides in both the - 
35 and -10 sequences. The spacing between the sequences was 
more in line with the distance found for the majority of 
bacterial promoters reported to-date (i.e. 17-18 bp).
Figure 5.8 mentioned previously shows a survey carried out 
by Graves and Rabinowitz (1986) on the promoter sites of 
Gram-positive cells. Their tabulations are based only on 
those systems for which the control regions have actually 
been identified by chemical means. However, if the promoter 
regions mentioned in this study are compared to other 
putative Lactobacillus transcriptional control regions, it 
can be seen that the spacing between the -35 and -10 
sequences is quite varied - as presented in Figure 5.9.
Figure 5.9
17 0
Compilation of promoter sequences from
Lactobacillus genes.
-45 -35 -10 -5
1. GCGTCAAGC TGGTCA CAACAACT GGTCGGCAA TACATT GAATTA
2. AATAAAACG CTTTAC TTTTTTAT TTTTCAAGGT TATAAT GAAAAT
3. TTTTCGACT TTGACA TGAAGGAT ATTAAGTTG C TTAATT ACGATC
4 . AGATGCTTT TTCACA GAGGCA TCTTGTA TACGGT GAGTGG
5. ACGGTCAAA TTAAAC GGGACTGGC TTTGTCAGC TATGTT GAAGAG
6. TCAGTGTCC TTGCCA GCAGCAGCTCAGGTAACGCAACC TATATT GAAACG
7. CTCGAACAG TTATGA AAAACCG TAATGACAG TTAAGT GGTAGA
8. CCGTAGTTG TTCATA GTTTCGTCA AAATCGTCACT TACAAT AATCTT
9. CAATAATTT TAAACA GAATCATT TATACTATA ATTAAT AAAAAC
Gram +ve TTGACA T TAtaAT AAtAt
Sequences are aligned by the -35 and Pribnow regions. The 
consensus sequence derived from the compiled list of Graves 
and Rabinowitz (1986) is given below. Sequences are from:-
1. L. casei pbg gene (Porter & Chassy, 1988) .
2. Lactobacillus 30a histidine decarboxylase gene 
(Vanderslice et al, 1986).
3. L. casei dihydrofolate reductase gene (Andrews et al, 1985).
4. L. casei D-2-hydroxyisocaproate dehydrogenase gene 
(Lerch et al, 1989).
5. L . bulgaricus /9-galactosidase gene (Schmidt et al., 1989).
6. L. leichmannii ORF 2a (this work).
7. L. leichmannii ORF 2b (this work).
8. L . leichmannii ORF 3 (this work).
9. L . helvetlcus subsp. jugurti cryptic plasmid pLJl
(Takiguchi et a l ., 1989)
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Covering the region 9-13 bp upstream of the presumptive 
initiator codon (ATG) is the sequence AGGAGG, which is 
slightly nearer to the consensus Shine-Dalgarno sequence, 
already mentioned.
5.3.2.3 ORF 3.
Sequences beginning at nucleotide 1413 (TTCATA; -35) and 
nucleotide 1439 (TACAAT; -10) exhibited good similarity with 
the reported consensus sequence of Gram-positive organisms, 
but again the spacing between the two sequences was slightly 
more than that in other bacterial promoters. Covering the 
region 11-18 bp upstream of the presumptive start codon ATG 
is the consensus SD sequence AGGAGGA, as mentioned 
previously.
5.3.2.4 Extended promoter region in Gram-positive 
organisms.
In addition to the putative Pribnow box around position -10 
from the proposed transcription origin, it is suspected that 
other upstream bases may play a role in an extended promoter 
site (Graves & Rabinowitz, 1986). The presence of TG at -16 
and -15 is noteworthy, with the T residue being the seventh 
most highly conserved base in the promoter region (76%) and 
the G less highly conserved (62%). 83% of the promoter
regions compared by Graves and Rabinowitz contained at least 
one TG pair in the -18 to -14 region and in several cases,
1 7 2
the TGTG doublet appeared. These nucleotides are only 
weakly conserved (less than 44%) in E. coli promoters. This 
feature however does not appear to be conserved in the 
promoter regions proposed in this study and appears only in 
one case in Figure 5.9; that of the dihydrofolate reductase 
gene of methotrexate-resistant L. casei (Andrews et al.,
1985).
Graves and Rabinowitz also found that downstream of the -10 
region, A residues are conserved at -7, -6 and -4 and T 
residues at -5 and -3, whereas no analagous conservation 
exists in E. coli. There is seen to be some conservation in 
this area in all three reading frames discussed in this 
section. Finally, A residues are again shown to be 
conserved in a cluster at positions 41-45 with a greater 
than 50% conservation rate. This can be seen in the 
promoter regions shown in Figure 5.8 but not unfortunately 
in the ORFs studied or indeed to such an extent in any of 
the promoter regions presented in Figure 5.9, other than 
that of histidine carboxylase in Lactobacillus 30a 
(Vanderslice et al., 1986).
The two additional conserved areas on either side of the 
typical Pribnow box broaden the promoter element to span the 
region from residues -18 to -4. In this extended region, 
out of the 29 promoter regions studied by Graves and 
Rabinowitz, 12 nucleotides were conserved at a rate greater 
than 50%. This extended promoter consensus could be 
important for recognition by, or binding of, RNA polymerase.
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Although all three of the putative promoter regions 
described contained few of the features of the extended 
consensus proposed for Gram-positive promoter sequences 
(Graves & Rabinowitz, 1986), they do share this with other 
Lactobacillus putative promoter regions (see Figure 5.9).
5.3.3 Downstream sequences of the putative open reading 
frames.
A sequence resembling a Rho—independent transcription 
terminator (Platt, 1986) was found 3 nucleotides following 
the presumed stop codon (TGA) for ORF 2. The RNA 
transcribed from this region could possibly form a large 
stem-loop structure with 27 bp in the stem and 34 bp in the 
loop (Figure 5.10a). The calculated free energy for this 
structure is -16.6 Real, which is within the range typically 
observed for Rho-independent terminators (Platt, 1986). A 
smaller stem-loop structure could also be found (see Figure 
5.10b) 307 nucleotides following the stop codon (TGA) of the 
putative ORF 2, which had a higher free energy of formation 
than the former (-20.6 Real). Another significant small 
stem-loop structure was found 116 nucleotides following the 
stop codon (TAA) of the putative ORF 1, which also had a 
high free energy of formation, -21.0 Real (Figure 5.10c).
Flour« 5.10a Structure of a putative Rho-independent
terminator for ORF-Ì-
1 7 4
Figure 5.10b structure of a second putative Rho
independent terminator of ORF 2.
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Figure 5.10c Structure of a putative Rho-independent
terminator for ORF 1.
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5.3.4 Analysis of the coding regions of the 
L. leichmannii 2.0 Kb DNA insert.
5.3.4.1 Nucleotide sequence analysis.
L. leichmannii 4797 DNA has a G + C content of 50.5% (Miller 
et al., 1970). The open reading frames under discussion;
ORF 2a, 2b and 3 have G + C content values of 50.3%, 49.8% 
and 47.8% respectively.
Codon usage of the three open reading frames were compared 
with data from other Lactobacillus genes and is outlined in 
Table 5.1. Lerch et al. (1989) also carried out a 
comparative analysis, stating that out of the sequences 
compared (comprising 1805 codons), only one example of AUA 
(isoleucine) codon usage was observed (Porter & Chassy,
1988). They did not however include ORF 2 from the 
insertion element ISL1, isolated from L. casei bacteriophage 
(Shimizu-Kadota et al., 1985). This open reading frame was 
larger than ORF 1 and contained 3 AUA codons. Perhaps Lerch 
et al. (1989) did not include ORF 2 in their calculations 
because a putative ribosome binding site was found only for 
ORF 1 and not for ORF 2. Lerch and his colleagues also 
stated that the codons AGA/G (Arginine) and UAG (Terminator) 
have not been found to be used by Lactobacillus genes so 
far. Yet again, ORF 2 of the insertion element ISL1 
(Shimizu-Kadota et al., 1985) seems to differ. It uses the 
terminator UAG and contains two AGA codons and four AGG
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Table 5.1 Codon usage comparison of some Lactobacillus 
genes.
1 2 3 4 5 6 7 8 9 10
uuu Phe 26 7 7 0 7 7 3 17 4 10
uuc Phe 23 1 1 1 i 1 0 8 0 3
UUA Leu 14 7 7 1 3 1 1 3 4 8
UUG Leu 24 3 7 1 7 5 5 12 2 8
CUU Leu 12 0 4 1 2 1 5 4 1 4
cue Leu 12 0 1 0 1 1 0 3 1 1
CUA Leu 4 0 0 0 2 2 0 13 1 3
CUG Leu 42 3 0 1 2 1 1 7 1 3
AUU lie 14 3 15 3 3 1 2 16 1 4
AUC lie 13 2 5 2 5 4 2 7 1 6
AUA lie 0 0 0 0 1 0 5 1 0 3
AUG Met 12 3 12 2 8 5 6 11 2 3
GUU Val 13 8 14 2 7 7 8 11 2 2
GUC Val 30 5 0 4 3 1 4 4 0 4
GUA Val 9 1 2 1 3 2 3 2 1 3
GUG Val 11 2 1 1 9 5 3 12 0 4
UCU Ser 9 0 5 0 0 0 1 4 2 1
UCC Ser 16 1 2 1 2 2 1 2 2 3
UCA Ser 5 0 9 0 5 3 4 5 1 5
UCG Ser 1 0 0 2 1 1 1 4 0 0
179
ecu Pro 8 3 4
ccc Pro 6 1 0
CCA Pro 18 2 14
CCG Pro 16 2 0
ACU Thr 10 1 12
ACC Thr 18 7 1
ACA Thr 3 2 3
ACG Thr 8 4 0
GCU Ala 28 6 17
GCC Ala 39 1 0
GCA Ala 8 3 9
GCG Ala 6 5 1
UAU Tyr 18 5 7
UAC Tyr 36 0 8
UAA ocher 1 1 1
UAG amber 0 0 0
CAU His 3 6 1
CAC His 15 1 1
CAA Gin 11 3 9
CAG Gin 27 6 0
AAU Asn 19 2 4
AAC Asn 30 1 8
AAA Lys 22 5 3
AAG Lys 43 4 17
5 4 0 3 1 0
0 0 0 3 0 2
1 1 2 7 1 2
1 1 1 9 1 3
2 2 1 2 0 1
3 2 7 10 2 2
1 1 3 8 1 5
7 6 2 5 0 5
1 1 2 9 2 10
7 5 3 17 8 8
6 4 5 5 1 4
4 4 6 10 1 4
3 2 1 19 3 8
3 3 0 6 2 5
0 0 0 1 1 0
0 0 0 0 0 1
7 7 3 15 1 5
1 0 0 6 0 4
2 2 4 18 2 17
4 4 2 6 1 3
1 1 3 13 3 5
1 0 5 1 2 7
4 2 6 12 4 13
7 4 7 13 6 5
i
0
0
1
1
0
2
2
4
1
1
2
3
2
1
0
0
0
1
2
6
1
3
0
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GAU Asp 25 14 15 3 12 11 1 25 3 8
GAC Asp 46 1 10 2 5 5 2 12 1 5
GAA GlU 62 5 22 2 7 5 3 23 6 7
GAG Glu 16 2 0 0 1 0 3 10 2 4
UGU Cys 1 0 1 0 1 1 3 1 0 2
UGC Cys 4 0 1 0 0 0 3 1 0 3
UGA opal 0 0 0 0 1 1 1 0 0 0
UGG Trp 2 4 6 2 0 0 5 10 1 5
CGU Arg 2 2 10 4 4 3 1 5 4 9
CGC Arg 12 3 0 0 1 1 1 3 2 4
CGA Arg 1 1 0 1 6 5 1 4 0 3
CGG Arg 23 2 1 0 2 2 1 5 1 0
AGU Ser 5 2 4 4 4 2 2 6 3 3
AGC Ser 24 1 2 0 5 2 2 3 0 7
AGA Arg 5 0 0 0 1 1 2 0 0 2
AGG Arg 1 0 0 0 1 1 3 0 0 4
GGU G ly 11 5 25 0 6 3 4 10 1 6
GGC G ly 37 5 3 1 7 5 6 13 0 2
GGA Gly 9 0 0 1 0 0 2 4 1 3
GGG Gly 19 0 0 0 4 3 0 6 0 1
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1 . ß—galactosidase gene from L. bulgaricus (Schmidt et al, 
1989).
2. dihydrofolate reductase gene from L. casei (Andrews et 
al, 1985).
3. histidine decarboxylase gene from Lactobacillus 30a
(Vanderslice et al, 1986).
4. Orf 1 (this work).
5. Orf 2a (this work).
6. Orf 2b (this work).
7. Orf 3 (this work).
8. ß—D-phosphogalactoside galactohydrolase (pbg) gene from 
L. casei (Porter & Chassy, 1988).
9. ORF 1 from insertion element ISL1 from L. casei
bacteriophage (Shimizu-Kadota et al, 1985).
10. ORF 2 from insertion element ISL1 from L. casei
bacteriophage (Shimizu-Kadota et al, 1985).
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codons. A few months following this publication, Schmidt et 
al. (1989) presented the nucleotide sequence of the p-
galactoside gene from L. bulgaricus and it could be seen 
that it used five AGA codons and one AGG codon.
Taking the three putative reading frames in the 2.0 Kb 
Hindlll Lactobacillus genomic DNA insert, ORF 1, ORF 2a/b 
and ORF 3, it can be seen that ORF 1 differs from the 
others. It uses the UAA (ochre) termination codon like the 
majority of the Lactobacillus genes, whereas the others (ORF 
2a/b and ORF 3) use the UGA codon. ORF 1 does not use AGA 
or AGG to code for arginine, whereas the others do. In 
fact, ORF 3 uses two AGA codons and 3 AGG codons. ORF 3 
also uses the codon AUA five times and ORF 2a, once.
No significant trend in codon usage for the Lactobacillus 
genus can be seen by comparing the codon usage of the 
putative open reading frames with the other Lactobacillus 
genes in Table 5.1, other than perhaps the more frequent use 
of the codon UUU for Phenylalanine, the codon GAA for 
glutamine and the non-use of codon UAG for termination (with 
the exception of ORF 2 from insertion element ISL1).
Considering the type of amino acids encoded by the ORFs 
under discussion, they all have a majority of hydrophobic 
amino acids as shown in Table 5.2.
18B
T » b l. 5.2
ORF 2 a ORF 2 b ORF 3 ORF
Acidic (Asp + Glu) 21 25 9 7
Basic (Arg + Lys) 19 26 22 8
Aromatic (Phe + Trp + Tyr) 13 14 9 8
Hydrophobic (Aromatic 49 70 54 27
+ lie + Leu + Met + Val)
This data is backed up by the hydropathy profiles, presented 
in Figure 5.11. These plots were performed, using a sub­
routine of the 'Staden-plus' programme. This routine plots 
the hydrophobicity of each section of the sequence using the 
hydrophobicity values of Kyte and Doolittle (1982). A 
window of size 'span' is slid along the sequence and a sum 
calculated for each position.
A comparison of nucleotide sequences between the ORFs 
contained within the L . leichmannii 2.0 Kb genomic Hindlll 
fragment and the btu genes (btuB and JbtuCED) revealed no 
significant homology, even though the G + C content of E. 
coli is approximately 50% (similar to 50.5% of 
L . leichmannii) and the preferred codon usage of the E . coli 
btuB gene (see Figure 3.2) does not appear to have any major 
significant differences from that of L. leichmannii.
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184Figure S.ll Hydropathic profiles of the deduced 
DolvDeDtides encoded by the three putative ORFs 
of L . leichmanni 2.0 Kb Hindlll genomic DNA 
fragment.
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It is likely that the two nucleotide sequences could be 
dissimilar and in fact the gene encoding the L. leichmannii 
Vitamin B12 receptor may not even be 'btuB-like', since 
recent findings have shown that S. typhimurium possesses not 
only a high affinity JbtuB dependent system, but also another 
cobalamin uptake system not present in E. coli (Rioux & 
Kadner, 1989b). It is unlikely that this system is tonB 
dependent; it did not confer susceptibility to phage BF23 or 
to the E colicins, and the DNA insert (encoding a 
polypeptide with an Mr of 84,000) did not hybridise to the 
btuB gene. However, a degree of homology between the 
polypeptides encoded by these genes would be expected at the 
site where binding of the Vitamin occurs.
5-3.4.2 Nucleotide sequence derived - amino acid analysis.
The nucleotide sequence derived BtuB, BtuC, BtuD and BtuE 
sequences of E. coli were compared to the nucleotide 
sequence derived (as yet, unknown) polypeptides of L . 
leichmannii, using the IBM AT Microgenie protein alignment 
sub-routine.
A region of homology was found between E. coli BtuB and the 
polypeptides encoded by the cloned L . leichmannii genomic 
DNA, illustrated in Figure 5.12. The homology between amino 
acid residues 61 and 68 of L. leichmannii ORF 1 and residues 
507 and 514 of the E. coli BtuB polypeptide is thought to be
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Figure 5.12 comparison of amino acid sequences.
E. coli BtuE 
L. leichmanr
Residue
507 Arg Asn Ala Ile Thr Asp Thr 
* *
ü  ORF 1 61 Arg Val Asn Ala Ile Thr Arg Thr
B
. nii
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significant as Moir et al. (1987) stated that, removal of
the C-terminus of the E. coli btuB gene prevents receptor 
function (being tested through both complementation and 
negative complementation). They also presented data to 
argue strongly that at least 216 C-terminal residues were 
not required for transfer to the outer membrane, but may be 
necessary for correct localisation in the membrane. It is 
therefore the C-terminal end of the protein which appears to 
be involved in B12 binding and so the region of homology to 
E. coli BtuB, found between residues 61 to 68 of ORF 1 from 
L. leichmannii may also be involved in B12 binding. It is 
unfortunate that the start of ORF 1 is unknown. The ATG 
codon taken to be the start site of translation predicts a 
polypeptide with an Mr of only 8,602 consisting of 77 amino 
acid residues. This data suggests that the entire gene may 
not be present. To ascertain whether there is more to ORF 1 
then represented in Figure 5.4, would require the cloning of 
a larger fragment of L . leichmannii genomic DNA and further 
nucleotide sequence analysis. Whether ORF 1 in its possible 
extended form encodes a Vitamin B12 receptor protein in 
L. leichmannii remains to be elucidated.
According to Sasaki and Kitahara (1964c), there are 
pertinent features to be noted regarding the amino acid 
composition of the Vitamin B12 complex. They found that the 
complex was indeed a B^2-peptide consisting of no sugar or 
base. It lacked cysteine and histidine, which was 
characteristic of being obtained from bacterial walls and 
possessed phenylalanine and tyrosine, two aromatic amino
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acids -thought to be involved in conjunction of the walls 
with the Vitamin and had up till then not been reported in 
the cell walls of lactic acid bacteria. From the data 
generated from ORF 1 in these studies, it appears that this 
was the only possible coding region within the 2.0 Kb 
L. leichmannii genomic fragment, which bears all of these 
features. However, analysis of sequences upstream of the 
£,. leichmannii genome is required to either refute or 
confirm this hypothesis.

189
Chapter 6 Expression analysis of the cloned L. leichmannii 
genomic DNA 2.0 Kb Hindill fragment.
6.1 Introduction.
The Vitamin B12~binding property of L. leichmannii has been 
studied. Kashket et ai. (1962) found L. leichmannii to be
capable of rapidly binding [60Co] Vitamin B12 amounts 
greatly in excess of maximal growth requirements. The 
quantity of Vitamin B12 stored was sufficient to support 
9000-fold increase in cell number when the cells were 
subsequently inoculated into Vitamin B12~free media. It was 
initially thought that the major binding site appeared to be 
a ribosomal glycoprotein (Kashket et al., 1962). However, 
in later years, it was shown that three quarters of the B12 
bound to the cell was found in the cell wall and the 
remaining quarter found in the particulate (ribosome) 
fraction (Sasaki, 1972). Apparently, the binding mechanism 
in L. leichmannii is a simple adsorptive process requiring 
the expenditure of little energy. This is suggested by the 
low activation energy of the binding phenomenon 
(fi = 1900 cal.) and the ineffectiveness of various metabolic 
inhibitors in altering the rate or amount of [60Co] Vitamin 
B12 binding by intact cells.
In order to determine whether the cloned L. leichmannii DNA 
fragment (outlined in Chapter 4) harbours the gene encoding 
the Vitamin B12 receptor protein from L. leichmannii, it was 
not only necessary to subject the fragment to expression
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analysis, but also to have a means of identifying the gene 
product.
Sasaki (1972) described a procedure of purifying the B12- 
complex (B12 bound to a polypeptide) from the cell walls of 
Lactobacillus. Therefore, the B12-complex was purified from 
the cell walls of L. leichmannii and polyclonal antibodies 
raised against it. These antibodies were then be used as a 
•probe' for the identification of the gene product.
6.2 Results and Discussion.
6.2.1 Complementation analysis.
The E. coll btuB- strain, Ll-431, was transformed with the 
recombinant pSECl and pNF48 (positive control) and tested 
for complementation, as described in Section 3.2.5.1. 
However, there appeared to be no BtuB+ transformants when 
pSECl was used to transform the E. coli JbtuB mutant Ll-431 
(i.e. no plagues formed upon infection of transformants 
phage with BF23). The 2.0 Kb Hindlll insert of pSECl was 
subsequently recloned in the opposite orientation in pBR325 
by restriction of pSECl with HindllZ, followed by religation 
and transformation into E. coli DH1. The resultant plasmid 
was designated pSEC2 and the orientation of the insert 
confirmed by restriction analysis. Subsequent 
transformation and complementation analysis of the JbtuB 
lesion in Ll-431 (as described above) with pSEC2 gave the 
same result as for pSECl.
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The absence of plaques does not necessarily mean that the 
btuB lesion in E. coli Ll-431 was not complemented by the 
inserts contained within pSECl and pSEC2, since the binding 
protein in L. leichmannii may not be suitable as a receptor 
for phage BF23. This could be due to several reasons, for 
example, a BF23 binding domain may not be present on this 
smaller protein and if one does exist, the orientation of 
the receptor in the cell of Lactobacillus may be such that 
binding is not permitted. Another reason may be that phage 
BF23 cannot replicate in Lactobacillus, although it may 
infect the cell.
Other lesions in E. coli have been shown to be complemented 
by Lactobacillus genes; for example, the E. coli leuB 
mutation was complemented by a I., bulgaricus gene encoding a 
serine tRNA (Hottinger et al., 1987) and it is thought that 
the restoration of the mutant leuB allele occurred by 
missense suppression. Also, the Streptococcus pneumoniae 
polA gene can functionally substitute for the E. coli polh 
gene (López et al., 1987).
6.2.2 Purification of the Vitamin B12 binding protein from 
the cell walls of L . leichmannii.
A Vitamin B12 binding protein was isolated from the cell 
walls of L. leichmannii by treatment with 0.2 M HC1 and 
purified, as described in the Methods section 2.21. Owing
the bindingto the stabilising effect of Vitamin B12, 
protein was initially isolated as a B12-complex.
Figure 6.1 is a diagrammatic representation of the structure 
of the B12 binding protein complex in the cell walls of 
Lactobacillus sp. Sasaki and Kitahara (1964b) believed that 
B12 binds to the site where pepsin acts since, if B12 is 
bound to the wall, pepsin cannot release the B12 complex and 
therefore destroy the binding activity. That is, B12 
protects the B12-binding protein complex from the action of 
pepsin. However, they found that 0.2 M HC1 destroyed the 
B^2~binding activity of the wall since the Vitamin bound to 
the wall was also released by treatment with 0.2 M HCl, 
showing that 0.2 M HCl acts at some other point closer to 
the basal structure of the wall than the site upon which 
pepsin acts. Their view was confirmed by evidence that 
material released from walls by treatment with 0.2 M HCl 
could still bind B12, whilst that with pepsin could not. 
Lipase and ribonuclease have no significant effect on the 
B12-binding activity of the wall (Sasaki, 1972).
CM-cellulose column chromatography, using gradient elution 
with phosphate buffer was found by Kitahara and Sasaki 
(1963) to give the most satisfactory purification.
(Retention on CM-cellulose is characteristic of proteins 
with a net positive charge). As shown in Figure 6.2, the 
complex was eluted between fractions between 25 and 32. The 
B12 complex was purified by rechromatography and was 
subsequently concentrated by using a small column of CM-
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rl<mr« «.1 Representation ot the structure of the Dia- 
bindinq complex In the wtll-
♦ t
A dot represents one molecule of B12• Arrows indicate the 
sites where 0.2 M HC1 ( ) and pepsin ( »
respectively.
) acts,
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Figure 6.2 CM-cellulo»e column chromatography of the _Bir- 
oomplw of the cell w l l  from L. leichmannil 
1112-
A B12 complex solution in 0.01 M phosphate buffer (pH 7.0) 
containing 0.1 M NaCl (PBN). 200 ml with optical
densities : 280 nm = 1.44 and 361 nm = 0.62 was placed on a 
CM-cellulose column (1.5 by 20 cm) equilibrated with PBN. 
Elution was performed as described in Methods and Materials.
Symbols : optical density at 3 6i nm (-----) ,
at 2 8 0 nm (--- ) and concentration of phosphate
buffer (--- ).
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cellulose, followed by dialysis. This was electrophoresed 
through a polyacrylamide gel and yielded a diffuse band of 
low molecular mass, shown in Figure 6.3.
Resemblance of the absorption spectrum of the complex to 
that of B12, over the range of 330 nm to 560 nm (Figure 6.4) 
clearly indicates that the complex contained a 
cyanocobalamin molecule. Slight shifts of peaks around 361 
nm and 550 nm to shorter wavelengths was observed for the 
®12 complex. The increased peak at 278 nm of the B12 
complex indicates involvement of polypeptide(s) in this 
complex.
Sephadex G-75 equilibrated with PBN was used with a column 
of 1.5 x 84 cm. The B12 complex in the equilibration buffer 
(3 ml) was layered on the top and eluted. The elution 
profile was monitored with a Uvicord monitor at 280 nm. The 
void and total volumes were determined by using blue dextran 
2000 and B12 respectively. Pepsin, soybean trypsin 
inhibitor and cytochrome c were used as reference standards 
in molecular weight determination of the B^2 complex, as 
described by Andrews (1964). The B^2 complex eluted at a 
similar position to that of trypsin inhibitor (see Figure 
6.5), which suggests that the molecular weight of the B12 
complex was in the region of 21,500, which corresponds well 
with the value obtained by Sasaki (1972).
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Figure 6.3 Polyacrylamide gel electrophoresis of the
purified B1S complex of the cell vails from
L. leichmannii.
A B
6 7
Key to tracks
A Purified B12-complex after CM-cellulose chromatography.
B B12“comP^ex solution before CM-cellulose
chromatography.
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Figure 6.4 Absorption spectrum of the purified B1= complex
of the cell wall.
O D
Key:-
(------) B12 complex
( --------------- ) B12
Absorption spectra were recorded using a Beckman DU-70 
spectrophotometer.
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Figur« 6.5 Gel-filtration on sephaflex 9-7$ of 
b12 complex from the cell wall ot
L. leichmannii.
Fraction number
Key:-
A280
A361
BD Blue Dextran
P pepsin
TI Trypsin inhibitor
CC Cytochrome c
B12 free B12
the pyrified
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The free binding protein and not the B12 complex was 
required for the production of antibodies. Preparation of 
the free binding protein was achieved by dissociation of the 
Vitamin B12~binding protein complex. Grasbeck had found 
dissociation to occur at high pH (12.9). When the pH of the 
b12 complex solution was brought to pH 12.9 with Grësbeck's 
buffer, consisting of NaOH, glycine and NaCl (Grasbeck et 
al., 1968), by elution through a 2 x 30 cm Biogel P-10 
polyacrylamide column, the detached polypeptide and Vitamin 
B12 eluted separately from the column. The column had 
previously been calibrated so that the elution volumes for 
large and small volumes were known. To ensure rapid 
neutralisation, the eluate was collected in tubes containing 
0.5 M NaH2PQ4.
6.2.3 Antibody production.
Purified protein was administered to a New Zealand white 
rabbit, initially mixed with Freund's complete adjuvant, 
followed by two further administrations of protein mixed 
with Freund's incomplete adjuvant, and antisera obtained as 
detailed in Methods section 2.24. Antisera to the E . coli 
Vitamin B12 receptor protein (BtuB) was also made available 
(kind donation by J. Armstrong), which allowed some 
comparative analysis.
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A preparation of outer membranes of a BtuB+ strain, NFB362 
(harbouring the plasmid pNF48) was made and electrophoresed 
through an SDS-polyacrylamide gel, together with cell wall 
extracts from L. leichmannii. A duplicate gel was run and 
both were Western blotted onto nitrocellulose (Section 
2.25). Antisera raised against E. coli BtuB was used to 
probe one blot and antisera raised against L. leichmannii 
Vitamin B12 binding protein used to probe the other. 
Peroxidase conjugated goat anti-rabbit IgG was used as the 
secondary antibody and chloronaphthol (Sigma) as the colour 
reagent reaction. It appeared from Figure 6.6 that the 
antisera raised against the L. leichmannii B12 binding 
protein was able to detect the E. coli Vitamin B12 receptor 
(BtuB), shown quite clearly in (b). However, antisera 
raised against E. coli BtuB could only just detect the 
Lactobacillus B12-binding protein. This difference in 
specificity could be because the antisera raised against L. 
leichmannii B12 binding protein was still in a 'crude' form, 
whereas that raised against E. coli BtuB had been 
immunoabsorbed against a total E. coli extract to remove 
anti-£. coli antibodies and therefore non-specific detection 
of bacterial proteins was markedly reduced.
6.2.4 Expression of the cloned 2.0 Kb genomic DNA Hindlll 
fragment from L. leichmannii in an E. coli system.
There are many examples of Lactobacillus genes being 
efficiently expressed in E. coli; for example, 0-D-
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Figure 6.6 Western Blot Analysis.
a) Probed with antisera
raised against E. coli 
BtuB
b) Probed with antisera 
raised against 
L. leichmannii B12 
binding protein.
A B C
Key to tracks:
A L. leichmannii cell wall extract (40 Mg protein)
B L. leichmannii cell wall extract (20 Mg protein)
C E. coli NFB362 outer membrane (20 Mg protein)
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phosphogalactoside galactohydrolase gene from E. coli has 
been expressed as efficiently as that from E. coli itself 
(Lee et al., 1982); high expression (catalytically active) 
of the thymidylate synthase gene has been achieved from 
L. casei (Pinter et al., 1988); the 0-galactosidase gene 
from L. bulgaricus has been efficiently expressed (Schmidt 
et al., 1989) and the D-2-hydroxyisocaproate dehydrogenase 
gene (D-HiCDH) from L. casei (Lerch et al., 1989) also.
An in vitro cell free coupled transcription-translation 
system obtained in kit form (Amersham) was used to identify 
the protein products of the cloned 2.0 Kb Hindlll fragment 
from L . leichmannii genomic DNA. To reiterate from Chapter 
3, this method, first described by De Vries and Zubay (1967) 
allows the expression of genes contained on a bacterial 
plasmid provided that the relevant control signals are 
present for initiation of transcription and translation.
Out of the three putative open reading frames encoded by the
2.0 Kb fragment, only ORF 2 (a or b) and ORF 3 possessed the 
relevant control signals necessary for in vitro expression 
in the Zubays reactions. Both ORF 2a and ORF 3 had 
predicted Mrs of 17,388 and 17,792 respectively, whereas ORF 
2b had a predicted Mr of 23,013; none of which correspond to 
the value estimated by Sasaki (1972) or that obtained in 
these studies, which was in the region of 21,500. However, 
ORF 1 which is possibly incomplete, has no relevant control 
signals (Pribnow box, Shine-Dalgarno sequence) present 
upstream of the presumptive initiation codon, within the
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2.0 Kb tfindlll genomic fragment cloned from L . lelchmannii. 
However, transcription of ORF 1 could theoretically be 
possible if there was 'read through' from the tetracycline 
resistance gene promoter in pBR325. Normally this is 
inactivated when DNA is cloned into the Hindlll site. 
However, since the Hindlll site of pBR325 lies within the 
promoter region rather than within a structural gene, 
insertional inactivation depends on whether the cloned DNA 
carries a promoter-like sequence able to initiate 
transcription of the tetracycline resistance gene.
To determine whether any of the protein products, expressed 
by any of these putative coding regions, is indeed the 
Vitamin B12-binding protein from L. leichmannii, pSECl and 
pSEC2 were subjected to expression analysis and the 
resulting proteins electrophoresed in duplicate on 15% SDS- 
denaturing polyacrylamide gels, followed by Western blotting 
onto nitrocellulose. One blot was probed with antisera 
raised against E. coli BtuB and the other probed with 
antisera to the B12-binding protein from L. leichmannii. 
Again, the secondary antibody used was peroxidase conjugated 
goat anti-rabbit IgG and chloronaphthol as the colour 
reagent reaction. Figure 6.7 shows the Western blot 
analysis.
It appears that, although the banding patterns of the two 
probings appear to be different, unfortunately there does 
not seem to be any difference between the tracks on each 
blot. The detection of a Mr-66,400 polypeptide on track A
204
Figure 6.7 Western blot analysis of Zubays produced 
polypeptides.
a) Western blot probed 
with antisera raised 
against E. coli BtuB.
b) Western blot probed 
with antisera raised 
against L. leichmannii 
B12~binding protein.
A plasmid pNF48 (harbouring E . coli btuB gene)
B plasmid pSEC2
C plasmid pSECl
D plasmid pBR325
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when probed with antisera to E. coli BtuB was expected 
(positive control). Without this control, there is no way 
of determining whether a negative result is due to the fact 
that, none of the putative open-reading frames (ORF 2a, ORF 
2b or ORF 3) encode for the B12-binding protein from 
L. leichmannii or, that ORF 1 should encode the B^2-binding 
protein but does not, because it is not present in its 
entirety on the 2.0 Kb Hindlll genomic fragment, cloned from 
L. leichmannii and therefore does not possess the relevant 
control signals for transcription and translation.
Expression studies were also carried out, using E. coli 
maxicells (as described in Methods section 2.17.1).
However, it appeared that not enough protein was transferred 
and the detection system used was not sufficiently 
sensitive.
6.2.5 Expression of the cloned 2.0 Kb genomic DNA tfindlll 
fragment from L. leichmannii in a Gram-positive 
system.
Expression studies were attempted using the method described 
by Thomson et al. (1984), outlined in Section 2.17.3. This
method, although functional in Streptomyces lividans, did 
not appear to result in any de novo proteins being 
synthesised from the recombinant L. leichmannii DNA.
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6.3 summary and Overview.
The B12~binding protein from L. leichmannii was isolated and 
purified, in order to raise antibodies against it to use as 
a 'probe', for the identification of any gene products 
encoded by the putative open-reading frames, located on the 
cloned 2.0 Kb Nindlll genomic DNA fragment.
Cross-reactivity was found between the E. coli BtuB protein 
and the antisera raised against the L. leichmannii binding 
protein. Likewise, cross-reactivity was found between the 
L . leichmannii B12 binding protein and the antisera raised 
against the E. coli BtuB protein. This data suggests that a 
degree of homology exists between the two proteins.
The use of the antisera raised in these studies as a 
'probe', for the detection of the B12 binding protein, which 
may be encoded by any of the putative open-reading frames 
located on the cloned 2.0 Kb L. leichmannii DNA fragment, 
failed. No plasmid encoded protein were found to be 
expressed by the Gram-positive system used and those 
expressed in the Gram-negative system (Zubays) were not 
detected by the 'probe' used. The failure to detect a B^2 
binding protein by this method does not suggest that the B12 
binding protein was not encoded by any of the putative ORFs, 
but that the detection system used was not sensitive enough. 
The E. coli B12 receptor protein (BtuB) is expressed from a 
weak promoter and it may be that the amount of protein
f
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transferred to the nitrocellulose was not sufficient, to be 
detected.
In order to determine whether any of the putative ORFs do 
encode the B12-binding protein from L. leichmannii, it would 
now be necessary to obtain N-terminal amino acid sequence 
information from the B12 binding protein purified in these 
studies. A direct comparison could then be made between the 
amino acid sequence of the B12 binding protein from 
L . leichmannii and the nucleotide sequence derived-amino 
acid sequences of the putative ORFs located on the cloned
2.0 Kb L. leichmannii genomic DNA fragment.
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Chapter 7 Transformation of Lactobacillus leichmannii.
7.1 introduction.
The introduction of DNA into bacteria by transformation is 
an essential step in the construction of recombinant 
strains. Members of at least fifteen genera of bacteria are 
naturally competent (i.e. they can take up DNA and thus 
acquire new genetic traits); current knowledge of the 
natural DNA uptake process has been reviewed (Stewart & 
Carlson, 1985; Saunders et al., 1984). Without natural DNA 
uptake, an alternative means of transferring DNA into target 
cells, in order to perform genetic manipulation, must be 
found. In some cases, this task is simple; for example, the 
induction of 'pseudocompetence' in E. coli by pretreatment 
of cells with Ca2+ or other divalent metal ions (Hanahan, 
1983) . In other cases, extreme measures must be taken. One 
approach, used first for the transformation of certain 
Bacilli (Chang & Cohen, 1979) and Lactobacilli (Boizet et 
al., 1988; Morelli et al., 1987), is to remove the bacterial 
cell wall, which is thought to present a barrier to DNA, 
with lytic enzymes. Transforming DNA can then be introduced 
into the resulting 'protoplasts' by the action of a fusant, 
such as polyethylene glycol (PEG). Walls are then induced 
to reform on protoplasts by growing them on regeneration 
media. Such methods tend to take time to develop and 
perform and they are usually restricted in scope to the 
specific strain for which they were developed.
Recently the situation has changed radically. The technique 
of 'electroporation' - the formation of holes or pores in 
the cell membrane by high voltage electricity - has found 
widespread application. Unlike other methods of gene 
transfer (with the exception of microinjection or protoplast 
fusion), electroporation is a physical, rather than a 
biochemical technique and this probably accounts for its 
wide applicability. Table 1.8 (Chapter 1, page 56) reviews 
the bacteria including many Lactobacillus sp. that have been 
successfully electroporated, to date.
7.2 Experimental considerations.
For practical reasons, capacitor discharge circuits are most 
commonly employed to reproducibly deliver pulses of an 
intensity and duration suitable for electroporation. The 
pulse generator shown in Figure 7.1 generates an electric 
pulse characterised by an exponential decay waveform.
The parameters of central importance for bacterial 
electroporation are:-
(i) the initial electric field strength (EQ), and
(ii) the time constant (T) .
The electric field strength is the applied voltage divided 
by the distance between parallel electrodes in the sample 
chamber and can be adjusted, either by setting the voltage 
output of the power supply, or by using cuvettes with a
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Figure 7.1 Components of the Gene Pulser electroporation 
apparatus - as shown in part A.
(from Miller, 1988).
A capacitor ( )  is charged to the desired voltage when 
switch places it in series with the power supply. 
Discharge of the capacitor across the pulse controller and 
sample results in an electric field that decays 
exponentially as shown in part B. The rate of decay is 
inversely proportional to the time constant (T). T (in 
seconds) is defined as the product of the total resistance 
(Rf, in ohms) and capacitance (Clf in farads). T is also a 
measure of pulse duration and is equal to the time required 
for Eq (the initial electric field) to decline to EQ/e.
particular gap distance. The time constant is a measure of 
the duration of the discharge curve. As shown in Figure 
7.1, T is equal to the time required for the initial 
electric field (E0) to decay to approximately 37% of its 
original value.
Using data from a variety of bacterial systems, it is 
possible to draw some general conclusions concerning the 
electrical parameters important for electroporation. With 
short pulses, increases in field strength lead to increased 
transformation efficiency. Similarly, at low field 
strength, increased pulse lengths are usually beneficial.
In general, electric field strength and time constant have 
compensatory effects. Higher voltages require shorter time 
constants and longer pulses reduce the voltage requirement 
(Miller et al., 1988; Dower et al., 1988).
Experiments with E. coli have shown that the frequency of 
transformation depends on the DNA concentration; the yield 
of transformants is a product of this frequency and the 
number of cells present (Dower et al., 1988). Thus, high 
efficiency (tfs/^g) transformation of E. coli is partly due 
to the use of very concentrated cell preparations 
(4 x 1010 ml-1) and small volumes (40 nl), thereby 
maintaining a high DNA concentration. These conditions are 
likely to be useful for Lactobacillus sp.
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Little information is available on the effects of plasmid 
size and topology on electroporation efficiency and a clear 
cut relationship between plasmid size and transformation by 
electroporation has not been observed. Large plasmids, 
exceeding 25 Kb, have been efficiently introduced into 
Lactobacillus and Streptococcus species (Chassy &
Flickinger, 1987; Labigne-Roussel et al., 1987). DNA 
molecules introduced into cells by electroporation appear to 
be intact and free of rearrangements.
The cell surfaces of Gram-positive and Gram-negative 
bacteria are complex structures that must be traversed by 
transforming DNA. Gram-positive organisms surround their 
cytoplasmic membrane with a thick, rigid, highly cross- 
linked peptidoglycan cell wall, and this appears to present 
a partial barrier to incoming DNA. Although S. lactis and 
L. casei have been electroporated at efficiencies ranging 
from 104 to 105 tfs/^g, transformation of the former species 
is increased several-hundred fold by mild treatment of the 
cells with lysozyme (Powell et al., 1988). This may be a 
general technique useful for Lactobacillus sp.
It has been seen that cells harvested in the early to mid­
exponential growth phase are generally optimal for 
electroporation (Miller et al., 1988; Powell et al., 1988; 
Taketo, 1988; Labigne-Roussel, 1987), although variable 
responses have been reported.
Finally, components of the electroporation medium have a 
pronounced effect on the efficiency of transformation.
Ionic strength, osmolarity, pH and other parameters may 
require adjustment for optimal effects on survival and 
efficiency. Therefore, an investigation of parameters 
influencing the frequency of transformation of Lactobacillus 
leichmannii was carried out. Parameters evaluated were; 
voltage, DNA concentration, type of buffer and buffer 
strength.
7.3 Experimental details.
Cells for electroporation were propagated in MRS media 
(Oxoid) and harvested at an A 6 0 q  =  0.7 (approximately 
4 x 107 CFU ml-1). Electroporation of L. leichmannii was 
carried out using a 'Gene Pulser'™, supplied by Bio-Rad 
Laboratories U.S.A., set at 25 nF. Electrode gaps of either 
0.4 cm or 0.2 cm were used, providing field strengths of up 
to 6.25 KVcm-1 and 12.5 KVcm-1 respectively. When the 0.2 
cm cuvettes were used the output of the pulse generator was 
directed through a Pulse Controller unit (Bio-Rad) 
containing a high power, 20 0 resistor in series with the 
sample, and a selection of resistors of 100 to 1000 0 in 
parallel with the sample. The effective resistance placed 
in parallel with the electrodes is much lower than that of 
the sample and determines the time constant of the pulse.
The pulse controller was set at 200 0 for these studies.
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7.3.1 0.4 cm electrode gap.
800 ¿il of cells were transferred to a cold 1.5 ml 
polypropylene tube, 0.5-1 /ig DNA solution (in a low ionic 
strength medium; TE) was added, the suspension mixed 
vigorously and left on ice for 10 mins. The cell/DNA 
mixture was placed between the chilled electrodes, the 
cuvette placed in the safety chamber and the appropriate 
pulse applied. Following the pulse, the cells were left on 
ice for a further ten minutes. Cells were appropriately 
diluted and plated onto selective MRS agar to screen for 
transformants.
7.3.2 0.2 cm electrode gap.
Only 40 /il of cells were used and there was no chilling on 
ice before and after electroporation. Following the pulse, 
960 /il of MRS media was added to the cells and selective 
agar used to screen for transformants.
In both cases, after dilution of the cells, the samples were 
incubated for 1 hour at 37°C to allow for expression of 
antibiotic resistance genes. Transformation efficiency was 
calculated as CFV/ng of plasmid DNA added. Dilutions were 
plated on non-selective agar to assess cell survival. 
Transformation frequency was calculated as 
transformants/survivors.
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7.4 Results and Discussion.
7.4.1 Transformation by electroporation with plasmid DNA.
The vectors pSA3 (Dao & Ferretti, 1985), pC194 (Horinouchi & 
Weisblum, 1982) and pCKl (Gasson & Anderson, 1985), but not 
pAM£l (LeBlanc & Lee, 1984) transformed L. leichmannii to 
chloramphenicol resistance by electroporation. Plasmid DNA 
was isolated from transformants (as described in Section 
2.6.1) and analysed by agarose gel electrophoresis 
(Figure 7.2). Restriction enzyme analysis confirmed the 
pSA3, pC194 and pCKl restriction patterns of the 'new' 
plasmids appearing in the transformed L. leichmannii (data 
not shown).
7.4.2 Effect of voltage on survival and transformation.
Variation of voltage had an effect on both survival and 
transformation efficiency and freguency. As can be seen in 
Table 7.1, at 2500 Vcm-1, 83% of the starting CFU count was 
recovered and the transformation frequency and efficiency 
were low. Increasing the voltage to 6250 Vcm-1 raised the 
efficiency and frequency, while slightly lowering the 
survival to 68%. Again, increasing the voltage to 7500 Vcm 1 
raised the efficiency and frequency and the survival rate 
dropped to 50%. Higher voltages resulted in higher survival 
CFU scores but no transformants were observed. Chassy and 
Flickinger (1987) found this same phenomenon with voltages
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Figur# 7.? Agarose gel electrophores of plasmids isolated 
from L. leichmannii 4797.
Plasmid DNA was isolated from L. leichmannii transformed 
with the vectors pSA3, pC194 and pCKl separately and 
electrophoresed through a 1% agarose gel.
Key to tracks:-
A pCKl transforming DNA
B pCKl transformant DNA
C pC194 transforming DNA
D pC194 transformant DNA
E pSA3 transforming DNA
F pSA3 transformant DNA
G A Hindlll DNA markers
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DNA Voltage
(KVcm-1)
% Survival 
CFUrec x 100
Frequency
CFUobs
Efficiency
CFUobs
CFUtot CFUrec pg DNA
pAM01 2.50 _ - -
5.00 - - -
6.25 - - -
7.50 - - -
10.00 - - -
12.50
CFUtot = total colony forming units used in the electroporation
experiment, as determined by dilution and plating on MRS 
agar plates.
CFUrec = colony forming units recovered after electroporation,
dilution and plating.
CFU0j3S = colony forming units observed as antibiotic resistant on
selective plates. Equals total number of cells 
transformed by electroporation.
of 6750 Vcm-1 and above with L. casei. They suggested this 
may be due to electroporation-induced 'dechaining' of L. 
cas&i cells, rather than a net increase in the number of 
viable cells.
7.4.3 Effect of DNA concentration.
To determine the effect of DNA concentration, different 
concentrations of pC194 were mixed with L. leichmannii 4797 
and electroporated. As shown in Figure 7.3, the total 
number of transformants increased progressively from 0.1 to 
5 nq. Transformants were not recovered if pC194 was not 
added to cells or if the cell—DNA mixture was plated prior 
to delivery of the electric pulse. The transformation 
efficiency, however, was greatest using 2 /¿g total DNA, even 
though the total number of transformants continued to 
increase with increasing concentrations of pC194.
7.4 ,.A Effect .of buffer type.
Electroporation was carried out with three different 
Electroporation buffers. ' HEB' = 7 mM N-2-hydroxy- 
ethylpiperazine-N'-2-ethanesulfonic acid (HEPES), pH 7.4;
272 mM sucrose, 1 mM MgCl2. 'PEB': 7 mM Potassium 
phosphate, pH 7.4, 1 mM MgCl2, 272 mM sucrose. ' EB': 10% 
glucose, after washes in distilled water. The lower- 
resistance buffer (PEB) generated time constants (decay time 
from peak voltage to approximately 37% of peak voltage)
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Tlcrure 7.3 The effect of pC194 DNA concentration on the
nnmhflr of transformants of L. leichmannii 4797.
pg D N A
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ranging from 3-5.3 msec and the higher-resistance buffer 
(HEB) produced time constants ranging from 5.3-14.4 msec.
7.4.5 Effect of buffer strength.
The effect of varying the buffer strength on transformation 
frequency is shown in Figure 7.4. Both HEB and PEB yielded 
more transformants at buffer strengths greater than IX. The 
best buffer concentrations for HEB (1.25X) and PEB (1.75X) 
resulted in approximately the same frequency of 
transformation.
7.5 summary and Overview.
Electroporation has become increasingly popular as a tool 
for transforming bacterial cells. Although it is much 
simpler and faster than previous transformation methods 
using such chemicals as CaCl2 (Hanahan, 1983) and 
polyethylene glycol (Kondo & McKay, 1984), reported 
electroporation efficiencies have been quite variable for 
bacteria, ranging from 0 to 109 transformants per nq of DNA.
This study has dealt with several parameters; final 
concentrations of cells have been suspended in a variety of 
buffers and buffer strengths, pulsed at field strengths 
ranging from 2.5 to 12.5 KVcm-1 and with a range of DNA 
concentrations. The capacitance (25 nF) and resistance
Figure 7.4 Transformation frequency as a function of 
buffer strength.
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Buffer strengths (x-fold) were obtained by proportionally 
increasing or decreasing all buffer components in HEB or 
PEB. Transformation frequencies obtained with L. 
leichmannii 4797 using HEB (A) and PEB (O).
Buffer strength ( x - f o ld )
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(200 Cl) were kept constant, since these particular values 
have been used in several successful bacterial 
electroporations to date.
The factors most likely to affect 'electrotransform-ability' 
of a bacterium are the membrane composition and the wall 
thickness, density and structure. Gram-positive bacteria 
have denser and thicker cell walls than Gram-negative 
bacteria, and, in general, Gram-negative strains 
electroporate more efficiently. Limited digestion of the 
cell wall with lysozyme has been shown to increase 
transformation efficiencies several-hundred fold (Powell et 
al. , 1988) and this technique may be required to increase 
the transformation frequencies of L. leichmannii. Another 
factor, which may help in increasing the frequency is growth 
of the cells in the presence of glycine (Haynes & Britz, 
1989).
However, to summarise briefly, cells of L. leichmannii were 
transformed to chloramphenicol resistance by the vectors 
pSA3, pC194 and pCKl at efficiencies of 0.05 - 2.8 x 102 
transformants per ng DNA. Approximately 50% of the CFU 
survived pulses of 7.5 KVcm-1 at 25 nF, conditions found to 
be optimal for the transformation process. Plasmid DNAs 
isolated from pSA3, pC194 and pCKl transformants were 
indistinguishable from authentic preparations, by gel 
electrophoresis.

Chapter 8 General Conclusions and Outloolc.
8.1 f l u m m a r y  of the Main Results.
The initial aims of this project included the isolation and 
cloning of a gene encoding the Vitamin B12 binding protein 
from Lactobacillus leichmannii, followed by expression 
analysis of the cloned gene and the determination of its 
nucleotide sequence.
L. leichmannii genomic DNA sequences bearing homology to the 
gene encoding the Vitamin B12 receptor protein in E. coli 
(btuB) were thought to have been cloned into a high copy 
number vector, pBR327, using a heterologous hybridisation 
approach. Expression analysis, using both in vivo and in 
vitro systems appeared to confirm this and the data 
indicated that the protein encoded by the cloned fragment 
had the same molecular mass as the BtuB protein of E. coli. 
However, problems were encountered throughout, with the 
clumping of cells in liquid culture and the spurious results 
obtained with restriction endonuclease mapping, which 
suggested that the recombinants obtained, pSDCl and pSDC2 
contained DNA which had possibly undergone re-arrangements 
and/or deletions. It appeared that a cross-over event had 
occurred between the E. coli HB101 host strain and the 
cloned L. leichmannii DNA, resulting in pSDCl and pSDC2 
containing the E. coli btuB gene and not any homologous 
sequences from L. leichmannii. This theory was confirmed by
the data generated from the initiation of nucleotide 
sequencing of the 2.0 Kb DNA insert.
Different high and low copy number vectors were used, in an 
attempt to clone DNA sequences homologous to the synthetic 
mixed oligonucleotide probe (derived from the E. coli btuB 
gene), since it was subsequently determined that the B12 
binding protein in L. leichmannii was only a third of the 
size of that in E. coli. A 2.0 Kb Hindlll L. leichmannii 
genomic DNA fragment was subsequently cloned into pBR325, 
where it was found to be stably maintained and had not 
undergone any re-arrangements during the cloning procedure. 
Nucleotide sequence data revealed three putative open- 
reading frames, one of which was variable in length. The 
first putative open-reading frame (ORF 1) was probably not 
complete as the presumptive initiator codon (ATG) may encode 
an internal methionine and the true initiator codon could be 
located further upstream on the L. leichmannii genome. This 
fact remains to be elucidated and would require further 
cloning and sequencing work to be carried out. The data 
generated from the nucleotide sequence of ORF 1 suggests 
that a degree of homology exists between the C-terminus of 
the E . coli btuB gene and the C-terminus of ORF 1 at the 
amino acid level, which looks very promising since, Moir et 
a l . (1987) presented evidence that the C-terminus was
responsible for the binding of the Vitamin.
The functions of ORF 2 and ORF 3 remain to be elucidated.
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The cloned L. leichmannii 2.0 Kb genomic DNA insert was 
subjected to expression analysis. It was shown not to 
complement the jbfcuB lesion in E. coli Ll-431, although this 
may be due to the inability of phage BF23 to undergo 
replication in L. leichmannii. A way of testing for this 
would be to radiolabel the phage to determine whether the 
phage can attach to the cell, i.e. if the B12 binding 
protein in L. leichmannii can act as a receptor for phage 
BF23, as does BtuB in E. coli.
The B-^-binding protein was purified from the cell walls of 
L. leichmannii and polyclonal antibodies raised to it. In 
theory, this antisera could then be used as a 'probe' to 
detect the polypeptides encoded by the cloned L. leichmannii 
2.0 Kb genomic DNA fragment by means of an in vitro 
expression system. However, on analysis, it appeared that 
the peroxidase-conjugated system used did not have the 
sensitivity desired. It is known that the BtuB protein in 
E. coli is expressed by a weak promoter and therefore the 
protein transferred to the nitrocellulose filter was not 
present in sufficient amounts to be detected by the Western 
blot analysis system used.
To achieve the final aims of this project, it was necessary 
to develop a transformation system for L. leichmannii that 
was rapid and easy to perform. Electroporation - the 
technique of introducing transient holes or pores in the 
membranes of cells, to allow DNA molecules to enter - is 
fast becoming a generalised method for the transformation of
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bacteria, although some bacteria still remain refractory to 
it.
Three plasmid vectors; pSA3 (Dao & Ferreti, 1985) which has 
previously been shown to replicate in Lactobacilli, pC194 
(Horinouchi & Weisblum, 1982) and pCKl (Gasson & Anderson, 
1985) were found to transform L. leichmannii 4797 to 
chloramphenicol resistance by electroporation although the 
frequency of transformation observed was low. The method 
now requires optimisation. A range of electrical field 
strengths had the most marked effect on the efficiency of 
transformation, which was to be expected. This result paves 
the way for future molecular genetics with L. leichmannii.
8.2 Future work.
One of the main aims not achieved within the duration of 
this project was the site-specific mutagenesis of the gene 
encoding the B12 binding protein in L. leichmannii. This 
would have enabled the specificity of a particular strain to 
be altered so that several strains of L. leichmannii would 
be specific to each of the different cobalamin analogues. 
However, it can be seen from these studies that much of the 
ground work has been carried out. Cloning of a larger 
L . leichmannii genomic DNA insert, containing the whole of 
ORF 1 would be necessary initially. Nucleotide sequence 
derived-amino acid sequence of ORF 1 could be compared to 
the N-terminal amino acid sequence data and site-specific 
mutagenesis of the gene achieved by the substitution of
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synthetic oligonucleotides. Results could be evaluated by 
growth of the L. leichmannii strain harbouring the modified 
gene (introduced by electroporation) in the presence of 
different cobalamins. Since L. leichmannii requires B12 to 
grow, evaluation would require only simple absorbance 
measurements.
These studies have reached a very interesting point and 
further work along the lines suggested could result in a new 
and exciting challenge to the Vitamin B^2 deficiency assay 
system in current use.
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